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List of abbreviations  
 
16-BAC, 16-benzyldimethyl-n-hexadecylammonium chloride  
2D-DIGE, two-dimensional fluorescence difference gel electrophoresis  
2DE or 2-DE, two-dimensional electrophoresis 
AhR, aryl hydrocarbon receptor 
AL1L1, aldehyde dehydrogenase family 1 member L1 
ANOVA, analysis of variation 
BFR, brominated flame retardant 
BN–PAGE, Blue native PAGE 
CBB, Coomassie Brilliant Blue 
CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate 
CTAB, cetyltrimethylammonium bromide 
CYP, cytochrome P450 
DTT, dithiothreitol 
ESI, electrospray ionization 
ET, euthyroid 
ETFB, electron transfer flavoprotein subunit beta 
f, female 
FSH, follicle-stimulating hormone 
GO, Gene Ontology 
GST, glutathione-S-transferase 
HBCD, hexabromocyclododecane 
HMG-CoA, hydroxymethyl-glutaryl-CoA 
HT, hypothyroid 
ICAT, isotope coded affinity tagging 
ICPL, isotope coded protein label 
IEF, isoelectric focusing 
IMAC, immobilized metal affinity chromatography 
IPG, immobilized pH-gradient 
iTRAQ, isobaric tags for relative and absolute quantitation 
KEGG, Kyoto Encyclopedia of Genes and Genomes  
LC, liquid chromatography 
LH, luteinizing hormone 
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m, male 
M2GD, mitochondrial dimethylglycine dehydrogenase 
MALDI, matrix assisted laser desorption ionization 
MIAPE, minimum information about a proteomic experiment 
Mr, molecular weight 
MS, mass spectrometry 
PAGE, polyacrylamide gel electrophoresis 
PBDE, polybrominated diphenylether 
PCB, polychlorinated biphenyl 
PCR, polymerase chain reaction 
PHAH, polyhalogenated aromatic hydrocarbon 
pI, isoelectric point  
PMF, peptide mass fingerprint 
PON, paraoxonase/arylesterase 
RIA, radioimmunoassay 
RuBP, ruthenium(II) tris(bathophenanthroline disulfonate 
SDS, sodium dodecyl sulfate 
SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SELDI, Surface-enhanced laser desorption/ionization 
SEM, standard error of the mean 
SILAC, stable isotope labeling by amino acids in cell culture 
SRM, selected reactions monitoring 
STRING, functional protein association networks  
T3, triiodothyronine 
T4, thyroxine, 
TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin 
TH, thyroid hormone 
TMT, tandem mass tags 
TOF, time of flight 
TSH, thyroid stimulating hormone 
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General introduction 
 
Proteomics 
 
Definition 
Proteomics aims at analysing the whole set of proteins (the “proteome”) present in a 
complex specimen (body fluid, cell, tissue) at defined conditions within one analysis. The 
proteome is not constant in its composition, but influenced by multiple factors like age, 
gender, hormonal and health status, and environment. Over the years, different strategies 
have developed to determine its complexity and to study abundance of hundreds to 
thousands of proteins in one experiment. This allows detection of yet unknown protein 
changes and pathways related to disease/treatment/exposure [Lottspeich and Zorbas, 
1998; Anderson and Anderson, 1998].  
 
Proteomic methods 
All proteomic methods have in common that a complex protein mixture is separated in 
multiple steps to single out proteins (or peptides) for detection, identification and 
quantification. During the last 20-30 years, these methods have become more and more 
refined, more complex, adapted to diverse molecule properties, and more sensitive.  
Presently there are two main types of proteomic approaches: gel-based (applying two-
dimensional electrophoresis, 2-DE [Rabilloud et al., 2010; Rogowska-Wrzesinska et al., 
2013; Oliveira et al., 2014]) or gel-free (using multi-dimensional liquid chromatography, 
LC [Liu et al., 2013; Altelaar and Heck, 2012; Zhang et al., 2013]), both together with 
protein identification by mass spectrometry (MS). Steps of the different approaches are 
illustrated in Figure 1: red lines for two-dimensional electrophoresis, gel-free or MS-
based (usually in combination with different LC-steps) in blue, or a combination of one-
dimensional electrophoresis and (LC-)MS, in green. 
Another difference between gel-based and gel-free proteomics is also displayed in the 
figure: electrophoretic systems separate intact proteins and resulting electrophoretic 
patterns are used for quantification and for search of proteins of different abundance. 
Only then protein spots (from 2-DE gels) or bands (from 1-DE) of interest are collected 
directly from the gels, proteins digested with specific enzymes and identified by MS-
methods. In contrast, gel-free methods usually start with a digestion step and only then 
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separate (usually by high-resolution multi-dimensional chromatography), quantify and 
identify the peptides or proteins from which they derive, respectively. 
 
Figure 1: Proteomic workflow. Gel-based approach in red (two-dimensional electrophoresis, 2-DE), gel-
free in blue (liquid chromatography, LC). Separation on one-dimensional electrophoresis gels (1-DE, in 
green) is also possible, often combined with LC on the peptide level, to achieve sufficient resolution. 
 
Proteins are identified based on their peptide patterns obtained after cleavage with an 
enzyme, usually trypsin, which cuts proteins at specific sites of the amino acid chains. 
Each protein gives a typical fragmentation pattern under standard conditions, and after 
mass-based MS-separation its peptides can be determined and the protein identified by 
comparison of its peptide mass pattern with dedicated databases.  
As soon as a set of proteins is known which change abundance under particular 
conditions, pathway analysis with specific web-based databases may be undertaken to 
find out more about the proteins, their biological functions and cellular locations in the 
body as well as their interactions. This allows further interpretation of collected data.  
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The present work is based on 2-DE, and Figure 2 gives an example of such a proteomic 
workflow. In a first step, the sample (e.g. rat liver homogenized in an appropriate buffer) 
is separated in a pH-gradient, in which proteins focus as sharp zones according to their 
charge (isoelectric point) [Westermeier, 2001]. A subsequent orthogonal separation is 
performed in an SDS-PAGE gel (polyacrylamide gel electrophoresis in the presence of 
sodium dodecyl sulfate) [Laemmli, 1970] where proteins migrate based on their 
molecular mass. In classical 2-DE, protein patterns are visualized with colorimetric 
stains. There is a more modern variety, 2D-DIGE (two-dimensional fluorescence 
difference gel electrophoresis), which works with fluorophores [Uenlue et al., 1997; 
Marouga et al., 2005]. Three different mass- and charge-matched cyanine dyes exist and 
are used to label protein samples before undertaking the electrophoresis step. In this way, 
on each gel two different specimens and an internal standard may be applied. After 2-DE 
separation, images for each single dye and sample are captured with a fluorescence 
scanner and single spot intensities evaluated with specifically developed software. The 
internal standard facilitates gel comparison and increases the reproducibility of the 
analyses [Alban et al., 2003]. This allows filtering the whole protein spot set for 
differentially abundant proteins, based on statistical criteria (minimum spot abundance 
change, P-value) and selection of spots of interest for MS-identification (steps 
highlighted in light green in the figure). Successful protein identification is the basis for 
pathway analysis and data interpretation together with result from other assays or 
determinations (e.g. animal data, hormone concentrations, etc.). 
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Figure 2: Design of a proteomic experiment. Example for workflow in a gel-based proteomic approach 
with 2D-DIGE, similar to the one used in this thesis. 
Abbreviations: CyDyes, fluorophores for protein labeling; IPG, immobilized pH-gradients for first 
dimensional separation; MALDI-TOF/TOF, matrix assisted laser desorption ionization-time of flight, a 
variety of MS.  
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Proteomics to study toxicological questions 
Proteomics is nowadays widely used in different fields related to health and disease (for 
humans and meanwhile also animals), research and diagnosis [Thibault and Gingras, 
2015; Eckersall et al., 2012], but still underrepresented in environmental / ecotoxicology 
research. Only recently, interest in this technique is growing [Nesatyy and Suter, 2007; 
Miller et al., 2016]. Proteomic methods have in common that they are holistic and non-
targeted, investigating all proteins detectable in an analytical system and not specifically 
a few that had been preselected by induction based on previous results. Thus, proteomic 
methods are able to detect not yet known to be affected or still little explored proteins and 
to relate them to specific pathways. In this way proteomics may help to reveal new or 
clarify ill understood mechanisms of actions of different toxic compounds.  
A candidate compound for proteomic study is hexabromocyclododecane (HBCD), 
because its mechanism of action is confusing and ill understood.  
 
 
HBCD 
 
The compound 
HBCD (C12H18Br6) is a brominated aromatic compound with six bromines bound in the 
molecule, resulting in 16 possible stereo-isomers. Technical products contain three main 
diastereomers (HBCD) besides traces of others (Figure 3).  
 
 
Figure 3. Structures of the main isomers that are present in the technical product of HBCD:  (left),  
(middle) and  (right) HBCD [Alaee et al., 2003]. 
 
In organisms, the different isomers are processed in a different way, the -HBCD isomer 
being retained the most in nature [Covaci et al., 2006; European Commission, 2008]. In 
contrast, in animal feeding experiments, the isomer detected is mainly HBCD, but 
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accumulation may differ in long-term chronic exposure and experiments whose length 
did not exceed four weeks at maximum [van der Ven et al., 2006]. 
 
HBCD and its industrial use 
Till 2013 HBCD has been used as a major brominated flame retardant (BFR), applied to 
prevent buildings and equipment from catching fire. The large global application of 
BFRs has led to increasing contamination in the environment as these substances are 
persistent, lipophilic and accumulate in biota [De Wit, 2002; Darnerud, 2003; Kiciński et 
al., 2012; Kalachova et al., 2012; Tomko and McDonald, 2013] and are shown to act as 
endocrine disrupters [Tomko and McDonald, 2013; Law et al., 2008; Covaci et al., 
2006]. Earlier bans or withdrawals of other BFRs [Law et al., 2008] have led to a sharp 
increase of environmental HBCD concentrations, but reports about toxic effects, 
persistency and accumulation resulted in a ban in 2013 by many industrial countries 
(Stockholm convention, https://treaties.un.org /doc/Publication/CN/2013/ CN.934.2013-
Eng.pdf). However, HBCD is still produced and applied in non-European countries, e.g. 
in the US. 
 
HBCD and its known effects 
HBCD is persistent and accumulates in animals and humans via the food chain, 
especially in adipose tissue [Covaci et al., 2006]. BFRs have been shown to interfere with 
several hormone systems, and also for HBCD animal studies indicate toxicological 
effects, especially in the liver and on the thyroid hormones [Cantón et al., 2008; Germer 
et al., 2006; van der Ven et al., 2006], though with a low acute toxicity. The thyroid 
hormone (TH) disruptive potencies shown in vivo cannot be related to a TH mimicking 
molecular structure, therefore the mechanism of action is expected to be indirect. This is 
supported by the fact that HBCD has been shown to enhance the effects of TH in vitro 
and ex vivo [Schriks et al., 2006; 2007].  
Previous in vivo experiments with Wistar rats exposed to high dosages (up to 100-200 mg 
HBCD/kg body weight/day during 4 weeks) showed for instance increased immuno-
histological staining of thyroid stimulating hormone (TSH) in the female pituitary, 
induction of T4-glucuronyl transferase and increased levels of different cytochromes as 
well as changes in the lipid metabolism [Cantón et al., 2008; van der Ven et al., 2006]. 
The responses in male and female animals were different, with females being more 
sensitive to HBCD exposure [Cantón et al., 2008]. All animals used in these experiments 
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had a normal thyroid hormone status, while in the human population also hypo- and 
hyperthyroid hormone levels occur regularly [Diez et al., 2003; Wilson et al., 2012]. A 
change in thyroid state is expected to increase the stress on the thyroid hormone 
homeostasis and influence the reaction to HBCD.  
 
Up to now, knowledge on HBCD effects has been collected from toxicological and 
developmental animal studies, hormonal data (ELISA, RIA), gene regulation data (PCR), 
or single protein determinations [Cantón et al., 2008; Germer et al., 2006; van der Ven et 
al., 2006]. Compared to transcriptomics, proteomic studies have the advantage to target 
the proteins, the actual players at a specific site, and gene and protein regulation are 
known to not always go in parallel [Greenbaum et al., 2003; Tian et al., 2004]. Only a 
few previous proteomic studies investigate effects of HBCD, either alone or in 
combination with other BRFs in vitro on isolated liver cells or in vivo on complete 
organs, mainly in zebrafish [Kling et al., 2008; Kling and Förlin, 2009]. No comparable 
studies have been performed in rats or other mammals.  
 
The still considerable use and production outside of Europe, environmental persistence 
and accumulation in food chains, and the not completely understood mechanism of action 
of HBCD made us undertake the present short-term exposure study in combination with 
applying the holistic approach of proteomics.  
 
 
This thesis 
 
The aim of the present work is to evaluate the use of proteomics in toxicological research 
by applying it for studying the influence of HBCD on the liver proteome of female and 
male rats exposed to sub-lethal doses of this compound for one week. 
 
Liver was chosen as sample, as it is the main detoxifying and protein synthesizing organ 
and one of the first tissues exposed to HBCD after oral uptake. It is also an example to 
evaluate the usefulness of gel-based proteomics in the field of environmental proteomics. 
 
Previously performed in vivo research with rats has indicated complex effects [van der 
Ven et al., 2006] that cannot yet be explained based on known mechanisms of action. 
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Therefore the present project follows a proteomic approach to study liver protein changes 
in global protein distribution in a non-targeted way followed by pathway analysis. 
Liver samples have been obtained in a previous study with short term exposure of eu- 
(ET) and hypothyroid (HT) female and male rats to lower HBCD levels (7 days; 0, 3, 30 
mg HBCD/kg body weight/day). The liver proteome was analysed by modern gel-based 
proteomic methods (comprising 2D-DIGE followed by protein identification with the 
help of mass spectrometric methods). Results were compared with data from thyroid 
hormones, dietary and reproduction related hormones, and put into a toxicological 
context. Proteins found changed in abundance were further analyzed and data interpreted 
by pathway analyses. 
These findings were put into context of the proteomic methods applied, of proteomic 
investigations involving other toxic organic compounds (endocrine disrupters), and 
compared to monitoring variability of protein pattern in rat serum. 
 
 
The following research questions have been defined: 
 
1) What are the possibilities and strategies in proteomics as a tool to study sub-lethal 
toxicological effects of compounds with a long term effect? 
2) Is it possible to see changes in the rat liver proteome in sub-lethal and short-term 
exposure to HBCD, by using a modern gel-based proteomic method?  
3) Which liver proteins and pathways are influenced by short term exposure to HBCD in 
euthyroid versus hypothyroid animals? 
4) What is the impact of gender on the liver proteome? 
5) Is gender reflected in serum protein composition and what implications does this have 
on the search for biomarkers? 
 
 
Thesis outline 
 
Firstly Chapter 2 provides more information about possibilities and strategies in gel-
based proteomics. It describes the workflow including different options/strategies 
depending on the sample type to investigate and sample pretreatment. 
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A more detailed overview on the application and the additional benefit of proteomic 
methods in toxicological investigations is given in Chapter 3, exemplified on the 
compound groups dioxins, polychlorinated biphenyls (PCBs), and polybrominated 
diphenyl ethers (PBDEs).  
 
Chapter 4 investigates pattern changes in the liver proteome of eu- and hypothyroid 
female rats which underwent short-time exposure with HBCD. The results with female 
rats are compared to a similar experiment in male rats as detailed in Chapter 5, revealing 
clear gender differences.  
 
In Chapter 6 gender related differences are studied in the serum proteome of rats under 
control conditions or during inflammation. 
 
The potential role of proteomic methods and the relevance of the gender-specific findings 
in rats with or without exposure to HBCD are summarized and discussed in Chapter 7. 
Future perspectives give an outlook on next steps to be taken to deepen/extend and 
confirm the present results.  
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 3  Protein Separation Strategies 
 Ingrid  Miller 
 3.1  Introduction 
 Proteomics aims at simultaneous analysis of complex protein mixtures. 
Contrary to protein analysis, it is not (primarily) interested in characterization 
or quantifi cation of single proteins. Proteomic investigations mainly rely on 
protein patterns, and protein identifi cation is achieved only at a later time. 
Therefore, proteomic strategies aim at high - resolution methods, usually two - 
or multidimensional, to provide a good overview on protein composition. 
Nowadays, there are two main types of proteomic workfl ow: (1) one approach 
relying on two - dimensional gel electrophoretic (2DE) separations of the 
sample, followed by appropriate detection, evaluation (including statistical 
analysis), and identifi cation of possibly interesting protein spots, and (2) the 
other approach taking advantage of mass spectrometric (MS) methods, usually 
in combination with one - or multidimensional liquid chromatography, after 
enzymatic or chemical cleavage of the protein specimen (see Chapter  2 for 
more details). The present chapter will focus on 2DE and associated protein 
separation strategies illustrating the numerous methodological possibilities 
this method can offer. The aim is to address the question,  “ What is possible; 
how is it possible? ” rather than,  “ What has been done in the animal proteomic 
fi eld? ” (which is covered elsewhere in this volume). 
 Therefore, the examples cited do not always concern animal applications, 
but try to illustrate methodology in an optimal way. 
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 3.2  “ Classical ” 2 DE 
 3.2.1  The Method 
 The term  “ (high - resolution) 2DE ” is nowadays used for the specifi c combina-
tion of fi rst - dimension isoelectric focusing (IEF) and second - dimension 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS - PAGE). 
Thus, two different properties of the protein determine its position on the gel, 
the isoelectric point (pI) and the molecular weight (Mr). IEF is performed in 
the presence of denaturing and reducing agents, to inhibit protein interactions, 
that is, split protein complexes into single components and complex proteins 
into their subunits. The method was fi rst described almost at the same time 
by O ’ Farrell ( 1975 ) and Klose ( 1975 ). At that time, the pH gradient for sepa-
ration in IEF was established by carrier ampholytes and usually performed 
in tube gels. Later on, immobilized pH gradient (IPG) methodology was 
developed (Bjellqvist et al.,  1982 ; Gianazza and Righetti,  2009 ), which 
allowed more stable pH gradients in thin - layer horizontal gels. Over the years, 
2DE methodology has become more refi ned in relation to separation range, 
resolution, and protein detection, until arriving at the present high - level 
(SWISS - 2D PAGE database,  http://us.expasy.org/ch2d/protocols/ ; G ö rg et al., 
 2000 ). It has become an established and widely used technique; precast gels 
are commercially available, in different types and sizes, together with ready -
 made reagents and kits to help the whole procedure. 
 The present standard protocols comprise several steps:
 1.  First dimension: IPG single strips of 0.5  mm thickness, a few milli-
meter width, and variable length are rehydrated to contain 8  M 
urea, 0.5% (w/v) CHAPS (3 - [(3 - Cholamidopropyl)dimethylammonio] - 
1 - propanesulfonate) as a zwitterionic detergent and 0.5% (v/v) carrier 
ampholytes, both to enhance protein solubilization especially of mem-
brane proteins, and 0.2% (w/v) dithiothreitol (DTT) as a reducing 
agent. Alternatively, instead of urea alone a mixture of 7  M urea and 
2  M thiourea is often used for cell or tissue lysates, as this mix has 
proven benefi cial for solubilization of membrane proteins or proteins 
tending to precipitate around their pI (Rabilloud et al.,  1997 ; Molloy, 
 2000 ). Samples are applied and focusing is performed until the optimal 
amount of volt hours is reached (for additional technical consider-
ations see Section  3.2.3.3 ). The strips are either immediately used or 
stored frozen at  − 20 ° C or  − 80 ° C. 
 2.  Equilibration: IPG strips are incubated in two different portions of tris 
HCl buffer with additional urea, SDS and glycerol, the fi rst containing 
DTT for protein reduction, the second iodoacetamide for alkylation. 
Concentrations may vary slightly, but formulations are mostly based 
on the methods outlined in the paper by G ö rg et al. ( 2000 ). 
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 3.  Second dimension: The equilibrated IPG strip is transferred on top 
of an SDS - PAGE gel of variable concentration and cross - linking (gra-
dient or homogeneous gel), with or without stacking gel. Protocols 
used are mainly based on the classical Laemmli system (Laemmli, 
 1970 ). 
 4.  Detection: As appropriate (see later Sections  3.5 and  3.6 ). 
 3.2.2  Applications 
 A typical 2DE experiment of an unknown or little characterized sample will 
usually start with a standard protocol, wide range IPGs, and SDS - PAGE gels 
with appropriate concentration for an average Mr range. This approach will 
help to get an overview of the distribution of the protein spots in the respec-
tive sample and to decide about further optimization of the separation system. 
 There are two main strategies that have been applied when investigating 
new samples or sample types: (1) After optimizing the separation system, the 
fi rst strategy aims at establishing spot maps and at identifying as many spots 
as possible (usually the ones with high to medium abundance or spots that 
seem characteristic of the sample). Once established, these protein identifi ca-
tion maps are universal tools for any kind of further investigations. (2) The 
second approach focuses from the very beginning on a comparison of differ-
ent samples (e.g., healthy/diseased animals, treated/untreated cells) and is 
only interested in spot pattern differences. After careful evaluation by quan-
tifi cation (including statistics) differentially regulated protein spots are 
selected for identifi cation. Nowadays, the second approach is usually pre-
ferred; it is indeed valuable when one specifi c question has to be addressed, 
in high - resolution patterns with a large number of spots, and with MS methods 
for spot identifi cation (where differentially regulated spots are cut out from 
the gel and further analyzed). Although MS procedures are also essential for 
protein identifi cation maps, Western blotting or other specifi c detection 
methods may be equally helpful (see also Section  3.5.2 ). 
 Proteomic investigation of animal - derived samples started quite soon after 
the initial techniques were developed, for example, in a paper comparing 2DE 
patterns of bovine and human milk (Anderson et al.,  1982 ). 
 Although 2DE protein patterns and main proteins of, for example, serum, 
seem comparable between species, homologous proteins may differ in physi-
cochemical parameters (pI, Mr) and/or concentration, while species - specifi c 
proteins have been found. Figure  3.1 a illustrates all these effects in serum 
samples of a few randomly selected species: goat (A), horse (B), pig (C), and 
dog (D). Two proteins, albumin (marked with  “ 1 ” ) and the  ß - chain of hapto-
globin (marked with  “ 2 ” ), an acute phase protein in most animal species, are 
indicated. Although homologous and present in all samples, they are localized 
at different positions on the gels. In contrast, haptoglobin levels of healthy 
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cows are below the detection limit of 2DE (if using unfractionated serum) 
and the  ß - chain is only found in infl ammatory states (Wait et al.,  2002 ). 
 Findings like these have been the reason for setting up reference maps for 
each species, such as for cat ( Felis silvestris ; Miller and Gemeiner,  1992 ), 
cow ( Bos taurus ; Wait et al.,  2002 ), horse ( Equus caballus ; Miller et al., 
 2004a ), and pig ( Sus scrofa ; Miller et al.,  2009 ). Most of these studies inves-
tigate not only the serum pattern of healthy animals, but also changes occur-
ring under specifi c conditions, such as infl ammation or pregnancy (Cairoli 
et al.,  2006 ). For laboratory animals like rat ( Rattus norvegicus ; a series of 
papers starting with Haynes et al.,  1998 ) and mouse ( Mus musculus ; Duan 
et al.,  2004 ; Wait et al.,  2005b ), more detailed studies exist, including follow -
 up studies of drug treatment (Eberini et al.,  2000 ; Gianazza et al.,  2002 ), as 
these species are often used as animal models for human diseases. 
 More reference patterns, some with clickable maps, can be found on 
WORLD - 2DPAGE ( http://www.expasy.org/ch2d/2d - index.html ), although 
the majority are from human or laboratory animal specimens of different 
types. There are also compilations of, for example, different cow organs and 
cells (Talamo et al.,  2003 ; D ’ Ambrosio et al.,  2005 ) and heart proteins of 
dogs, rats, and humans (HSC - 2DPAGE at Harefi eld Hospital,  http://www.doc.
ic.ac.uk/vip/hsc - 2dpage/ ). 
 As mentioned earlier, differential regulation and comparison of at least two 
different states is an often used proteomic approach; Figure  3.1 b,c show 
typical examples. Serum protein patterns of a control rat and of an animal 
with acute infl ammation differ in (up - and down - ) regulation of a number of 
proteins, depending on the stimulus, resulting in acute and chronic infl amma-
tion (Fig.  3.1 b; for more details see Eberini et al.,  2000 ; Sironi et al.,  2001 ; 
Gianazza et al.,  2002 ). 
 Exposure of male chubs ( Leuciscus cephalus ) to water contaminated with 
estrogenes or endocrine - disrupting chemicals leads to expression of moderate 
to high levels of serum vitellogenin (Flammarion et al.,  2000 ; Grillitsch et 
al.,  2003 ). It is detectable in the serum of exposed male chubs as different 
fragments (Fig.  3.1 c; Kanaya et al.,  2000 ). Vitellogenin is the major egg yolk 
 Fig. 3.1 (Left)  Classical 2DE as a global approach, with serum as an example. Ten centimeter - long 
IPGs in the range of pH 4 – 10 (nonlinear gradient), SDS - PAGE on gradient gels (10% – 15%) of 
14  ×  14  cm, silver stain; 0.5  μ L of each serum sample was applied. (a) Comparison of serum protein 
patterns of different animal species. Sera have been obtained from clinically healthy animals: 
(A) goat, (B) horse, (C) pig, (D) dog. Two proteins are indicated: (1) serum albumin, (2) haptoglobin 
 β - chain. (b) Comparison of two different states: changes due to infl ammation. Left image: serum of 
a male control rat (Sprague Dawley); right image: serum of a male rat with acute infl ammation (Miller 
et al.,  1999 ). (c) Comparison of two different states: changes due to exposure to chemicals. Left 
image: serum of a healthy male chub ( Leuciscus cephalus ); right image: serum of a male chub that 
had been exposed to bisphenol A - contaminated surface water. 
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protein and is typically found only in the serum of female fi sh, with seasonal 
changes. 
 3.2.3  Modifi cations 
 The standard methods are usually able to give a good global view of the 
proteome of the respective sample, for example, to show the overall pI and 
Mr distribution of the proteins, the range with the components of highest/
lowest concentration, and sometimes also gel areas with largest variation. 
Based on this overview the initial 2DE protocol may be adapted to the specifi c 
needs of the sample. 
 Table  3.1 gives an overview of the individual 2DE steps and their possible 
modifi cations leading to moderate or profound changes in methodology. 
These possible changes in the protocols will be further discussed in following 
sections. 
 3.2.3.1  First Dimension  IEF allows selection of the pH gradient according 
to one ’ s needs, and over the years appropriate protocols have been developed. 
 Table 3.1  Possible variation in single steps 
 Steps  Procedure  Variation 
 Sample  Sample preparation 
 Pretreatment 
 Prefractionation 
 Body fl uids: dilution to appropriate concentration 
(choice of diluent) 
 Tissues: solubilization (complete or sequential/
differential) 
 Detergents, labeling 
 For example, chromatography, electrophoresis, 
affi nity methods 
 First dimension  IEF/IPG 
 Others (native 
PAGE, BN - PAGE) 
 Conditions: native, unfolding, reducing; additives 
 Change in pI range 
 Change in matrix (agarose) 
 Equilibration   
 Second dimension  Zone electrophoresis  SDS - PAGE, native PAGE; additives (DTT, BAC) 
 Change in Mr range 
 Detection  Staining  Overall protein 
 Specifi c (glyco - , phospho - ; zymograms), for 
post - detection 
 Immunoreagents 
 Post - detection  MS, evaluation  
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In IPGs, the charge - bearing acrylamide derivatives (Immobilines ™ [GE 
Healthcare Life Sciences, Munich, Germany], acrylamidobuffers ™ [Fluka, 
Buchs, Switzerland], etc.) that form the pH gradient are polymerized into the 
gel. There are commercially available gels or strips, but gels can also be lab -
 made. Different types of pH ranges and gradient shapes are possible: wide or 
ultrawide pH ranges (Gianazza et al.,  1989 ), narrow ranges of just a few 
selected pH units, or even ultra - narrow  “ zoom ” gels of less than one pH unit 
(Hoving et al.,  2000 ). Also, the shape of the obtained pH curve may be 
adapted to the specifi c needs: linear gradients for samples with even protein 
distribution over the whole pH range, or a nonlinear shape for specimens like 
serum and related biological fl uids. Otherwise, for the latter the pH range 
4.5 – 6 is rather crowded with many high - to medium - abundance proteins 
focusing within this range (Gianazza et al.,  1985 , see also Fig.  3.1 b). Narrow 
pH gradients allow a more specifi c look at the selected area, so that low - copy 
proteins are more clearly seen or a higher resolution of otherwise crowded 
areas is caught. Due to its higher spatial resolution this approach may reveal 
previously undetected protein spots or additional isoforms (Westbrook et al., 
 2001 ). If sample amount is not limited, narrow - range IPGs can help to avoid 
prefractionation (and possible alteration of the sample due to this step), when 
 “ unwanted ” proteins migrate out of the gel and collect at the electrode strips, 
whereas proteins of interest concentrate and focus at their pIs. 
 Figure  3.2 compares separation of a commercially available pig immuno-
globulin G (IgG) preparation in a nonlinear pH 4 – 10 and a linear pH 6 – 10 
gradient. In particular, the more alkaline spots are better resolved in the less 
steep pH 6 – 10 gradient. Furthermore, the clustered light and heavy chains of 
IgG can be seen as spot chains or single spots, which may be either IgG 
 Fig. 3.2  Classical 2DE in different pH ranges. (A) IPG pH 4 – 10 (nonlinear gradient). (B) IPG pH 
6 – 10 (linear); SDS - PAGE and silver staining as in Figure  3.1 . Sample: purifi ed pig IgG (Accurate 
Chemical  & Scientifi c Corporation, Westbury, NY). 
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breakdown products or minor contaminants of the preparation. This also 
highlights the versatility of 2DE for product control. 
 Approaches with varying pH ranges have been described for human 
lymphoma samples (Hoving et al.,  2000 ) and heart proteins (with partially 
overlapping pH ranges, Westbrook et al.,  2001 ), and also for mouse serum 
proteins in the pH ranges 3 – 6 and 5 – 8, which were used to study changes 
due to burn injuries or due to lipopolysaccharide - induced acute - phase response 
(Duan et al.,  2004 ). Separation of the acidic protein  α 1 - acid glycoprotein in 
a pH 2.5 – 5 gradient was also shown in a pig serum protein map in addition 
to the normal pH 4 – 10 nonlinear gradient (Miller et al.,  2009 ). 
 3.2.3.2  Second Dimension  2DE can also be varied in the second dimension, 
depending on the expected Mr range of the proteins to separate. The most 
often used parameter for adaptation is the T value (the percentage of acryl-
amide plus bisacrylamide). Slabs can be cast either as homogeneous gels or 
as gradient gels, usually in the range of 8% to 15% T. Gradient gels give a 
higher resolution and sharper spots as the pore size decreases during the 
migration of the proteins. Some additional resolution may be gained with 
slightly prolonged runs, provided the buffer capacity is high enough (Fig. 
 3.1 b). Use of a stacking gel with lower cross - linking is not obligatory. In 
addition to the standard Laemmli buffer system (Laemmli,  1970 ), a tris -
 tricine buffer system has been suggested, allowing protein separation in the 
range of 1 – 100  kDa, so that smaller molecules can be better resolved than 
with the usual method (Sch ä gger and von Jagow,  1987 ). In the original recipe 
the gel consists of a small - pore separation gel (16% T), a spacer (10% T), 
and a stacking gel (4% T). A taurine buffer system has also been suggested 
to obtain a wider Mr range (2.5 – 250  kDa) (Tastet et al.,  2003b ). Commercial 
gels are available for several electrophoresis chambers, but with a buffer 
composition different from the original Laemmli system. Gels thus have a 
longer shelf life but protein separation patterns might be different. 
 3.2.3.3  Technical Considerations  Discussions on different possibilities in 
2DE also have to take into account technical considerations and equipment. 
At present, the most used setup is a combination of IPG strips run in a hori-
zontal chamber and of vertical SDS - PAGE. At the inception of 2DE, second -
 dimension SDS - PAGE was also performed in horizontal gels (G ö rg et al., 
 1985 ), but vertical gels offer several advantages: protein transfer from the 
fi rst to the second dimension is easier; SDS - PAGE gels can have a thickness 
up to 1.5  mm allowing higher protein loads; multiple gels can be run in 
parallel in the same electrophoresis chamber. Another important technical 
point is the question of strip rehydration and sample application. IPGs are 
usually processed as dry strips, even if they are lab - made; as it is not easy to 
cast IPG gels containing denaturing/reducing additives, plain gels with the 
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appropriate pH gradient are polymerized, washed and dried, and when 
required rehydrated in the appropriate solutions. Strips are either reswollen 
to the original thickness in cassettes similar to the polymerization chamber, 
in the presence of excess solution, or the exact amount of liquid is applied in 
a groove of a reswelling tray and the dry strip is placed onto it, gel - side down. 
Both incubation procedures take between a few hours to overnight. Samples 
may be applied in different ways: mixed into the rehydration solution from 
which they are supposed to be absorbed into the complete strip ( “ in - gel rehy-
dration ” ; Rabilloud et al.,  1994 ) or applied onto the already rehydrated strip 
via cup loading (in small sample cups) or on fi lter paper pads. In - gel rehydra-
tion may be benefi cial for dilute or even salt - containing samples, but it takes 
hours for larger proteins to diffuse into the strips. Therefore, active reswelling 
may be supported by low voltage (G ö rg et al.,  1999 ). Sample loading via cups 
or fi lter pieces allows selective application at an appropriate pH, which is 
favorable for labile proteins. The pros and cons of the methods have been 
discussed in detail (Westermeier and Naven,  2002 ). Protein patterns may 
change due to different sample treatment and application (some examples are 
given in Wait et al.,  2005a ). In addition, sample application may be one of 
the steps that is most prone to give rise to protein losses (sometimes also 
selectively; for an estimation on protein losses in 2DE see Zuo and Speicher, 
 2000 and Zhou et al.,  2005 ). Sample application is followed by the fi rst -
 dimension run, performed either gel - side up or down, depending on the 
electrophoresis chamber. Strips may be protected from drying out and from 
oxidation by a cover fl uid (paraffi n oil). The length of the run depends on 
strip length, pH range, and sample type, and is usually given in kVh. Focused 
strips may be stored frozen (at  − 20 ° C or  − 80 ° C). 
 3.3  Other Varieties of 2 DE 
 3.3.1  Different Additives and Separation Conditions 
 Protein classes with specifi c properties (e.g., hydrophobic or alkaline pro-
teins) need adaptations to the 2DE systems that are larger than the ones 
described in the previous section. 
 3.3.1.1  Detergents  Detergents in combination with the denaturants urea 
and thiourea usually help to dissolve membrane proteins if they are not too 
hydrophobic. Nevertheless, it has been found that in most cases membrane 
proteins are underrepresented in the 2DE patterns (Rabilloud et al.,  2008 ), 
especially in semi - preparative gels. Nonionic or zwitterionic detergents like 
CHAPS help to solubilize proteins by interaction, but are not supposed to 
change the surface charge and the electrophoretic mobility of the respective 
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proteins. In addition to the formerly used Triton X - 100 and Nonidet P - 40, 
several other detergents have been synthesized and tested for their suitability 
to improve solubility of membrane proteins. These include linear sulfobeta-
ines, amidosulfobetaines, or dodecylmaltoside (Rabilloud et al.,  2008 ). 
Although some systematic studies exist (Tastet et al.,  2003a ), the effi ciency 
of detergents is best tested empirically; selection will not only depend on the 
specifi c sample type but also on the question that needs to be addressed with 
2DE. Changing the detergent in the separation system (e.g., solubilization 
plus IPG run) may have a large impact on the spot patterns. This has been 
shown for instance for human red blood cell ghosts (Luche et al.,  2003 ). 
Approaches for membrane protein separations other than classical 2DE will 
be discussed in Section  3.3.2 . 
 3.3.1.2  Reducing Agents and Alkaline Proteins  The formerly used volatile 
and intensely smelling reducing agent  β - mercaptoethanol has nowadays been 
replaced by dithiothreitol (DTT) for most applications. DTT works very well 
in acidic, neutral, and slightly alkaline pH ranges. Being a weak acid, it 
becomes ionized above pH 8 and migrates toward the anode. Without further 
precautions, the alkaline region becomes more and more depleted of reducing 
agents and inadequately protected cysteines may be reoxidized under these 
conditions. This phenomenon is seen on the gel as horizontal streaks of basic 
spots. Tributylphosphine has been proposed as an alternative (introduced by 
Herbert et al.,  1998 ), usually with an additional alkylation step with iodoacet-
amide, as it is poorly stable (Herbert et al.,  2001 ). Unfortunately, complete 
alkylation of all proteins in a mixture is not easy to control and, furthermore, 
pIs of basic proteins become modifi ed upon reaction. The use of organic 
disulfi des like hydroxyethyldisulfi de (HED) has also been suggested (Olsson 
et al.,  2002 ), as they form mixed disulfi des upon oxidation of the protein 
cysteinyl groups. HED can be used in combination with DTT and is able to 
maintain reducing conditions during the complete course of the fi rst - dimension 
separation, even in alkaline pH ranges. 
 There are several precautions that should be taken when separating alkaline 
proteins in wide - range IPGs, and more importantly in narrow - range alkaline 
strips. IPGs should be run under paraffi n oil protection to avoid oxidation; 
additionally, this oil may be degassed and fl ushed with argon. Samples should 
be applied anodically by cup loading to avoid longer exposure to alkaline pIs. 
Alkaline IPGs need less Vh than wider pH ranges, and overfocusing also 
results in streaking. It has been recommended that dimethylacrylamide is used 
in place of acrylamide and that up to 16% isopropanol and/or methylcellulose 
is included in the gel to suppress reverse electroosmotic fl ow (water transport 
to the anode) (G ö rg et al.,  1997 ). Depletion of DTT during the run can be 
reduced with higher DTT starting concentrations in the gel and additional 
electrode pads soaked in DTT (Hoving et al.,  2002 ). Taking into account all 
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these measures, even histones with pI of up to 12 can be focused with good 
quality (Righetti et al.,  1996 ; G ö rg et al.,  1997 ). 
 3.3.1.3  Redox Options  Reducing agents such as DTT break disulfi de bonds 
and turn them into sulfhydryl groups. This concerns intra - as well as inter-
chain disulfi de bonds and, in the presence of chaotropes, leads to destruction 
of secondary and tertiary structure (unfolding), and — for proteins consisting 
of more than one chain — to the destruction of quaternary structure (dissocia-
tion of the molecule into subunits). If reduction of the sample is omitted and 
proteins are only exposed to SDS, the quaternary structure is not destroyed 
and unfolding of the proteins is only partial. Properties of the proteins, includ-
ing apparent Mr and pI, are in this case closer to that of the native protein, 
but these shifts very much depend on the protein and its particular structure. 
This effect can be utilized in 2DE for separation of proteins that show similar 
properties in classical 2DE (found as close spots/spot chains in crowded 
regions on the 2DE gels). This approach can be used instead of, or in com-
bination with, the strategies described in Section  3.2.3 . Examples have been 
reported for mouse serum (fi g. 2 of Wait et al.,  2005b ), where better separa-
tion of  α 1 - antitrypsin, serum protease inhibitor,  α 2 - HS - glycoprotein, and 
group - specifi c component can be achieved using nonreducing gels. This 
approach is similarly benefi cial for acidic bovine proteins in pH range 4 – 6 
(Cairoli et al.,  2006 ) and thus allows more exact follow - up of single - protein 
levels during gravidity. Theoretical and practical aspects of this redox 
approach have been detailed in Wait et al. ( 2005a ), and illustrated by exam-
ples of human, mouse, rat, and cow serum protein patterns. 
 Proteins consisting of a single polypeptide chain usually show small to 
moderate pI and Mr shifts due to reducing/nonreducing treatment. Well -
 known examples are albumin (lower pI without reduction, at the same time 
an apparent Mr of about 55  kDa instead of 68  kDa) and transferrin (Wait et 
al.,  2005a ). Both proteins have a considerable number of intra - chain disulfi de 
bonds. The described shifts are demonstrated in Figure  3.3 a (compare images 
A2/A3, B3/B4). Changes in multimeric proteins are even more pronounced: 
native homodimers are about twice as large as their monomers, whereas 1D 
SDS - PAGE single bands of heterodimers upon DTT treatment are split into 
more than one band with lower Mr. Examples of multimeric proteins are the 
Igs: the main representatives — IgG, IgA, IgM — each consist of two light and 
two heavy chains connected via disulfi de bonds, and, depending on the Ig 
class, they exist as mono - , di - , or pentamers. They are responsible for primary 
and secondary immune response and host defense, but can also be a sign of 
a plasma cell tumor. In the latter case they appear as monoclonal antibodies, 
all produced as identical replicates of one specifi c molecule produced by only 
one replicating cell clone. They give a typical electrophoretic pattern with 
very distinct spots/spot chains, especially the Ig light chains. Image A1 in 
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Figure  3.3 a shows the serum protein pattern of a dog with lymphoma; the 
monoclonal light (indicated with L - ) and heavy chain (type IgG) can be 
clearly distinguished using classical reducing/denaturing 2DE. For diagnosis 
it is often interesting to learn about the presence of Bence Jones proteins (free 
monoclonal light chains) or complete monoclonal Ig. Bence Jones proteinuria 
is a sign of spillover of excess free monoclonal light chains, whereas the 
appearance of intact Ig marks the beginning of renal damage, which often 
develops in the course of gammopathies. The urinary protein pattern corre-
sponding to the canine patient in image A1 is depicted in image A2. This 
specimen also reveals the two chains of the monoclonal antibody in reductive 
 Fig. 3.3  Nonclassical 2DE (2DE under different conditions). (a) Reduction or not: detection of 
single chains and subunits. Case study of a dog with monoclonal gammopathy (IgG): the IgG subunits, 
light (L) and heavy ( γ ) chains, were detected under reducing conditions in serum (A1) and urine (A2); 
nonreducing 2DE revealed that in the urine free light chains (as dimers, L - L) and complete IgG were 
present (A3). (b) Infl uence of denaturation and reduction: the pattern of rabbit milk. Conditions as 
indicated below the images; gels B1 – B3 were stained with Coomassie R - 250 (milk volumes applied: 
10  μ L in B1, 4  μ L in B2 and B3), gel B4 with silver (0.2  μ L milk, heated in the presence of DTT and 
SDS). Notice the shift of the two indicated proteins: albumin (1) and transferrin (2); SDS - PAGE gels 
are aligned according to Mr. 
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testing. When omitting DTT in 2DE (image A3, otherwise same sample), one 
can easily discern intact monoclonal Ig and some free light chains (in this 
case present as a dimer). Two other examples for dogs with monoclonal dis-
orders, chronic lymphatic leukemia and plasmacytoma, and differing Ig pat-
terns have been previously discussed (Miller et al.,  2004b ). All these examples 
show that the nonreducing pattern is most useful for the study of complex 
intact molecules versus asynchronous production of single chains (which in 
addition may have a different degree of polymerization). 
 3.3.1.4  Denaturing versus Native 2 DE  The native structure of a protein is 
determined by its sequence, but is only observed in appropriate environments. 
A protein in solution may exist as a mixture of interconverting conformations, 
in different isomeric forms, or as aggregates, or complexes with other proteins 
or small molecules. Changing the solvent conditions by adding chaotropes 
usually leads to loss of structure, accompanied by loss of biological activity 
(denaturation) and dissociation of molecular assemblies. The presence of high 
concentrations of reagents such as urea leads to an unfolding of proteins and 
exposure of groups otherwise buried inside the molecule. Thus, protein prop-
erties may change considerably, depending on the studied protein. 2DE can 
also be performed under native conditions, when in all separation steps urea, 
SDS, and reducing agents are omitted. The patterns obtained look quite dif-
ferent, for instance, for bovine adult and fetal serum (Manabe et al.,  1987 ), 
compared with classical 2DE patterns of adult bovine serum (Wait et al., 
 2002 ) . Native 2DE has the advantage that proteins retain their biological 
function, thus making it possible to apply enzymatic staining for the identi-
fi cation of particular proteins. This has been described for the detection of 
esterases and transferases in cytosol of bovine retina (Shimazaki et al.,  2004a ) 
or dehydrogenases in mouse liver (Shimazaki et al.,  2004b ). In addition, using 
immunodetection after native 2DE, antibodies with specifi city for conforma-
tional epitopes can be applied. A series of immunoblots with different specifi c 
antibodies has been used for the identifi cation of bovine serum/plasma pro-
teins (Manabe et al.,  1987 ). 
 Manabe et al. ( 1999 ) have suggested performing 2DE series with increas-
ing degree of denaturation/reduction to gather systematic information on 
proteins and their constituent polypeptides. The group has shown a series of 
2DE images obtained with human serum as a sample and IEF with carrier 
ampholytes in the fi rst dimension. Similar results have been obtained with 
pig serum (own unpublished results). The following four types of separations 
have been suggested:
 •  type I: non - denaturing IEF and native PAGE; this type refl ects physi-
ological conditions. 
 •  type II: non - denaturing IEF and SDS - PAGE; this combination allows 
studying dissociation of noncovalently bound protein subunits. 
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 •  type III: non - denaturing IEF and reducing SDS - PAGE (with urea and 
DTT in the intermediate equilibration step); disulfi de - bonded polypep-
tides are dissociated during equilibration. 
 •  type IV: classical 2DE (denaturing/reducing IEF and SDS - PAGE). 
 For the described types I – III the pI distribution of the serum proteins does 
not change; only differences in Mr due to dissociation of subunits and aggre-
gates are noticed, resulting usually in more, smaller fragments. Between type 
III and IV there is a noticable pI shift due to inclusion of denaturing and 
reducing agents, but less change in Mr. 
 A similar series of separations is shown in Figure  3.3 b, but using IPGs for 
the focusing step and a slightly different combination of running conditions: 
rabbit milk has been separated using native 2DE (image B1), non - denaturing 
IPG/SDS - PAGE without reduction (image B2), denaturing IPG/SDS - PAGE 
(both dimensions without reduction, image B3), and classical 2DE (image 
B4). Images B2 – B4 are aligned with reference to Mr. Two proteins, albumin 
(1) and transferrin (2) are marked throughout the series to illustrate their shifts 
as a function of separation conditions. 
 3.3.2  Combination of Other Media or Separation Methods 
 3.3.2.1  IEF in Agarose  High Mr proteins may not be appropriately sepa-
rated in IPGs or well transferred to the second - dimension gel, especially as 
solubility of most proteins decreases at their pIs. One possibility to overcome 
this limitation is performing IEF in agarose gels, a matrix that has much larger 
pores than polyacrylamide. Agarose IEF (with carrier ampholytes mixed into 
the gel) can also be performed under denaturing conditions, in the presence 
of 5  M urea and 1  M thiourea and with an SDS - PAGE step in the second 
dimension (Oh - Ishi and Maeda,  2002 ). The method has been applied to tissue 
extracts and in the study of different diseases, for example, cancer and endo-
crine disorders (Oh - Ishi and Maeda,  2007 ). 
 3.3.2.2  Zone Electrophoresis in Agarose  The fi rst dimension of 2DE need 
not always be IEF. Zone electrophoresis offers a wide variety of possibilities 
for separation under native conditions, as pH, ionic strength, and buffer ions 
may be selected for the specifi c separation task. In a series of older papers 
the genetic polymorphism of several serum proteins was studied by a com-
bination of zone electrophoresis under different conditions: The fi rst dimen-
sion was performed in the non - sieving matrix agarose, usually at low pH (e.g., 
5.0 or 5.4), and the second dimension in alkaline 12% PAGE. Gels were 
stained with Coomassie, but also specifi cally for enzymatic activity. This 
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setup has been applied to study Pi ( α 1 - antitrypsin) phenotypes in horse (Juneja 
et al.,  1979 ) and cattle (Juneja and Gahne,  1980 ), as well as to other poly-
morphic horse serum proteins (with agarose electrophoresis at higher pH in 
the fi rst dimension; Juneja et al.,  1984 ). 
 3.3.2.3  Diagonal Electrophoresis  Proteins of a complex mixture may also 
be separated by SDS - PAGE in a 2D manner, using the Mr as a separation 
criterion in both dimensions. As in classical 2DE, a lane/gel strip from a fi rst -
 dimension run is laid on top of a second SDS gel and electrophoresis is 
performed perpendicular to the fi rst dimension. With identical runs in both 
dimensions, proteins align as spots in a diagonal. By introducing minor 
changes in one of the dimensions, deviations from this pattern are generated 
and may give hints concerning the composition of the sample mixture and 
the structure of the separated proteins. Using gels of different cross - linking 
or pore size may cause changes in behavior of anomalously migrating SDS -
 protein complexes (e.g., glycoproteins, highly basic or hydrophobic proteins) 
due to sieving effects. Protein reduction between fi rst and second dimension 
gives information about intra - or inter - subunit disulfi de bonds (see scheme in 
Wait et al.,  2005a ). Urea infl uences the folding and SDS binding of the pro-
teins, while the introduction of other buffer ions (glycine, tricine, bicine) 
affects the mobility of the protein zones (Braun et al.,  2007 ). Further diver-
sity is achieved by inclusion of cationic detergents such as 16 - benzyldimethyl -
 n - hexadecylammonium chloride (16 - BAC; Hartinger et al.,  1996 ) or 
cetyltrimethylammonium bromide (CTAB; Akins et al.,  1992 ). These deter-
gents proved particularly benefi cial for integral membrane proteins with 
more than one transmembrane domain, but need fi rst - dimension separations 
at low pH where proteins migrate to the cathode (Hartinger et al.,  1996 ). 
For the very alkaline histones an acetic acid – urea (AU) or AU triton 
X - 100 (AUT) system has been developed, which allows separation of histone 
species or variants. AU may be combined with a second - dimension run in a 
gel containing a nonionic detergent (Lubrol - WX) that also produces diagonal 
electrophoresis - like patterns (Bhatnagar and Bellv é ,  1978 ). AU or AUT can 
also be used as a fi rst or second dimension of SDS - PAGE, either with equili-
bration alone or with staining of the fi rst - dimension lane between the runs 
(Davie,  1982 ). Both approaches allow further differentiation of histone 
modifi cations. 
 3.3.2.4  Blue Native ( BN - )  PAGE and Clear Native ( CN - )  PAGE  Most of the 
described approaches denature the protein sample, by addition of either strong 
detergents or chaotropes. BN - PAGE uses milder conditions than classical 
2DE and this allows the study of protein complexes, giving insight into the 
interaction of proteins in the cell. The specifi c features of BN - PAGE are mild 
detergents (triton X - 100, dodecylmaltoside, digitonin), separation at pH 7.5, 
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6 - aminocaproic acid as non - detergent zwitterionic compound to enhance 
solubilization, and inclusion of the blue dye Coomassie Brilliant Blue G - 250 
(CBB G) in the cathodic electrophoresis buffer (Wittig and Sch ä gger,  2008 ). 
Protein complexes are separated according to size, and gradient gels of dif-
ferent pore size may be used. During the electrophoretic run, blue bands of 
stained proteins/protein complexes are visible; separation can be followed, 
and there is no need for further staining that may lead to damage of proteins 
or to loss of small molecules. CBB G causes a negative charge shift of the 
proteins; it remains tightly bound to the proteins and membrane proteins are 
thus converted to water - soluble proteins. Subsequent to separation, BN - PAGE 
allows in - gel measurements of enzyme activity by histological staining as 
well as isolation of membrane protein complexes in enzymatically active 
form (e.g., by electroelution) (Sch ä gger and von Jagow,  1991 ). In a second 
dimension the complexes may be resolved into individual polypeptides by 
SDS - PAGE (Brookes et al.,  2002 ). The fi rst samples studied, and still a very 
prominent application, were mitochondria from different species, namely, the 
fi ve mitochondrial respiratory subcomplexes that separate nicely in a pore -
 size gradient. The single complexes were isolated with around 95% purity, 
and enriched up to 20 - fold (Wittig and Sch ä gger,  2008 ). After a denaturing 
second - dimension SDS - PAGE their component subunits were identifi ed by 
immunoblotting and MS. This combination of methods allows the establish-
ment not only of an  “ inventory ” of the mitochondrial subproteome but also 
of the ability to monitor changes due to treatment, for example, with the 
protein synthesis inhibitor chloramphenicol (Brookes et al.,  2002 ). Further 
refi nements of the method have been suggested, for instance, the use of 
agarose in the fi rst dimension, which makes it possible to analyze protein 
complexes up to 8  MDa (Nijtmans et al.,  2002 ). 
 Clear (or colorless) native PAGE uses the same protein solubilization con-
ditions and buffers as BN - PAGE, but without CBB G in the sample and 
cathode buffer. It is not a charge shift technique; it fully relies on the intrinsic 
charge of the molecules. Thus, in contrast to BN - PAGE, proteins with alkaline 
pI migrate to the cathode and are lost, and membrane proteins often tend to 
give smearing bands. CN - PAGE is the mildest electrophoretic technique and 
allows analysis of physiological supramolecular structures. Lately, there have 
been attempts to introduce charge shift induced by noncolored mixed micelles 
of neutral or anionic detergent in the cathode buffer, but this modifi ed method 
is not as mild as CN - PAGE and favors dissociation of labile subunits from 
protein complexes (Wittig et al.,  2007 ). 
 Refi ned setups also exist for 2D separation combining two runs of BN -
 PAGE with different detergents. Disruption of supramolecular structures into 
smaller protein complexes is achieved only in the second dimension. Features 
and applications of all described varieties of this type of native PAGE have 
been reviewed (Wittig and Sch ä gger,  2008 ). 
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 3.4  Sample Complexity 
 At present, only extrapolations exist for determination of the number of pro-
teins in a cell, for instance, in yeast 20,000 – 30,000 proteins or protein spots 
have been estimated for the pH range 3.5 – 11.5 (based on an extrapolation 
from narrow - range gradient IPG 2DE, yielding 2700 spots for 0.7 pH units; 
Corthals et al.,  2000 ). Practical experiments have shown many more spots 
than predicted in theory, most likely due to isoforms, posttranslational modi-
fi cations, breakdown products, and so on. Higher sample concentrations may 
even increase the spot number as long as the overall protein load does not 
reduce separation quality. For human serum a list of 289 proteins that have 
all been detected and quantifi ed (Anderson and Anderson,  2002 ) has been 
compiled. The concentration range between the highest and lowest abundance 
proteins (albumin and Interleukin 6, respectively) spans over 10 orders of 
magnitude. This large range derives from the fact that apart from the classical 
 “ plasma proteins ” this body fl uid contains not only tissue proteins (as leakage 
markers), but also, for example, low concentrations of mediators such as the 
interleukins. In general, the proteome of cells or tissues shows a more con-
sistent protein distribution, but even so concentration ranges of 6 – 8 orders of 
magnitude have been estimated for cells (Anderson and Anderson,  1998 ; 
Lescuyer et al.,  2007 ). With conventional proteomic methods 2 – 4 orders of 
magnitude may be covered (Anderson and Anderson,  2002 ), but sensitivity 
may be increased by sample pretreatment. Prefractionation simplifi es the 
protein mixture by reducing the amount and number of proteins to be loaded 
into the gel matrix. In general it is advisable to use prefractionation methods 
that are based on principles not involved in the following 2DE step (solubili-
ties, properties at native conditions, affi nities). The following sections will 
deal with selected examples. 
 3.4.1  Protein Solubility 
 Some of the most frequently used samples for proteomic analysis are body 
fl uids or cells/tissues. In the fi rst case, proteins are already in a solution and 
the questions that arise include how to introduce the appropriate additives for 
proteomic analysis; how to achieve the appropriate protein concentration; or 
how to remove possibly interfering contaminants (such as salts, lipids, nucleic 
acids, and other proteins). For cellular material there are two approaches: (1) 
to lyse cells/tissues completely and to try to get all proteins into solution, and 
(2) to apply a stepwise solubilization with solutions of different dissolving 
power. A lysis buffer that allows complete lysis is, for instance, 9  M urea, 4% 
CHAPS, 1% DTT, and 0.8% carrier ampholytes, with or without appropriate 
protease inhibitors (for other recipes see  http://us.expasy.org/ch2d/protocols/
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protocols.fm1.html ). The composition of the lysis buffer is usually adapted 
according to the specifi c needs of the sample (see Chapter  2 ). Tissue material 
of more rigid structure or bacteria may need an additional mechanical disrup-
tion before extraction (the range of methods spans from simple freezing/
thawing or sonication to grinding under liquid nitrogen, bead beating, pro-
cessing by pressure cycling technology, or French press). 
 Sequential extraction applies stepwise buffers/solvents with increasing 
extraction power. First developed for differential solubilization of  Escherichia 
coli proteins (Molloy et al.,  1998 ), this approach has proven similarly helpful 
for plasma membrane proteins of mammalian cells (Abdolzade - Bavil et al., 
 2004 ). Solubilization, assisted by vortexing and sonication, proceeds from a 
simple tris buffer (extracting many cytosolic proteins) to a lysis buffer with 
urea, CHAPS, DTT, and another buffer containing urea, thiourea, tribu-
tylphosphine, and multiple zwitterionic surfactants. The residual pellet is 
solubilized in an SDS - containing buffer with boiling and may be analyzed by 
1D SDS - PAGE or, appropriately diluted, by 2DE. 
 3.4.2  Precipitation 
 Protein precipitation is an easy way to remove nonprotein contaminants (salt, 
lipids, nucleic acids) from the sample. In addition, the protein content of the 
sample may be increased. The most commonly used precipitating agents in 
proteomic applications are trichloroacetic acid (TCA)/cold acetone or ethanol, 
as shown for human platelets (Zellner et al.,  2005 ). These two precipitants are 
often the basis for commercial sample preparation kits. The patterns of the 
pretreated samples may differ depending on the preconcentration method, and 
also in comparison with the original sample, but should be highly comparable 
for samples with the same history. However, as for all additional steps intro-
duced into the method, the pros (removal of interfering substances) and cons 
(new source of technical errors/changes) have to be carefully considered. 
 3.4.3  Subcellular Fractionation 
 Subcellular fractionation has two important benefi ts: it not only reduces 
protein complexity and diversity but also preselects for biologically associ-
ated proteins. The aim of subcellular fractionation is to separate cell organ-
elles with as little damage as possible. Fractionation protocols have to be 
adapted to the specifi c tissue type and the species. Organelles differ in size 
and density; therefore, they can be separated by differential pelleting (step-
wise increase of centrifugation speed and collecting the pellet after each step) 
or by centrifugation in a density gradient (Graham and Rickwood,  1997 ). 
There are a large number of applications for this procedure (e.g., Pasquali 
et al.,  1997 ; Guillemin et al.,  2005 ; de Ara ú jo et al.,  2008 ). 
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 3.4.4  Ultrafi ltration 
 Small centrifugal ultrafi ltration devices containing membranes of defi ned 
cutoffs (usually 3, 10, 30, and 100  kDa) are commercially available. When 
cutoff fi lters of 4 – 10  kDa are used, ultrafi ltration of protein samples has two 
advantages: the sample is desalted and concentrated, which both may prove 
benefi cial for the obtained 2DE protein pattern, and a low Mr fraction is 
obtained whose contents of peptides or protein breakdown products may be 
further investigated by other means, like high - resolution MS. This approach 
has successfully been tested on cell and tissue lysates (bovine liver) and serum 
(Chernokalskaya et al.,  2004 ). 
 3.4.5  Prefractionation by Electrophoretic Methods 
 Most of the electrophoretic methods used for prefractionation include separa-
tion in solution. The absence of a solid matrix minimizes protein surface 
interactions and consequent loss of protein. The most often used separation 
parameters are pI and mobility/size, but affi nity may also be included. 
Separation conditions selected often differ from the 2DE system applied later 
on. An overview on electrophoretic prefraction methods is given in Righetti 
et al. ( 2003 ). 
 3.4.5.1  p I - Based Separations  Over the years several devices that allow gel -
 free separations according to pI have been developed and manufactured. 
Some of them are available in different sizes, as they can be equally used to 
purify proteins on a preparative scale or for sample pretreatment prior to 2DE. 
Proteins are fractionated in solution within defi ned pH ranges either (1) under 
conditions comparable with 2DE (e.g., to preconcentrate proteins of a selected 
pI range as a step prior to narrow - range IPGs), or (2) utilizing pI shifts due 
to inclusion/omission of additives during sample pretreatment. 
 The Rotofor ™ cell (Bio - Rad Laboratories, Hercules, CA) performs liquid -
 phase separations in carrier ampholyte solutions. After focusing, samples are 
collected from the up to 20 compartments that are separated by liquid -
 permeable nylon screens (for a schematic drawing see fi g. 2 in Righetti et al., 
 2003 ). 
 Figure  3.4 a shows an example for such a fractionation: pig serum has been 
focused under non - denaturing conditions in the pH range 3 – 10. Single frac-
tions were tested afterwards in reducing SDS - PAGE. From the graph of 
Figure  3.4 b pH and protein content of the fractions can be read. Fractions 5 
and 6 contain mainly albumin, in high concentrations, whereas from fraction 
10 onward IgG dominates. Two acidic, consecutive fractions were selected for 
testing in 2DE (Fig.  3.4 c,d). Although the average pH of these two fractions are 
3.95 and 4.48, respectively, 2DE reveals proteins with pIs between about 3.3 
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and 5.5 in both cases. There are two reasons for the broader pI distribution: the 
heterogeneity of the single proteins, seen in the spot trains, and pI discrepancies 
for some proteins between the Rotofor run (without denaturants) and the fi rst -
 dimension IPG of classical 2DE. As prefractionation was also performed in the 
absence of reducing agents, acidic spots of Ig light chains and the  μ - chain are 
missing in this pattern (compared with pig serum 2DE in Fig.  3.1 a). 
 Using denaturing/reducing conditions in both prefractionation and IPGs 
has also been helpful, for instance, for enrichment of low - abundance serum 
proteins. Identifi cation of these preconcentrated proteins was much easier by 
immunological means (Hochstrasser et al.,  1991 ), and this should also be the 
case for MS identifi cations. Carrier ampholyte - based preparative IEF has also 
been applied to skim milk proteins (Kim and Jimenez - Flores,  1993 ). 
 The multicompartment electrolyzer relies on the use of isoelectric mem-
branes, fabricated with the same Immobiline chemicals as used in IPGs. 
Proteins of interest are trapped in solution between membranes of selected 
 Fig. 3.4  Sample prefractionation. Prefractionation: separation of pig serum on a Rotofor ™ (Bio -
 Rad) in a pH 3 – 10 gradient under non - denaturing conditions. (A) Equal protein amounts of the 20 
fractions collected were tested in reducing SDS - PAGE in a 10% – 15% gradient gel and the pattern 
was silver stained. M, Mr marker; S, serum (original sample). (B) The pH and the protein content in 
the 20 fractions were determined and depicted as curves. Two consecutive fractions (3 and 4) were 
selected and analyzed in 2DE (classical system) using a pH 3 – 6 gradient. The silver stained patterns 
are shown in (C) and (D). 
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pIs that act as  “ pH barriers. ” The method was originally designed for 
purifi cation of protein isoforms to gain enough material for their further 
physicochemical characterization (Righetti et al.,  1990 ). As a small - size pre-
fractionation device with several compartments and fi xed pIs of isoelectric 
membranes it has been commercialized and utilized for the separation of 
plasma proteins or bacteria (Herbert and Righetti,  2000 ; Zuo et al.,  2001 ). 
Fractionation is run with the same additives as subsequent IPGs, thus, protein 
solutions can be directly processed in 2DE. 
 3.4.5.2  Free - Flow Electrophoresis  Samples are continuously injected into 
a solution fl owing as a thin fi lm (0.4  mm) between two parallel glass plates 
and, by introducing an electric fi eld perpendicular to the fl ow direction, pro-
teins are separated and fi nally collected into up to 96 fractions (Wildgruber 
et al.,  2008 ). The system can be run for a long time under stable conditions 
while continuously feeding with sample. Separation is performed either as 
IEF in selected pH ranges or as zone electrophoresis. Being a gel - free system, 
it allows separation of a variety of samples, including components of larger 
size — complete cells (Baier et al.,  1988 ), single organelles (Mohr and V ö lkl, 
 2002 ), and protein complexes or mixtures (Burggraf et al.,  1995 ; Wildgruber 
et al.,  2008 ). 
 3.4.5.3  Preparative Gel Electrophoresis  One commercial apparatus exists 
for fractionation of proteins in polyacrylamide gels based on native electro-
phoresis or SDS - PAGE (PrepCell ™ , Bio - Rad). Proteins are separated in a gel 
polymerized in cylindrical form around a cooling fi nger by continuous elution 
electrophoresis. The ring - shaped protein bands migrate off the bottom of the 
gel and are continuously collected in a fraction collector. Separation param-
eters are adapted by selection of the concentration of the homogenous poly-
acrylamide gel and allow enrichment of low - abundance proteins as well as 
separation of protein isoforms with only small mass or mobility differences. 
Protein fractions are not always collected in buffers immediately suitable for 
subsequent 2DE, thus, often an additional desalting step may be needed. SDS 
removal, also partly from proteins, can be achieved for instance by precipita-
tion using potassium ions (Sandri et al.,  1993 ). Fountoulakis and collaborators 
have used this system for fractionation of different complex samples in order 
to enrich low - abundance proteins (e.g., mouse brain proteins, Fountoulakis 
and Juranville,  2003 ; or human urine, Zerefos et al.,  2006 ). 
 There are several other systems used for sample prefractionation, for 
example, Off - Gel ™ electrophoresis (Michel et al.,  2003 ) commercialized as 
the OFFGEL fractionator (Agilent, Santa Clara, CA), which is also based on 
the principle of IPGs, or the Gradifl ow ™ system (Gradipore, Sydney, 
Australia), an electrokinetic membrane apparatus that can process proteins on 
the basis of pI, mobility, size, or affi nity (Locke et al.,  2002 ). 
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 3.4.6  Prefractionation by Chromatographic Methods 
 Chromatography includes a broad range of physical methods that separate 
components of a complex mixture as a function of their distribution between 
the stationary phase and a mobile phase that percolates through the stationary 
bed. The mobile phase drives the single components of the mixture through the 
chromatographic column; the retention time or their binding behavior depends 
on their affi nity toward the respective chromatographic material. Several chro-
matographic methods have been tried for prefractionation purposes prior to 
2DE separations: ion exchange, hydrophobic interaction, reverse - phase, gel 
permeation, and affi nity chromatography, the latter in numerous varieties 
(Lescuyer et al.,  2004 ). A brief overview of the different types is given in the 
following sections, with a special focus on affi nity methods. 
 3.4.6.1  Chromatographic Methods  Ion exchange chromatography uses a 
charged stationary phase to separate charged compounds; the stationary phase 
carries functional groups that interact with oppositely charged groups on the 
proteins. Bound proteins are released by increasing salt concentration or after 
shifts in pH. Ion exchange chromatography separates under non - denaturing 
conditions based on the charge of the folded proteins; therefore, fractionation 
patterns may differ considerably from the ones obtained in IEF. Changes in 
low - abundance brain proteins of rats treated with kainic acid, a potent neu-
rotoxin and excitatory amino acid, were detected more clearly when the 
sample material was prefractionated on an anion exchange resin (Krapfenbauer 
et al.,  2001 ). For nuclear proteins of sea urchin embryos subfractionation 
was achieved using a weak cation exchange resin and compared with the 
original map (Harrington et al.,  1992 ). Cation exchange chromatography 
using various types of resin was also the method of choice for fractionation 
of bovine whey; although here 1DE was suffi cient to document pattern dif-
ferences (Hahn et al.,  1998 ). 
 Hydrophobic interaction chromatography separates proteins on the basis 
of differences in hydrophobicity. Proteins are adsorbed in the presence of 
salt onto hydrophobic groups of an uncharged matrix and are then eluted 
by lowering the salt concentration or even by adding acetonitrile. Adsorption 
can be performed under denaturing conditions in the presence of urea and 
detergents. This was one type of fractionation applied to soluble proteins 
of the bacterium  Haemophilus infl uenza and maps obtained were compared 
with protein patterns from chromatofocusing and heparin chromatography 
(Fountoulakis et al.,  1999 ). 
 Reverse - phase chromatography uses a nonpolar stationary phase with alkyl 
chains; polar compounds are eluted fi rst while nonpolar compounds are 
retained and released only upon addition of organic solvents into the aqueous 
buffer system. Differentially expressed proteins between striate cortex of 
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kitten and adult cat were detected by this protein enrichment method (Van 
den Bergh et al.,  2003 ). 
 Gel permeation chromatography is not often used as a prefractionation 
method prior to proteomic applications, as it sorts molecules according to 
size, similar to SDS - PAGE. However, it could be applied making use of dif-
ferent conditions (e.g., native/denaturing). 
 3.4.6.2  Affi nity Chromatography and Depletion  Affi nity chromatography 
separates protein mixtures based on a highly specifi c biologic interaction, 
such as that between antigen and antibody, enzyme and substrate, or receptor 
and ligand. It thus offers high fl exibility and allows development of tailor -
 made solutions for specifi c problems. 
 There are two general strategies in affi nity material used for prefraction-
ation: it can either be used to enrich proteins bearing specifi c groups (e.g., 
phospho - , glyco - ) or for the specifi c removal of high - abundance proteins 
(depletion methods). 
 Immobilized metal affi nity chromatography (IMAC) is a useful method for 
enriching metal - associated proteins and peptides. It is based on the interaction 
between proteins and transition metal ions (e.g., copper, nickel, and zinc) 
immobilized on a solid support. It allows, for instance, enrichment of phos-
phoproteins and  - peptides (Dubrovska and Souchelnytskyi,  2005 ), and is 
often used as a prefractionation step for MS analysis. 
 Lectins react specifi cally with different carbohydrate residues on proteins, 
which makes glycoprotein enrichment through lectin affi nity chromatography 
possible (Mechref et al.,  2008 ). Binding or nonbinding proteins may be 
further investigated by proteomic methods (Yang et al.,  2005 ). It has to be 
taken into account that — when comparing samples from different states (e.g., 
treated/untreated cells) — the glycosylation pattern of proteins may change 
and, due to altered binding behavior, modifi ed proteins may then appear in 
different fractions. 
 Depletion strategies usually aim at removing high - abundance proteins from 
complex mixtures in order to enable analysis of the residual mixture more 
clearly. The majority of applications concern albumin and IgG depletion from 
serum. The immobilized triazine dye Cibacron Blue F3GA is known to retain 
human serum albumin with high affi nity (Travis et al.,  1976 ), but it works 
less well with albumin of other species (Miller and Gemeiner,  1998 ). 
Staphylococcal protein A or protein G binds IgG, and immobilized protein 
A or G is often the reactive part of commercial depletion cartridges. Not all 
IgG isoforms bind equally well, especially when comparing different animal 
species. Other commercial products used for albumin and IgG depletion take 
advantage of antibody - based affi nity. In addition, products that bind up to six 
or more highly abundant serum proteins (including IgA, transferrin,  α 1 -
 antitrypsin, haptoglobin) have been developed. Quite a number of commercial 
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products have been developed and validated for application on human serum 
(Bj ö rhall et al.,  2005 ; Brand et al.,  2006 ). It was noticed, however, that 
albumin depletion might also remove low - abundance proteins including cyto-
kines (Granger et al.,  2005 ). 
 There are only few reports on use of depleted animal sera. One of them 
applied a specifi c anti - mouse - albumin coupled adsorbent in a study of burn 
injuries in mice (Duan et al.,  2005 ). Although some other proteins were also 
removed by this treatment, inter  α - trypsin inhibitor heavy chain 4 was 
detected as a novel acute - phase protein in this species. Whether the com-
mercial products developed for human serum proteins may also be success-
fully applied for animal samples has to be tested for each single case. In the 
author ’ s knowledge, up to now only one product has been specifi cally pro-
duced to remove mouse and rat albumin (Qiagen, Hilden, Germany). 
 3.4.6.3  Further Mining of the Proteome  As for protein purifi cation, one 
single chromatographic step allows enrichment of particular proteins, but 
multidimensional chromatography or combinations with other methods are 
more effective. Digging deeper into the proteome with this more sophisticated 
approach resulted in the identifi cation of 325 distinct proteins (from 3700 
spots) for human serum and 150 proteins for human urine (Pieper et al.,  2003 ; 
Pieper et al.,  2004 ). Similar results would be expected for the respective 
animal body fl uids. 
 A few years ago a new idea for detection of very low - abundance proteins 
was developed: originally called  “ Equilizer technology ” (Righetti et al.,  2006 ), 
this product is now commercialized as ProteoMiner Beads ™ (Bio - Rad). 
Polymeric beads coated with a combinatorial library composed of millions 
of hexameric peptide baits are incubated with the sample. As there is only a 
limited number of similar peptides, only a small part of the high - abundance 
but all of low - abundance protein molecules are bound, thus resulting in an 
enrichment of the latter. As this method shifts proportions of the proteins in a 
mixture, it is suitable for detecting yet unknown proteins of low abundance, 
but seems less well suited for comparison of quantitative differences. 
 3.4.7  Additional Methods 
 Immunoprecipitation, for instance, with antibodies against functional groups, 
is another method for enrichment of protein classes. Immunocomplexes 
obtained by reaction of antigen and antibody are bound to immobilized 
protein A or G, from which they can be eluted with chaotropes or SDS - sample 
buffer. Phosphoproteins have thus been investigated, utilizing antisera against 
phosphotyrosine (Stancato and Petricoin,  2001 ). 
 Selectivity in sample collection may further help to limit diversity of the 
material under investigation: laser capture microdissection allows to selec-
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tively pick only cells with specifi c properties (Banks et al.,  1999 ); diversity 
of cell populations may be reduced by fl uorescence - activated cell sorting 
(FACS) or antibody - coated magnetic beads (Thadikkaran et al.,  2008 ). 
 3.5  The Infl uence of Staining 
 3.5.1  General Protein Stains 
 The most used dyes for staining of overall protein patterns in proteomic appli-
cations are CBB R and CBB G, silver, and the fl uorescent dyes of the 
SYPRO ™ family (Invitrogen, Carlsbad, CA) as well as CyDyes ™ (GE 
Healthcare, Little Chalfont, UK) (Miller et al.,  2006a ). CBB R is used in solu-
tions with organic solvents (methanol, ethanol) in combination with acids 
(acetic acid, trichloroacetic acid) to fi x the proteins (Gianazza et al.,  2002 ). 
For CBB G this is possible as well, but lately it has often been applied as a 
colloidal stain (Neuhoff et al.,  1985 ; Miller et al.,  2004a ). Silver staining exists 
in many varieties, being either based on a gel impregnation step in neutral 
silver nitrate solution followed by development under alkaline conditions 
(sodium carbonate) or performed as an ammoniacal silver staining (Rabilloud, 
 1992 ). Besides CBB and silver, which produce stained protein patterns visible 
to the human eye, fl uorescent dyes are increasingly used; they need gel scan-
ning under specifi c illumination (ultraviolet [UV], laser) to visualize the spot 
patterns. These fl uorophores include the family of SYPRO stains, mainly 
SYPRO Ruby (Berggren et al.,  2002 ), which are post - electrophoretic stains 
like the colorimetric dyes mentioned before. Pre - electrophoretic labeling of 
proteins is performed with CyDyes, which react specifi cally with amino acids 
present in the investigated proteins: lysine (CyDye DIGE Fluor Minimal Dyes, 
GE Healthcare, Little Chalfont, UK; Viswanathan et al.,  2006 ) or cysteines 
(CyDye DIGE Fluor Labeling Kit for Scarce Samples, saturation labeling, GE 
Healthcare, Little Chalfont, UK; Greengauz - Roberts et al.,  2005 ). 
 Staining mechanisms of the mentioned dyes are different, and also their 
sensitivity. Whereas sensitive silver stains may detect as little as 1  ng pro-
tein in a spot, CBBs need an approximately 10 - fold greater concentration. 
Fluorescent dyes lie in a range similar to silver or even below. They offer the 
advantage that the linearity range of the measured signal is much larger (about 
3 – 4 orders of magnitude), whereas in silver staining concentration changes 
of a factor of only up to 10 may be reliably quantifi ed. The less sensitive CBB 
shows a slightly broader range for staining proteins proportionally to their 
concentration than silver (Miller et al.,  2006a ). 
 Figure  3.5 depicts a series of 2DE gels of one horse serum sample. The 
protein concentration applied onto the gel is adapted according to the sensitiv-
ity of the respective stain, to achieve comparable intensity of spot patterns. 
In the upper row 5  μ L serum was separated in each panel and stained with 
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CBB R, CBB G, and Fast Green FCF. In the lower row the sample amount 
was 0.5  μ L each for silver stain, the fl uorescence stains Deep Purple ™ (GE 
Healthcare) and ruthenium II tris (bathophenanthroline disulfonate) (which is 
similar to SYPRO Ruby; Lamanda et al.,  2004 ), and the cyanine dye Cy3 
(minimal dye). Besides this factor of 10 in sensitivity between stains, it is 
obvious that staining intensity of spots may vary depending on the detection 
method. This concerns, for instance, IgG heavy and light chains, and also one 
spot that is marked with an arrow. This is the main spot of the haptoglobin 
 β - chain. When calculating the amount of this spot (single spot volume com-
pared with sum of spot volumes present on the respective gel), a different 
percentage is obtained for each of the staining methods. A histogram in the 
upper right panel of Figure  3.5 illustrates these data. For the investigated spot, 
levels happen to be considerably lower for Fast Green FCF and silver stain. 
More details on this study of horse serum proteins and the infl uence of stain-
ing are given elsewhere (Miller et al.,  2006a ). 
 One advantage of cyanine minimal dyes has not been mentioned yet: three 
dyes (Cy2, Cy3, Cy5) with similar chemical and electrophoretic but different 
spectral properties have been developed. This allows a difference gel electro-
phoresis (DIGE) approach where three different samples are labeled each 
with one of the fl uorophores, then mixed and separated in one single 2DE 
 Fig. 3.5  Infl uence of staining. Horse serum was separated in 2DE (classical system) and proteins 
detected with different stains. A close - up of the 25 – 120  kDa region. Upper panel: 5  μ L horse serum 
as sample; proteins were stained with Coomassie Brilliant Blue R - 250 (CBB R), Coomassie Brilliant 
Blue G - 250 (CBB G), and Fast Green FCF (Fast Green). Lower panel: 0.5  μ L horse serum as sample; 
proteins were stained with silver stain (Silver), Deep Purple ™ (GE Healthcare Life Sciences), the 
fl uorescent dye ruthenium II tris (bathophenanthroline disulfonate) (RuBP; Miller et al.,  2006b ), and 
pre - electrophoretically labeled with the cyanine dye CyDye DIGE Fluor Minimal Dye Cy3 ™ (GE 
Healthcare Life Sciences). The major spot of the haptoglobin  β - chain is indicated by arrows. The 
upper right panel shows the percentage of this spot (single spot volume compared with sum of spot 
volumes present on the respective gel) on each of the shown gels. Labeling on the x - axis corresponds 
to CBB R (1), CBB G (2), Fast Green (3), Silver (4), Deep Purple (5), RuBP (6), Cy3 (7). 
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gel. Scanning with three different settings allows an image to be obtained 
for each dye and easier comparison of comigrat ing spots. Only a small 
percentage of the lysine residues present in the proteins are labeled; therefore, 
the protocol is called  “ minimal labeling. ” There exist also two cyanine dyes 
(Cy3, Cy5) for saturation labeling that modify cysteine residues. This amino 
acid is less widely and less evenly distributed in the proteins than lysine; 
therefore, patterns obtained with this stain may look quite different. In addi-
tion, proteins without cysteine residues exist. 
 3.5.2  Specifi c Stains 
 Besides general protein stains, dyes specifi c to different functional groups 
have been developed. There are two modern fl uorescent dyes (Pro - Q ™ 
Diamond and Pro - Q ™ Emerald, by Molecular Probes, Eugene, OR) that are 
used as stains after electrophoresis to detect phosphoproteins or glycopro-
teins, respectively. Both can be combined with each other and with the overall 
protein stain SYPRO Ruby (Wu et al.,  2005 ; Zong et al.,  2008 ). In addition, 
it has been shown that a combination of CyDyes and Pro - Q ™ Diamond is 
possible and can be used for protein quantifi cation (Stasyk et al.,  2005 ). Care 
has to be taken as results from phospho - specifi c stains do not always corre-
spond to radioactive  32 P - labeling (Chen et al.,  2004 ). 
 Other specifi c gel stains that may be applied after 2DE are — apart from the 
older classical periodic acid - Schiff stain for glycoproteins that is not very 
sensitive — enzymatic stains, provided that a separation system is used that 
does not impair enzymatic function (Shimazaki et al.,  2004a,b ). 
 Blotting to nitrocellulose or polyvinylidene difl uoride (PVDF) is a versatile 
tool for further specifi c staining. It conserves the patterns obtained by the 
separation, concentrates the proteins during the transfer, and immobilizes 
them on the membrane. Blots are incubated with antibodies against functional 
groups or single proteins, which are then detected by enzyme - conjugated 
antibodies against the primary antibody and a specifi c colorimetric substrate 
reaction. Alternatively, enhancement systems with chemiluminescence may 
be used (Gallagher et al.,  1998 ). Stripping of blots and reprobing with differ-
ent antibodies is also possible. For exact localization of the spots in the 
context of the overall pattern, general protein stains can be applied for the 
membrane: for high protein load the reversible dye Ponceau S (Salinovich 
and Montelaro,  1986 ), the more sensitive colorimetric gold stain (Daneels et 
al.,  1986 ), or SYPRO Ruby (or ruthenium II tris [bathophenanthroline disul-
fonate]) for fl uorescence detection (Miller et al.,  2006b ). 
 Antibodies against phosphoproteins are directed against P - tyrosine, P - 
serine, or P - threonine and thus may give hints about the position of the 
phosphate group. For glycoproteins, different enzyme - labeled lectins are 
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available. The best known is concanavalin A, one with broad specifi city 
(against  α - mannosyl groups). 
 Detection and identifi cation of particular animal proteins is often hampered 
by the lack of specifi c antibodies. If the protein of interest has an evolutionary 
conserved structure, cross - reactive antibodies may be used after carefully 
pretesting. This was one of the methods successfully applied for establishing 
reference serum protein maps of different species (see Section  3.2.2 ). 
 3.6  “ Post - detection ” 
 Staining protein spots in a 2DE gel is not always the end of the experiment. 
For a comparison of samples representing two different states (of health, 
treatment, etc.), quantifi cation of spot volumes and comparison of multiple 
gels are necessary. To achieve reliable results, it is important to select the 
appropriate staining method, sample amount (in order to avoid saturated 
spots), and the necessary number of technical and biological replicates (Miller 
et al.,  2006a ). For instance, silver staining has to be carefully controlled to 
obtain patterns that allow subsequent quantifi cation. Minimal CyDyes allow 
a setup with two samples (labeled with Cy3 and Cy5) and an internal standard 
(a pool of all samples in the respective experiment, labeled with Cy2); the 
latter allows more reliable normalization (Alban et al.,  2003 ). This approach 
lowers technical variation, and thus smaller differences between single 
samples may be detected with statistical signifi cance (Miller et al.,  2006a ; 
Karp and Lilley,  2007 ). 
 Based on quantitative and statistical evaluation spots of interest are often 
selected as candidates for identifi cation. Those may be cut out from the gel, 
enzymatically digested and identifi ed by MS methods. Having this in mind, 
the 2DE approach has to include a staining method that allows identifi cation 
afterwards (such as by modifying the silver stain, omitting glutaraldehyde 
and part of the formaldehyde; Shevchenko et al.,  1996 ), sometimes also an 
upscaling of the method to be able to analyze small spots (by increasing 
sample amounts and using a different stain). For manual spot picking from 
DIGE - gels it is advisable to restain the gels, preferably with a colorimetric 
stain. When investigating animal proteins, protein identifi cation by MS 
methods is often hampered by the lack of annotations for animal proteins in 
the databases. In some cases, these problems can be solved by  de novo 
sequencing and cross - species identifi cation as discussed in detail in Wait 
et al. ( 2002 ) for bovine serum proteins. 
 During the last years it has become state - of - the - art to verify proteomic data 
with another, independent method. This is often done by 1D immunoblotting 
(see Section  3.5.2 ). Nevertheless, this method may give results that are diver-
gent to proteomic data: for example, isoforms that differ only in pI cannot be 
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detected by 1D blots. In this case, 2DE blots may solve the problem. Another 
source of variation lies in the biological nature of the antibodies: being spe-
cifi c for defi ned epitopes on the protein molecule, they may react with dif-
ferent molecular species of the same protein with different avidity. 
 3.7  Future Trends 
 2DE is a high - resolution and versatile method for analysis of proteomic ques-
tions. Comparing different proteomic approaches (classical and alternative 
2DE, LC - MS/MS), it has been shown in several studies that even analysis of 
the same samples may result in identifi cation of different protein subsets with 
only partial overlap of the detected  “ subproteomes ” (Anderson et al.,  2004 ; 
Hunzinger et al.,  2006 ). Each of the investigated methods has its strengths, 
the one of classical 2DE being that it gives a rapid overview on hundreds of 
proteins/protein spots and allows detection of isoforms. Only the combination 
of as many methods as possible can lead us to a global view and understand-
ing of biological questions. This will also mean involving even more than the 
presently applied approaches, even modifi cations of  “ old - fashioned ” methods 
if they help to complement our knowledge. 
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Proteomics has the potential to elucidate complex patterns of toxic action attributed to its
unique holistic a posteriori approach. In the case of toxic compounds for which the mech-
anism of action is not completely understood, a proteomic approach may provide valuable
mechanistic insight. This review provides an overview of currently available proteomic tech-
niques, including examples of their application in toxicological in vivo and in vitro studies.
Future perspectives for a wider application of state-of-the-art proteomic techniques in the
field of toxicology are discussed. The examples concern experiments with dioxins, polychlo-
rinated biphenyls, and polybrominated diphenyl ethers as model compounds, as they exhibit
a plethora of sublethal effects, of which some mechanisms were revealed via successful
proteomic studies. Generally, this review shows the added value of including proteomics in a
modern tool box for toxicological studies.
Proteomics aims at investigating the
proteome, that is, the whole repertoire of pro-
teins present in a specific sample, such as body
fluid, cell, or tissue, under well-defined circum-
stances, within one analysis. Proteomics is one
of the pillars of the “omics” approaches, which
also include transcriptomics and metabolomics.
The relevance of the proteome compared to
the transcriptome is that it includes the post-
translational processes and thereby is closer
to the functional effects. The proteome is not
constant, but variable over time and depen-
dent on many conditions, such as gender, age,
hormonal, health status, and environmental
influences, including exposure to compounds.
Although the term “proteomics” was coined in
1994 by Marc Wilkins, the first papers describ-
ing one of the key methods date back even to
the year 1975 (O’Farrell, 1975; Klose, 1975)
Current address for A. J. Murk is Sub-department of Environmental Technology, Bornse Weilanden 9, 6708 WG Wageningen, The
Netherlands.
Address correspondence to A. C. Gutleb, Department Environment and Agro-biotechnologies, Centre de Recherche Public–Gabriel
Lippmann, 41, rue du Brill, L-4422 Belvaux, Grand-duchy of Luxembourg. E-mail: gutleb@lippmann.lu
and were based on general protein analytical
techniques. At that time, proteomics was a
synonym for a single method, two-dimensional
electrophoresis (2-DE). Since then, besides
improvements in 2-DE, additional methods
and approaches have been developed, mainly
different mass spectrometric (MS) techniques
complemented by liquid chromatography (LC)
steps to further improve separation and identi-
fication. Thus, today a large panel of methods
for proteomic investigations is available, as
described later.
Proteomics determines the protein compo-
sition of a sample in qualitative and quanti-
tative respects. Currently available instrumen-
tation and techniques allow the simultaneous
detection of hundreds to thousands of proteins
present in the same sample by the use of high-
resolution multidimensional separations. Such
225
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an approach provides a good overview of the
whole proteome and may reveal differences in
protein patterns between samples from differ-
ent treatments or exposure scenarios in vitro or
in vivo.
Although classical protein investigations
start from a hypothesis and focus on spe-
cific proteins accordingly, current proteomic
analyses are in general not target driven, but
rather looking for differences in the overall pro-
tein pattern and then setting out to identify
and investigate those proteins more specifically.
The observed changes or differences between
exposure groups of such an agnostic search
can then be put into the context of already
known mechanisms. Following this approach,
potentially new and additional links between
different pathways are revealed. Such results
complement already known mechanisms based
on hypothesis-driven experimental data, and
in this way further increase our knowledge
and understanding regarding biological pro-
cesses or toxicological mechanisms. Therefore,
proteomics has become an important tool for
investigations in the biochemical and medi-
cal field, to elucidate mechanisms, understand
species differences, or find biomarkers for spe-
cific diseases (Megger et al., 2013), for exam-
ple, for cancer (Polanski and Anderson, 2007).
Compared to this, toxicological research does
not yet use the full potential of proteomics.
Only in a small number of studies have
such approaches been successfully applied to
date, for investigation of compounds with
a low acute toxicity (Lasserre et al., 2009,
2012; Sotoca et al., 2011; Campos et al.,
2012).
In this review, first, the currently available
methods are examined for different approaches
to separate, quantify, and identify the proteins
and interpret resultant data. Proteomics-related
specificities of sample preparation and exper-
imental setup are provided. Successful appli-
cations of proteomics in animal studies test-
ing dioxins, polychlorinated biphenyls (PCB),
and polybrominated diphenyl ethers (PBDE)
are described, illustrating this in investigations
focused on liver as a target organ. Finally, the
review discusses the added value of including
proteomics in a tool box for in vivo and in vitro
toxicological studies.
CURRENT PROTEOMIC METHODS
In general, any proteomic workflow consists
of several distinct steps like sample prepara-
tion, separation, quantification, identification,
and data interpretation. In detail, there are
different approaches that rely on different sep-
aration principles and technical equipment,
which are described in the following sections.
There are two main approaches, as illustrated
in Figure 1: the gel-based (two-dimensional
electrophoresis, indicated in red lines) and the
gel-free or MS-based (relying on MS methods,
usually in combination with LC steps, shown as
blue lines). In addition, there is also a combina-
tion of one-dimensional electrophoresis, to pre-
fractionate the sample, and further MS-based
separation/detection, as displayed in violet.
Digest
PEPTIDES
MS
PROTEINS
Pathway analysis, verification
Sample preparation
2-DE Gels LC
LC
qual. quant.
SAMPLE
1-DE Gels
FIGURE 1. Proteomic workflow, general overview of the main
approaches. Red lines display gel-based workflow, blue lines MS-
based approaches, and violet a combination of both; dotted lines
show optional steps. The terms “qualitative” and “quantitative”
MS distinguish between identification of proteins based on a suf-
ficient number of peptides, and quantitative comparison between
samples, both by MS methods.
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Proteomic analysis can be performed on
the level of intact proteins, as in gel-based
approaches, starting with a separation step.
Gel pieces are collected and embedded pro-
teins are cleaved to peptides, usually with the
enzyme trypsin that cuts peptide bonds at spe-
cific sites. Peptide mixtures are then separated
according to size by MS methods and identified
by comparison of their masses with dedicated
databases (Westermeier and Naven, 2002). The
mass distribution of these patterns obtained
under standardized conditions is typical for the
respective proteins, as is further discussed in
the following. Alternatively, protein mixtures
may be digested without previous fractiona-
tion and the separation step only performed on
the peptide level, followed by quantitative MS
analysis (Gevaert and Vanderkerckhove, 2011).
Both approaches allow additional LC steps,
helping to reduce the complexity of the protein
or peptide mixtures.
The following sections describe the
workflows of the different approaches.
GEL-BASED METHODS
Protein Separation
In 2-DE, proteins are separated according
to two different criteria, based on their physico-
chemical properties: In the first step, proteins
are focused as sharp zones according to their
charge in a gel containing a pH gradient. This
step is called isoelectric focusing, as proteins
migrate to the position in the gradient where
their net charge is zero (their isoelectric point).
After a buffering step (equilibration), a second
orthogonal separation is performed, this time
in sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE), that is, polyacry-
lamide gel electrophoresis in the presence of
sodium dodecyl sulfate. The latter compound is
a detergent that enhances the solubility of pro-
teins and by providing a negative charge causes
the proteins to separate in the gel accord-
ing to their molecular mass (Laemmli, 1970).
Both dimensions are typically performed under
reducing and denaturing conditions, such as in
gels containing urea/thiourea, reducing agents,
or SDS; thus, the proteins are no longer in their
native state, but are rather split into subunits
and are unable to interact with each other. This
prevents uncontrolled reactions during analysis.
Variations of this suggested protocol exist, often
for specific applications (Miller et al., 2010a).
Following electrophoresis, protein patterns
are stained for visualization and image capture.
Depending on the stain applied, Coomassie
(Kling et al., 2008; Kling and Forlin, 2009),
silver (Son et al., 2003; Berg et al., 2011), fluo-
rophores (Oberemm et al., 2005; Strathmann
et al., 2007; Miller, 2012), spot patterns are
detectable in the visible light range or by flu-
orescence with appropriate scanners and with
different sensitivity. Single spot intensities are
evaluated with specifically developed software
(Miller et al., 2006).
2-DE comprises multiple single steps,
including (non-automatable) manipulations,
that all may add up to considerable gel-to-gel
variation/technical error in the analysis, as
they may influence spot pattern/intensities.
Therefore, a new technology was developed
several years ago, two-dimensional fluores-
cence difference gel electrophoresis (DIGE),
where three mass- and charge-matched cya-
nine dyes were developed for chemical labeling
of protein samples prior to electrophoresis;
a mix of up to three samples may be run on
one gel, and 2-DE patterns detected by scan-
ning at different wavelengths match perfectly
(Uenlue et al., 1997; Marouga et al., 2005;
Greengauz-Roberts et al., 2005; Timms and
Cramer, 2008). For analysis of more than three
samples, the concept of an internal standard
was introduced. A pool of all samples of the
respective experiment is labeled with one of
the dyes and included in all the gels. This
leaves the two other dyes for the samples
under investigation. The use of an internal
standard facilitates comparison of different
gels and lowers the minimally detectable
difference of the method (Alban et al., 2003).
Thus, approximately a 30% difference in single
spots between samples is reliably detectable,
whereas for conventional gels (one sample/gel)
a factor of 1.5–2 may be required. DIGE is
sensitive and allows quantification of protein
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spot concentrations with a higher dynamic
range (about 2–4 orders of magnitude), but
needs specific and expensive equipment and
reagents. This method enabled the comparison
of brain-region-specific changes of proteins
in polychlorinated biphenyl (PCB)-exposed
(Kodavanti et al., 2011) and polybrominated
diphenyl ether (PBDE) 99-exposed (Alm et al.,
2008) rodents with high sensitivity, pointing out
also small differences during fetal or neonatal
development. This may potentially have high
importance in the light of chronic effects of
early-life-stage low-dose exposure and may be
the cause of observed behavioral changes (Kaya
et al., 2002; Winneke et al., 2002; Erhard and
Rhind, 2004; Zala and Penn, 2004; Lilienthal
et al., 2006; Gutleb et al., 2011).
The next step after 2-DE or DIGE sepa-
ration and quantification is the identification
of the proteins present in the spots of inter-
est. Usually, proteomic approaches are per-
formed to compare different states of the
proteome (with/without treatment or exposure,
healthy and diseased state), and only differen-
tially regulated spots are subjected to identifi-
cation. These are cut out from the gel, trypti-
cally digested into peptides, which are subse-
quently eluted from the gel plugs, and identi-
fied by MS methods as detailed in the following
section.
Protein Identification by MS
In a mass spectrometer molecules are ion-
ized, sorted, and separated according to their
mass to charge ratio and subsequently mea-
sured. Depending on the conditions used, such
as the energy applied, charge and obtained
fragments of each molecule may vary, but are
typical for the respective compound.
Trypsin cleaves proteins at specific sites of
the polypeptide chain (typically at the car-
boxylic side of the amino acids lysine and
arginine), thus not only reducing the size of
the molecule (which enhances exact molec-
ular mass determination), but also creating a
larger number of peptides that are individu-
ally detected by MS. Protein identification relies
on those specific, reproducible, and predictable
fragmentation patterns. Peptide-mass finger-
printing (PMF) is the simplest way of identi-
fying a protein. In this approach, experimen-
tally determined peptide masses are searched
against a comprehensive database, retrieving
the hits with highest probability according to
mass accuracy and peptide number for a par-
ticular protein (predicted masses obtained by a
theoretical digestion of the respective protein).
The predominant limitation of this approach
is that it is applicable only to proteins from
sequenced genomes and that identification
can be most easily achieved with pure pro-
teins. Therefore, it is limited to well-investigated
species and to simple protein samples or gel-
based experiments (isolated spots or bands).
PMF is performed on matrix assisted laser des-
orption ionization-time of flight (MALDI-TOF)
instruments. To confirm PMF results or deter-
mine the amino acid sequence of unidentified
peptides, single peptides may be further frag-
mented by changing analyzing conditions or
the type of instrument. This approach may be
performed on a MALDI-TOF/TOF (including a
second time-of-flight step) instrument or on an
electrospray ionization (ESI) mass spectrome-
ter (Westermeier and Naven, 2002). In addi-
tion, all 2-DE experiments cited in the previ-
ous section applied this approach for protein
identification.
GEL-FREE OR MS-BASED APPROACHES
The most simple, though nowadays sel-
dom applied, gel-free approach is “shotgun”
proteomics, that is, the immediate tryptic diges-
tion of a complex protein mixture, followed by
MS analysis of the peptides. The large num-
ber of proteins present limits the number of
detectable peptides and thus sensitivity of the
approach considerably, as for each protein of
the mixture several to many peptides were cre-
ated in the cleavage step. This challenge is over-
come by reducing the sample complexity, for
instance by additional liquid chromatography
(LC), and sometimes also SDS-PAGE, which
are both helpful steps for quantitative MS
applications.
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Liquid Chromatography as a Separation
Step
Liquid chromatography (LC) is a well-
known, often-applied, and much-appreciated
separation method to reduce the complex-
ity of the protein samples (Oliver, 1989).
As indicated in Figure 1, it may be utilized
for separation of proteins as well as pep-
tides (also as a prefractionation step of original
protein mixtures before 2-DE; Krapfenbauer
and Fountoulakis, 2009). A variety of differ-
ent chromatographic methods are available,
depending on the physicochemical properties
that are selected as separation criteria. Ion-
exchange and reversed-phase chromatography
were found helpful, as well as different affin-
ity chromatography steps (e.g., group-specific
enrichment for phosphoproteins; Thingholm
et al., 2009). Chromatographic separation of
peptide mixtures may also be a versatile step
to facilitate protein identification in approaches
involving a one-dimensional SDS-PAGE step
(Sarioglu et al., 2006; Campagna et al., 2011;
Brunelli et al., 2012), when proteins with major
abundance tend to mask minor protein compo-
nents.
LC is performed in miniaturized systems
that handle small amounts of liquids (nanoLC)
and is a key method especially in gel-free
proteomics (Brewis and Brennan, 2011; Matros
et al., 2011; Capriotti et al., 2011). In combi-
nation with quantitative MS it currently allows
detection and reliable quantification of thou-
sands of peptides in a single LC run.
Quantitative MS
Compared to MS varieties applied in gel-
based approaches, which are mainly directed
toward qualitative issues (protein identifica-
tion), in the present case MS also covers the
quantitative aspect. It is performed in peptide
mixtures by most often including one- or mul-
tidimensional LC for reduction of the sample
complexity, especially in case of labeled sam-
ples (as detailed below). Many different types
of instruments are available, with even more
possible setups and configurations (Gevaert and
Vanderkerckhove, 2011).
The main strategies for quantification of
proteins or peptides are metabolic labeling,
chemical (enzymatic) labeling, use of standards
spiked into the samples, and label-free quan-
tification. The first three strategies (Table 1) rely
on stable isotopes as labels that differ between
samples. The labels do not affect the separation
of the samples, while allowing them to be dis-
tinguished in the mass spectrometer. The con-
cept behind these approaches is to introduce
in every protein or peptide an amino acid with
heavy isotopes (usually 13C, 15N, or 18O), which
result in an amino acid with higher molecular
mass, but with all the other physicochemical
properties unchanged. MS is able to distinguish
different isotopes of a given element and even
in mixtures the “heavy” (e.g., 13C) and the
“light” (e.g., 12C) isotopes may be quantified
through the comparison of the relative intensi-
ties. The introduction of a stable isotope label
in the protein/peptide may be achieved by
metabolic labeling or by chemical/enzymatic
labeling, at different stages of the proteomic
experiment (Table 1). A typical example for
metabolic labeling is SILAC, where cells grow-
ing in medium supplemented with heavy argi-
nine and lysine result in a complete labeling
of the whole proteome in five to seven gener-
ations. This approach was successfully applied
to mammalian cell lines (Ong et al., 2003;
Piechura et al., 2012), but also to organisms
like mouse (Kruger et al., 2008) or zebrafish
(Westman-Brinkmalm et al., 2011), by provid-
ing feed containing heavy amino acids. Refined
protocols allow application of this approach for
TABLE 1. Different Labeling Approaches in Quantitative MS
Metabolic labeling Chemical labeling Spiking
Organism + (SILAC) − −
(Living) cell + (SILAC) − −
Protein − + (iTRAQ) +
Peptide − + (ICAT, TMT) +
Note. Labeling or adding a labeled compound is or may be
performed at different stages before or in the proteomic inves-
tigation (indicated by “+”). SILAC, stable isotope labeling by
amino acids in cell culture. iTRAQ, isobaric tags for relative and
absolute quantitation. ICAT, isotope coded affinity tagging. TMT,
tandem mass tags. Methods reviewed in Bantscheff et al. (2007)
and Gevaert and Vanderkerckhove (2011).
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larger animals and humans (this approach is
known as “SUPER-SILAC” (Geiger et al., 2010,
2011).
Chemical labeling introduces stable isotope
labels in proteins or peptides typically at the
N-terminus or at the ε-amino group of lysine,
mostly in the form of complex tags (TMTs,
iTRAQ). These tags are specifically developed
well-matched sets of up to 6–10 multifunc-
tional molecules that ensure specific bind-
ing to the protein/peptide. Differently tagged
molecules still show similar elution behavior
on chromatographic resins, but isotope mass
differences become obvious in MS analysis.
Quantitative analyses in MS may be performed
in parallel, in one single run (in up to 10 chan-
nels for the TMT and up to 8 for iTRAQ).
Label-free approaches, so called because
there is no use of stable-isotope tags, achieve
quantification by counting matching spectra
for each protein (spectral count approach;
Lundgren et al., 2010; Bantscheff et al., 2012)
or by integrating the area under the peaks in
the mass spectrum (Binz et al, 2008; Neilson
et al., 2011). For obtaining quantitative results,
they require absolute reproducibility in the
peptide separation and a high number of tech-
nical replicates, to ensure statistical relevance
to the obtained results. In a semiquantitative
approach, label-free MS was applied to study
the influence of PCB138 on fetal brain proteins
(Campagna et al., 2011).
An Additional Electrophoretic Separation
Step
One-dimensional electrophoresis is some-
times used as an additional separation step
of the original protein sample even in the
MS-based and otherwise gel-free proteomic
approach. The benefits are an additional clean-
ing and fractionation step of the proteins
according to selectable criteria and tryptic in-
gel cleavage. Such an approach with SDS-PAGE
was selected when investigating the influence
of PCB on rat brain cells (Brunelli et al., 2012)
or fetal brain proteins (Campagna et al., 2011).
Stained bands were cut out of the gel and
proteins were digested to peptides, which were
further separated, identified, and evaluated
with MS methods.
EVALUATION AND INTERPRETATION
Proteomics includes a strong quantitative
aspect. The only qualitative issue, as previ-
ously pointed out, is protein identification by
MS methods, based on a sufficient number of
peptides characteristic for a particular protein.
Score values obtained in database searches with
dedicated search engines such as MASCOT and
SEQUEST express the likelihood of a correct
identification and a ranking in case of multiple
hits.
Most of the proteomic methods and investi-
gations rely on relative quantification, express-
ing the concentration of single proteins or pep-
tides in relation to an internal standard (e.g.,
DIGE) or to the overall applied protein amount
(e.g., 2-DE with conventional staining). This is
also the basis for most MS applications. Only
recent MS methods allow absolute quantifica-
tion by addition of a spiked internal standard.
Statistical evaluation follows the usual
guidelines of good laboratory practice (GLP)
(number of experiments, analysis of vari-
ance [ANOVA], statistical tests). Recommended
cutoff values for selection of differentially
expressed proteins have already been discussed
for gel-based approaches in a previous section.
There exist also community-based standards
and guidelines for the analysis and documen-
tation of mass spectrometric proteomic experi-
ments (MIAPE = minimum information about
a proteomics experiment: Binz et al., 2008;
Taylor et al., 2008).
The general aim of a proteomic approach
includes also an interpretation of the observed
differential regulations, that is, putting the
identified proteins with changed concentration
into a biological context. There are databases
available (e.g., GO, which is gene ontol-
ogy; see www.ncbi.nlm.nih.gov/sites/entrez?
Db=gene) that allow one to classify findings
according to their biological functions or sub-
cellular localization and attribute them to spe-
cific pathways. These comparatively new tools
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gain popularity as they may help to detect
less evident connections between proteins. Still,
some connections may be missed if single com-
ponents of a pathway do not show up as sta-
tistically significantly regulated (“false negative”)
or are not found due to modifications/missing
peptides or incomplete databases (less well
annotated species).
SAMPLE PREPARATION
This topic is dealt last within this review,
as sample preparation depends on the type of
proteomics experiment. Almost any kind of bio-
logical material might be subjected to proteome
analysis, but with different needs for sample
preparation. Proteins in body fluids are already
in solution and only additives appropriate for
proteomic analysis need to be added, taking
care to achieve an adequate protein concentra-
tion and remove possibly interfering substances
(e.g., high concentrations of salts from urine).
Cells and tissues have to be lysed, for exam-
ple, in urea and detergent-containing buffers,
if necessary also aided by freezing/thawing,
sonication, or homogenizing with mechanical
disruption. Tissue material of more rigid struc-
ture or small organisms may be pulverized in
frozen state in liquid nitrogen by grinding with
mortar and pestle followed by extraction with
lysis buffer. Lipophilic or membrane proteins
may need additional or specific types of deter-
gents for solubilization (for 2-DE) or extraction
with organic solvents (for LC, MS). Numerous
protocols, depending on sample source and
analysis method, have been published (see
Posch [2008], a compilation for 2-DE).
Depending on the sample type, the
obtained protein solutions may be highly com-
plex and at the same time display an uneven
distribution of proteins, that is, a few highly
abundant proteins besides a large number of
minor proteins. For example, albumin, trans-
ferrin, and immunoglobulins comprise more
than 70% of the whole protein content of
serum, and the concentration range of proteins
detectable in this body fluid spans more than
10 orders of magnitude, from albumin with
approximately 35–50 mg/ml to interleukin-6 in
the picograms per milliliter range (Anderson
and Anderson, 2002). In tissues and cells, pro-
tein concentration ranges differ by 6–8 orders
of magnitude (Lescuyer et al., 2007), while
proteomic approaches have been estimated
to cover 3–4 orders of magnitude in protein
concentration simultaneously in one separation
(Anderson and Anderson, 2002). Several strate-
gies were developed for enrichment of minor
components or depletion of major proteins
which allow mining deeper into the proteome
(Miller, 2011). Prefractionation of the origi-
nal sample is an appropriate means to arrive
at subproteomes, for example, of subcellu-
lar organelles (Bruno et al., 2002; Lasserre
et al., 2012). In addition, chromatographic
steps (1) based on different separation crite-
ria and (2) taking advantage of specific protein
properties, such as isoelectric point, hydropho-
bicity, and interaction with affinity matrices,
may reduce sample complexity and reveal oth-
erwise hidden proteins (Miller, 2011; Capriotti
et al., 2012).
EXAMPLES OF PROTEOMICS ADDED
VALUE IN TOXICOLOGICAL STUDIES
(DIOXINS, PCB, AND PBDE)
For a widely studied group of ubiquitous
compounds, polyhalogenated aromatic hydro-
carbons (PHAH), a literature search was per-
formed to study the application of proteomic
methods and the value thereof. More specifi-
cally the focus was on PCB, PBDE, and dioxin-
like compounds. These lipophilic chemicals
occur in complex mixtures in the environ-
ment and accumulate in organisms includ-
ing humans. Metabolism of PCB and PBDE
is species, gender, and age dependent (Murk
et al., 1994; Berg et al., 2010), and these
metabolites accumulate (Montaño et al., 2013)
and possess their own toxic properties (Freitas
et al., 2011; Montaño et al., 2012; Kraugerud
et al., 2012), which further complicates the
understanding of the mechanism of action of
these compounds. In vivo effects are diverse
and strongly depend on species, gender, time
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of exposure, endpoint of interest, or exposure
concentrations (Kaya et al., 2002; Lyche et al.,
2004; Oskam et al., 2005; Gutleb et al., 2007;
2010a; 2010b; Zimmer et al., 2008). A sim-
ilarly wide range of effects was observed in
vitro in different cell systems (Aarts et al., 1995;
Bingham et al., 2007; Huljic et al., 2008; Lauer
et al., 2009).
The mechanisms underlying the adverse
effects have been studied with many differ-
ent techniques, such as histopathology, enzyme
activity measurement, reporter gene assays,
and genomics, but also proteomics. Here, the
proteomic methods applied in this field and
their results are reviewed, including details
of proteomics related specificities of sam-
ple preparation and experimental setup. The
added value of successful applications of
proteomics is discussed in toxicological studies
testing dioxins, PCB, and PBDE. Focus will be
on the often-investigated liver as target organ
and location of predominant metabolism.
A systematic literature review searching
in the database Ovid SP Version OvidSP_
UI3.10.00.104 (http://ovidsp.tx.ovid.com;
including Resources Animal Production and
Veterinary Science 1973 to 2013 Week 42, and
Ovid Medline, all topics 1946 to October 30,
2013) for peer-reviewed publications until
October 2013 using proteomic terms in
combination with 2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD), PCB, and PBDE as keywords
resulted in 34 full-length articles (Suppl.
Table 1), which is less than 0.2% of the number
of full length publications obtained without the
proteomic keywords.
Supplementary Table 1 presents the
proteomic methods applied in the reported
studies, thereby detailing investigated species,
applied sample types, separation principles,
detection and identification method, and the
most important findings. The majority of the
proteomic studies summarized in this table are
based on 2-DE methods, applying MS only
for protein identification. Among them, an
increased shift toward 2D-DIGE applications
was noted during the last years. The greater
sensitivity of this method allows working with
smaller sample amounts. Since 2006 only 5 of
34 references mostly rely on MS in combi-
nation with fractionation via SDS-PAGE and
LC or magnetic beads. They were applied as
semiquantitative MS (Brunelli et al., 2012;
Campagna et al., 2011; Chen et al., 2009) and
quantitative MS (Sarioglu et al., 2006; Hu et al.,
2013). Due to recent technical developments
making them more applicable, the use of
MS-based methods is likely to increase in the
future.
As Supplemental Table 1 also shows, the
compound groups selected for this review were
mainly studied in rodents, mostly in liver and
brain, but also other organs. As the liver is
the main detoxifying and protein synthesiz-
ing organ, data focused on liver to describe
effects found via proteomic methods. Both
the reported liver effects from in vivo exper-
iments and in vitro experiments with primary
hepatocytes or hepatoma cell lines are included
and summarized in Table 2 (and in a more
comprehensive form in Suppl. Table 2).
A number of investigations focused on the
impact of dioxin (TCDD) on the protein pattern
in rat liver. The aryl hydrocarbon receptor (AhR)
plays a central role in the responses to dioxins,
together with the ARNT protein (Okey et al.,
2005). Differences in status of the AhR may (to
a large extent) explain differences in sensitivity
of rat strains for TCDD, as for example Long-
Evans rats are more sensitive than Han/Wistar
rats (Pohjanvirta et al., 1993). A comparative 2-
DE investigation in these two rat strains showed
that the abundance changes in several liver pro-
teins of exposed animals was related either to
the strain only, or to TCDD exposure (a sin-
gle oral dose of 100 μg TCDD/kg body weight
[bw] 5 d prior to proteomic analysis), or to
both (Pastorelli et al., 2006). Evidence indicated
that TCDD- and strain-related changes were
oxidative stress-related proteins (e.g., carbonic
anhydrase, peroxonase 3, and apolipoprotein
A-I as protective response to lipid peroxidation)
and apoptosis inducing factor and the so-called
MAWD-binding protein. The latter is a novel
target for TCDD, but its biochemical and physi-
ological role is not yet clarified. Similar effects
were found in Sprague-Dawley rats 7 d after
a single high dose (1–50 μg TCDD/kg bw)
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as well as after 4 wk of a daily administra-
tion of a lower dose (0.01–2.5 μg TCDD/kg
bw) (Lee et al., 2005). Again protective mecha-
nisms were induced, such as proteins protecting
against lipid peroxidation (like apolipoprotein
A-IV) or counteracting TCDD-induced hyper-
thyroidism (like phosphoglycerate mutase) (Lee
et al., 2005).
As discussed previously, protein complex-
ity may be reduced and method sensitivity
for selected protein subpopulations increased
by subcellular fractionation. This was accom-
plished by preparation of microsomes isolated
from rat liver (Bruno et al., 2002). They rep-
resent the endoplasmic reticulum fraction of
the cells, with functions in protein and lipid
synthesis, regulation, and detoxification. Upon
TCDD challenge, the xenobiotic-metabolizing
enzymes were studied, as well as changes in
the transactivating factor nuclear factor (NF)-κB
pathway and NF-κB binding proteins. Changes
were gender dependent in regulation and
appearance (isoform pattern of single proteins)
(Bruno et al., 2002).
Two in vitro studies on TCDD-exposed rat
hepatoma cells (cell line 5L, i.e., epithelial-
like cells that express both AhR and ARNT),
performed by the same group of investigators,
used the same exposure protocol but differ-
ent proteomic methods: nano-LC-MS/MS of
isotope-labeled proteins (Sarioglu et al., 2006)
or 2-DE with fluorophore staining (Sarioglu
et al., 2008). The main technical improvements
introduced with these studies were the use
of several narrow-range pH gradients in the
first dimension and a sensitive protein stain
for 2-DE (Sarioglu et al., 2008), as well as
a quantitative MS approach (Sarioglu et al.,
2006); both approaches allowed reliable detec-
tion of small concentration changes between
samples. Thus, both studies yielded a high
number of regulated proteins, 89 by the MS
approach and 73 in the gels, respectively.
Several pathways were affected, such as cell
cycle regulation, growth factor signaling, and
control of apoptosis. Among them were also
some alterations that could be interpreted as
adaptive response to TCDD-induced oxida-
tive stress and affected mitochondrial functions.
Interestingly, only nine of the proteins were
found in both studies, although similar path-
ways were affected. This surprisingly small over-
lap may be explained by the basics of the
methods, specifically the nature and proper-
ties of the detectable proteins, but indicated
the complementarity of the two approaches.
Previous studies, on quite different topics, also
reported that the choice of methodology affects
the spectrum of proteins detected (Anderson
et al., 2004; Wolff et al., 2006; Wu et al.,
2006). Overall, the described two proteomic
studies by Sarioglu et al. (2006, 2008) showed
up aspects not covered by a previous non-
targeted transcriptomic approach whose main
new findings were related to potential protein
myristoylation in carcinogenesis (Kolluri et al.,
2001).
In marmosets, 4 wk after a single dose
of 100 ng TCDD/kg bw administered subcu-
taneously, no apparent histological alterations
were observed in the liver. Proteomic inves-
tigation of this organ, however, identified a
TCDD-induced spot as porin, an ion chan-
nel protein, and changed levels of proteins
attributed to increased catabolism, which might
be an indication of later obvious adverse
effects (Oberemm et a., 2005). At the same
time, parallel investigation of thymus proteins
showed deregulation of immune-response-
regulated proteins. The effect of TCDD expo-
sure on the protein pattern in this organ even
was greater than that on the liver (Oberemm
et al., 2005). This is in accordance with noted
immunotoxic effects of TCDD (de Swart et al.,
1994; Ross et al., 1996; Luebke et al., 2006).
Only one early paper described the appli-
cation of 2D-DIGE to a TCDD study in birds
(Hisex White, a layer chicken strain). In ovo
injection of 20 ng TCDD immediately after lay-
ing and before incubation of the egg was inves-
tigated for its effects in the liver proteome of
1-d-old chickens (Bruggeman et al., 2006). Two
spots that were affected most were consistently
regulated and identified: One upregulated spot
belonged to the γ-chain of fibrinogen, a pro-
tein responsible for blood clotting. A spot with
decreased intensity was identified as a homo-
logue to NADH ubiquitine oxyreductase, which
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is involved in electron transport and energy sup-
ply, connected to the mitochondrial respiratory
chain. Bruggeman et al. (2006) suggested a cor-
relation to the lower body weight gain noted in
the exposed hatchlings. So-called wasting syn-
drome (reduced body weight without reduced
food intake) is a well-known effect of dioxin
exposure, and might be related to the changes
revealed by proteomic results. These results
need further verification; only one fibrinogen
spot was found regulated although the protein
consists of three spot chains, each consisting of
multiple spots (Miller et al., 2010b).
Thus far, the influence of PBDE on the
liver proteome was only reported in fish, apply-
ing exclusively gel-based approaches. The liver
is an important target organ of PBDE in fish.
In an in vivo experiment male and female
zebrafish were exposed to a mix of 11 bromi-
nated flame retardants including BDE28, 183,
and 209 in feed (10–100 nmol/g feed) for
21 d (Kling et al., 2008). Proteins of cellular
maintenance were found differentially regu-
lated in all animals, but interestingly the oxida-
tive stress protein response differed between
genders. In addition, in female fish protein lev-
els related to iron homeostasis were decreased.
Due to the applied substance mixture, effects
cannot be attributed to single components
(Kling et al., 2008). Proteomic analysis with
2D-DIGE of Atlantic salmon (Salmo salar L.)
primary hepatocytes exposed to three differ-
ent PBDE congeners, either separately or as
a mixture, was performed in addition to a
larger scale gene microarray analysis. Overall
results revealed compound-specific effects on
several biological systems (glucose homeosta-
sis, endocrine metabolism, cell cycle control,
proliferation signal pathway) (Søfteland et al.,
2011). Methods proved complementary, as not
all protein regulations found in DIGE could
be validated on the gene level in additional
real-time quantitative polymerase chain reac-
tion (RT-qPCR) experiments. This illustrates
that protein and gene regulation may differ,
but proteins are the functional compounds
on site. On the other hand, the lack of
comprehensive species-specific databases ham-
pered protein identifications. These issues are
discussed in more details in the following
section.
These examples show the additional value
of including proteomics in a toolbox for path-
way analysis for in vivo and in vitro toxicological
studies. Proteomics could fill the gaps in under-
standing the mechanism underlying observed
toxic effects of TCDD such as wasting syn-
drome, hepatotoxicity, immunotoxicity, hyper-
keratosis, or changes in retinoid levels. Findings
from proteomic investigations may also indicate
yet unknown mechanisms due to its holistic
approach.
IMPORTANT ASPECTS TO CONSIDER IN
EXPERIMENTAL SETUP/STUDY DESIGN
In addition to the normal requirements
for performing a good experiment (appropri-
ate controls and biological and technical repli-
cates, adequate sample material and storage),
there are some aspects specific to proteomic
experiments.
Sensitivity of Proteomic Approaches
Proteomic approaches that reveal in an
untargeted manner overall protein distribution
monitor all changes visible in the sample mate-
rial. Focusing research topic as precisely as pos-
sible, with ideally only one variable parameter
between samples to compare, helps to detect
only changes relevant to the specific topic.
Consistent contamination of the samples with
other proteins lowers the sensitivity to detect
small pattern changes, as only a limited protein
amount may be applied per analysis to achieve
optimal protein separation. Inconsistent accom-
panying proteins, present due to inappropriate
sample preparation, lead either to highly vari-
able data or to inappropriate data interpretation
and erroneous selection of candidates for fur-
ther investigations (Miller et al., 2006). Most
proteomic methods rely on relative quantifica-
tion, relating concentration of single compo-
nents to overall protein content, and monitor
changes of ratios. Variable protein composi-
tion of samples due to inconsistent sample
D
ow
nl
oa
de
d 
by
 [A
rn
o C
. G
utl
eb
] a
t 0
8:5
4 0
3 J
un
e 2
01
4 
75
236 I. MILLER ET AL.
preparation alters these ratios. With an appro-
priate experimental setup, proteomic methods
are sensitive enough to detect also biological
variation of healthy individuals (Winkler et al.,
2008).
Protein Microheterogeneity
Proteins may show microheterogeneity,
which is either gene based or due to posttrans-
lational modifications (phosphorylation, glyco-
sylation). In contrast to genomic approaches,
proteomics discerns these different isoforms
(also called protein species) of the same protein,
for instance, as multiple spots in 2-DE or differ-
ent masses of tryptic peptides in MS. Changes of
those modifications may be specific for patho-
physiological conditions. It was reported that
oxidation results in a reversible shift of the
peroxiredoxin-1 spot in 2-DE gels to lower iso-
electric points (Wagner et al., 2002; Chevallet
et al., 2003). This effect is not noticeable in
one-dimensional electrophoresis, as the mass of
the intact protein does not markedly change.
Thus, although this microheterogeneity makes
protein or peptide patterns more complex and
more difficult to interpret, it may provide insight
into subtle but toxicologically relevant changes
in fine structure of the affected proteins.
Selection of Sample Type
Whole-body lysates yield too general pro-
teomes and should therefore be avoided
unless the organisms are too small to dissect.
Preferably single organs or even better isolated
organelles need to be analyzed. Selection of
subsamples needs to be based on the likely pri-
mary target of the studied toxic compound or
the type of interaction of interest. Often the
liver is studied as major protein synthesizing
and detoxification organ. Other tissues are also
relevant, such as the thymus as discussed earlier
(Oberemm et al., 2005), the nervous system,
the reproductive system, and embryonic tissue.
Target organs reflect local effects, and detection
of local specific marker proteins may display
greater sensitivity than detection of the same
proteins diluted in serum or plasma (Hartwell
et al., 2006). For nondestructive and chronic
biomonitoring, however, plasma proteins seem
more suitable and may be a valuable source for
new methods of targeted proteomics.
In vivo protein responses, either in animals
naturally exposed or from animal experiments,
integrate the homeostatic feedback reactions
of the body to the compound, thereby some-
times masking specific primary effects. In vitro
cell culture or ex vivo experiments with pri-
mary cells from selected tissues allow studying
primary effects without compensating mecha-
nisms. Unfortunately, immortal cell lines often
do not fully reflect the qualities of the original
cells anymore, while primary cells can only be
kept in culture medium for a limited length of
time (usually days) as they tend to change their
behavior (Spreafico et al., 2006). This is known
from studies with enzyme activity, for exam-
ple, cytochrome P-450 isoenzymes (Wortelboer
et al., 1990). A more uniform reaction is to be
expected from in vitro experiments with cell
lines; however, they may have lost some of their
original tissue-type properties (Gutleb, 2011).
Selection of Species
As MS identification needs reliable and
extensive databases for protein identification,
the selection of animal species is impor-
tant when planning an in vivo or in vitro
proteomic experiment. Animal protein or
gene databases—although increasing in num-
ber of species and details covered—are usu-
ally less complete than human. Although
cross-species identification of evolutionary con-
served proteins is possible as well as man-
ual sequencing of peptides, these approaches
may not always be successful and are also
time-consuming (Medzihradszky and Chalkley,
2014). Homologous proteins, even if existing
in the selected species, may differ in sin-
gle amino acids or protein modifications, and
those changes not only can be seen in their
electrophoretic or chromatographic behavior
but also induce different tryptic cleavage, result-
ing in a distinctly altered peptide pattern.
Similarly, for less well characterized animal
species, immunoreagents for verification of
D
ow
nl
oa
de
d 
by
 [A
rn
o C
. G
utl
eb
] a
t 0
8:5
4 0
3 J
un
e 2
01
4 
76
PROTEOMICS IN TOXICOLOGICAL STUDIES 237
results are often not available. All these issues
may be rather limiting when dealing with eco-
toxicological questions, especially when work-
ing with marine species and pollution (Apraiz
et al., 2006; Gomiero et al., 2006). If pro-
tein identification is not possible due to paucity
of databases, establishing protein signatures for
potentially harmful conditions may be a useful
alternative.
Selection of Exposure Time
In general, changes on the protein level as a
response to challenges occur more slowly than
on the transcriptome level. The speed is depen-
dent on the protein of interest, with a wide
time range from minutes to days (Hough et al.,
2012; Gan et al., 2012; Smith et al., 2011).
Breakdown of proteins due to exposure may
occur rapidly, but visibility of an altered protein
production depends on the cell type, the half-
life/turnover rate, and the original level of the
affected protein (Gerner et al., 2002). Absolute
changes in abundant proteins are less well
detected than the same changes in minor pro-
teins, unless only newly synthesized protein is
monitored (e.g., by incorporation of isotopically
labeled amino acids; Gerner et al., 2002). With
increasing exposure time, side effects and com-
pensation reactions within the cell occur, also
in vitro, resulting in time-dependent, slightly
different protein patterns. Time-course studies
thus seem advisable to obtain additional useful
information.
Compound-Specific Marker Proteins
Exposure of organisms to any type of agents
most often leads to both general as well as spe-
cific protein responses. The general ones com-
prise often a similar set of proteins (sometimes
called “balancer proteins” [Petrak et al., 2008;
Wang et al., 2009] or general stress-response
proteins). Besides this general reaction of the
body, the biomarkers that indicate specific reac-
tions to the toxic agent may be difficult to filter
out. For example, in a recent PCB-153 expo-
sure study in Atlantic cod (Gadus morhua),
Berg et al. (2011) reported that approximately
80% of proteins found regulated in brain were
among those frequently noted general-response
proteins and therefore most likely not stressor
specific; still, six proteins were regarded as spe-
cific responses, among them the most strongly
upregulated ones. Other examples show that
also the usually more abundant general stress-
response proteins have their benefits and may
be indicative for a specific stage of disease,
if their time course and ratios are taken into
account; for instance, acute and chronic inflam-
mation in the rat affected the same proteins,
but to a different degree (Gianazza et al.,
2002).
FUTURE PERSPECTIVES OF
PROTEOMICS FOR TOXICOLOGICAL
STUDIES
New technologies or developments aim at
creating easier to handle and high-throughput
applications for routine analyses, or for use
by less specialized scientists. Large-scale search
for regulated proteins can be performed with
antibody microarrays (Spisak et al., 2007).
These rely on comprehensive antibody pan-
els immobilized on chips for specific detection
of large sets of proteins and are species spe-
cific. Elaborate to establish, they may be easy
to apply as soon as commercially manufac-
tured and available for the species of interest.
Contrary to this broad-range screening, there is
an MS-based trend toward specific detection of
selected proteins called “targeted proteomics.”
Here, modern “assays” based on selected reac-
tion monitoring (SRM) are developed specifi-
cally for proteins or peptides of interest. SRM
quantifies, by MS methods, peptides that are
unique for selected proteins. This allows spe-
cific simultaneous detection of multiple targets
at low amounts in complex mixtures. Each of
these assays needs to be set up and validated
(Picotti et al., 2009; Picotti and Aebersold,
2012), but then they can be applied in a high-
throughput manner. This method provides an
interesting perspective and the potential for
future biomonitoring and screening, also on
a large scale, once the databases have been
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improved and potential target proteins have
been identified.
In situ proteomics is a new keyword for
methods derived from a combination of protein
analysis and histological methods. They allow
tissue-, cell-, and organelle-specific localization
of proteins and the study of their distribu-
tion, for example, by proteomic investigation
of particular cell populations. In addition to
the more traditional immunostaining, confo-
cal microscopy, and collection of specific cell
populations under the microscope by laser cap-
ture microdissection for proteomic applications
(Banks et al., 1999; Gillespie et al., 2004),
recently developed MALDI imaging adds MS
methods to this panel (Schwartz and Caprioli,
2010; Seeley et al., 2011). First applications
were mainly focused on smaller molecules, for
answering metabolomic questions, but there
are already reports on proteomics data (Burnum
et al., 2008; Seeley and Caprioli, 2008). In the
MS field, new technical developments are to be
expected, including more easy to use variations
of present methods. Together with improved
protein databases, proteomics will offer an
exciting addition to the current toolbox of
toxicological research.
SUPPLEMENTAL DATA
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 Exposure of female rats to HBCD for
7 days leads to liver proteome
changes.
 Thirty-one spots were of signiﬁcantly
different abundance due to HBCD
exposure.
 Proteins with similar functions were
affected in eu- and hypothyroid
states.
 Main protein targets were in meta-
bolic processes and oxidative stress
response.
 Overall 150 spots varied signiﬁcantly
when comparing thyroid states.
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A B S T R A C T
Hexabromocyclododecane (HBCD) is a brominated ﬂame retardant known for its low acute toxicity as
observed in animal experiments. However, HBCD exposure can affect liver functioning and thyroid
hormone (TH) status. As exact mechanisms are unknown and only limited toxicological data exists, a gel-
based proteomic approach was undertaken. In a eu- and hypothyroid female rat model, rats were exposed
to 3 and 30 mg/kg bw/day HBCD for 7 days via their diet, and exposure was related to a range of canonical
endpoints (hormone status, body weight) available for these animals. Alterations in the liver proteome
under HBCD exposure were determined in comparison with patterns of control animals, for both thyroid
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states. This revealed signiﬁcantly changed abundance of proteins involved in metabolic processes
(gluconeogenesis/glycolysis, amino acid metabolism, lipid metabolism), but also in oxidative stress
responses, in both euthyroid and hypothyroid rats. The results provide a more detailed picture on the
mechanisms involved in these alterations, e.g. at the protein level changes of the proposed inﬂuence of
HBCD on the lipid metabolism. Present results show that proteomic approaches can provide further
mechanistic insights in toxicological studies.
ã 2016 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Hexabromocyclododecane (HBCD, C12H18Br6) was one of the
most commonly used brominated ﬂame retardants (BFRs) used until
2013, mainly in the building industry as an addition to extruded and
expanded polystyrene foams and to a lesser extent also for
impregnation of equipment. Earlier bans of other BFRs led to an
increased production and use of HBCD that was followed by
increasing environmental concentrations (Law et al., 2008). In
2013 the compound was banned in many industrial countries under
the Stockholm convention (https://treaties.un.org/doc/Publication/
CN/2013/CN.934.2013-Eng.pdf),but it isstillproduced and appliedin
theUSA asnon-signatory. Technicalgrade HBCDconsistsofamixture
of three diastereomers, namely a- (10%), b- (9%) and g-HBCD
(81%), which differ in bioaccumulation potential (Szabo et al.,
2010). The large global application of BFRs including HBCD has led to
increasing contamination of the environment as these lipophilic
substances are persistent and accumulate in various biota and
adipose tissue of humans (Covaci et al., 2006; Darnerud, 2003; De
Wit, 2002; Kalachova et al., 2012; Kicinski et al., 2012; Tomko and
McDonald, 2013). Many BFRs including HBCD are known to act as
endocrine disrupters(Covaci et al., 2006; Law et al., 2008; Tomko and
McDonald, 2013; van der Ven et al., 2009).
Animal studies have conﬁrmed low acute toxicity of HBCD.
However, there are clear indications of toxicological effects,
especially in the liver, on the immune system and on serum
thyroid hormone (TH) concentrations, TH dependent develop-
mental processes and sex-dependent responses (Canton et al.,
2008; Germer et al., 2006; van der Ven et al., 2006). Results from in
vivo studies give evidence for the potential disruption of TH
dependent processes, where exposure occurs physiologically in the
presence of circulating THs. Interestingly, HBCD did not respond in
the in vitro T-Screen when tested without any thyroid hormone
present, while it potentiated the effect of 3,30,5-triiodothyronine
(Schriks et al., 2006).
These three factors (still considerable use and production
outside of Europe despite of the ban in 2013, environmental
persistence and accumulation in food chains, and the not
completely understood mechanism of action) convinced us to
undertake the present short-term exposure study in combination
with applying the holistic a posteriori approach of proteomics.
Low serum concentrations of TH (hypothyroidism) negatively
affect neurological development, energy metabolism, early devel-
opment and can also lead to heart failure, whereas hyperthyroid-
ism, the elevation of TH concentrations, typically induces fatigue
and tachycardia and negatively affects bone health and fertility
(Cooper, 2003; Roberts and Ladenson, 2004; Warner and Mittag,
2012). Prevalence of hypothyroidism varies by region, iodine status
and gender with women having a higher prevalence (Canaris et al.,
2000) and as many as 3–5% of pregnant women are developing
sub-clinical hypothyroidism (Teng et al., 2013). Variations of TH
and thyroid stimulating hormone (TSH) concentrations within the
reference ranges are associated with adverse health outcomes
(Taylor et al., 2013), stressing the potential impact of even
moderate TH disruptions. Current human exposure to TH disrupt-
ing compounds falls in the range of in vitro effect concentrations90and exposure is even much higher in wildlife (Montaño et al.,
2013), resulting in TH alterations in wild living animals (Gutleb
et al., 2010).
In standard in vivo toxicological research, generally healthy,
euthyroid (ET) rats are used as models. However, for compounds
such as HBCD the comparison of ET versus hypothyroid (HT)
animals provides an alternative when exploring modes of action
that are currently not fully understood but where TH is known to
modulate HBCD effects (Schriks et al., 2006).
Especially as mechanisms of HBCD toxicity are so complex and
still far from being understood, proteomics, with its unique holistic
a posteriori approach, may contribute important information and
may identify biomarker candidates for chronic effects (Miller et al.,
2014). In order to elucidate if HBCD induced subtle effects
dependent on the thyroid status, state-of-the-art gel-based
proteomic experiments were performed on liver samples from
ET and HT HBCD exposed female rats for which concentrations
were chosen based on previously published in vivo studies (Canton
et al., 2008; van der Ven et al., 2006). The data on affected
pathways from the proteomic approach were compared and linked
with classical biochemical and hormonal endpoints.
2. Animals, materials and methods
2.1. Animals, treatment and experimental protocol
The animal experiment was approved under number
2007-041 by the Animal Welfare Committee of Wageningen
University (Wageningen, The Netherlands). Wistar WU
(HsdCpbWU) rats were obtained from Harlan (Horst, the
Netherlands). Female rats were put on an iodide-poor diet based
on AIN 1993 requirements (Research Diet Services, Wijk bij
Duurstede, the Netherlands) (Reeves et al., 1993; Schroder-van der
Elst et al., 1998 Schroder-van der Elst et al., 1998), supplemented
with 0.75% sodium perchlorate in the drinking water to deplete
endogenous iodide stores (Rijntjes et al., 2009). Control rats
received the iodide poor diet supplemented with 7 mg iodide per
100 g dry weight of the diet to fulﬁll normal iodide requirements.
After two weeks these rats mated and the offspring was weaned at
postnatal day 28 and group housed per diet. The offspring was kept
on the respective diet throughout their life and housed individually
on day 86 postpartum. As HBCD exposure was performed in
custard pudding to avoid discomfort due to oral gavage (ter Veld
et al., 2008), these rats were accustomed to eat 0.5 ml of custard
pudding (Campina, Zaltbommel, the Netherlands, packed in glass
bottles) at the age of 99 days. The HBCD was dissolved in corn oil
and on a daily basis freshly mixed with commercial custard
pudding (100 ml corn oil added to 0.9 ml custard pudding). After
four days of training, HBCD exposure started. The ET and HT
animals were assigned to 3 exposure groups each (n = 6) and orally
administered 0, 3 or 30 mg of HBCD/kg body weight in 0.2 ml
commercial custard pudding per 100 g body weight. They received
the exposure custard 5–30 min before the start of the dark period
for 7 consecutive days, and all ﬁnished it within 5 min. All rats
within a group were of different breeding couples to prevent
parent-dependent effects. The room temperature (20.5–21.5 C),
42 I. Miller et al. / Toxicology Letters 245 (2016) 40–51humidity (55–65%) and light regime (60–80 lux) were kept
constant. At the termination of the experiment, all animals were
sacriﬁced 5–6 h after the start of the light period using CO2/O2.
Blood was collected by heart puncture (5 IU heparin per ml blood),
followed by decapitation. Liver and white adipose tissues were
snap frozen and stored at 80 C. Serum was frozen at 20 C.
2.2. Hormone measurements
Radioimmunoassays (RIAs) for total and free T3 (Diagnostic
Systems Laboratories, Webster, TX, USA; DSL-3100 and DSL-41100,
respectively), corticosterone (MP Biomedicals, Santa Ana, CA, USA;
07-120102) and leptin (Merck Millipore; RL-83K) were performed
according to the manufacturer’s protocols. Luteinizing hormone
(LH), follicle-stimulating hormone (FSH), and TSH were deter-
mined by validated in-house double-antibody RIAs for rat serum
analysis (Mattheij et al., 1995; Palm et al., 2001a,b) using materials
supplied by the National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK; Bethesda, MD, USA). For LH, rLH-I-9 was
used as label and anti-rLH-S-11 as antiserum; for FSH, rFSH-I-7 as
label and anti-rFSH-S-11 as antiserum; for TSH, rTSH-I-9 as label
and anti-TSH-RIA-6 as antiserum; and using Sac–Cel donkey anti-
rabbit (Wellcome Diagnostics; Dartford, UK) as a secondary
antibody. The levels of hormones were expressed in terms of
the NIDDK standards. The detection limit of the assays were:
0.25 ng/ml for T3, 25 ng/ml for corticosterone, 1 ng/ml for leptin,
0.03 ng/ml for LH, 0.4 ng/ml for FSH and 0.1 ng/ml for TSH. The
intra- and interassay variation was determined using several pools
of rat serum and were less than 10% for all purchased RIAs and less
than 9% for all in-house RIAs.
2.3. Determination of internal HBCD dose
Chemical analyses to determine the internal levels of HBCD
were performed at IMARES. In short, 100 mg of adipose tissue
samples were extracted by use of a Soxhlet apparatus with
(hexane/acetone 3:1) and samples were spiked with 13C-labeled
a-, b- and g-HBCD (Cambridge Isotope Laboratories; Andover, MA,
USA) before extraction for quantiﬁcation purposes. The obtained
extracts were cleaned-up using concentrated sulphuric acid. Next,
extracts were evaporated and dissolved in 1 ml methanol. a-,
b- and g-diastereomeres were determined by LC-ESI-MS using a
Surveyor LC coupled with an LCQ Advantage Ion Trap MS according
to the method described by van der Ven et al. (2009). Calibration
ranged from 5 to 1000 ng/ml, samples with concentrations above
the calibration curve were diluted to fall within the calibration
range. R2 was >0.999 for all compounds. The lower limit of
quantiﬁcation was 5 ng/ml in the ﬁnal extract.
2.4. Statistical analysis (for hormonal measurements)
Data is expressed as mean  standard error of the mean (SEM).
Statistical analysis was carried out using SPSS 19.0 for Windows.
Data was tested for normality using the Shapiro–Wilk test. If
normality could not be assumed, dose groups were
LOG10 transformed. Means of all rats were compared using a
two-way Univariate Analysis of Variance (ANOVA). Correlation
between internal g-HBCD dose and other measured parameters
was tested with the Spearman’s rank correlation test. Values of
P < 0.05 were considered to be signiﬁcant.
2.5. Proteomics
Four samples per experimental group (ETand HT; 0, 3 and 30 mg/
kg/day HBCD, respectively) were randomly selected for proteomic
experiments. Liver samples were subjected to two-dimensional91ﬂuorescence difference gel electrophoresis (2D-DIGE) following the
protocol previously reported with minor modiﬁcations (Haas et al.,
2011; Pasquali et al., 2013). In brief, rat liverswere homogenized with
the GE sample grinding kit in lysis buffer (urea 7 M; thiourea 2 M;
CHAPS 2% w/w; tris 30 mM) containing protease inhibitor Complete
Mini (Roche, Brussels, Belgium). After centrifugation for 15 min at
30,000g the supernatant was collected and stored at 20 C until
use. Fifty mg per sample, as determined by the Bradford method
(Bradford, 1976), were labelled with CyDyes according to the
manufacturer’s instructions and separated on IPGs of a non-linear
3–10 pH-range followed by SDS-PAGE in 12.5% precast gels (SERVA
Electrophoresis GmbH, Heidelberg, Germany). Gel images acquired
using a Typhoon 9400 were analyzed by the DeCyder 7.0 software
package (both GE Healthcare, Diegem, Belgium). Gels were matched
and subjected to univariate and multivariate analysis in order to
highlight differentially expressed spots with the following criteria:
for univariate analysis fold change of at least 1.3, P < 0.05 and
ANOVA P < 0.05; for multivariate analysis two way ANOVA P-value
was considered to be signiﬁcant when P < 0.05.
Differentially abundant spots were automatically picked,
tryptically digested and spotted on the MALDI target by the use
of the Ettan Spot Handling Workstation (GE Healthcare, Diegem,
Belgium). Protein identiﬁcation was carried out on the Applied
Biosystems MALDI-Tof-Tof 4800 Proteomics Analyser (Applied
Biosystem, Gent, Belgium) as previously described (Haas et al.,
2011). Protein identiﬁcation was performed by searching peptide
mass ﬁngerprints (PMF) and MS/MS spectra against the SwissProt
database with “Rattus norvegicus” as taxonomy. Searches were
performed using the ProteinPilot software (Sciex, Nieuwerkerk aan
den Ijssel, The Netherlands) and the searching algorithm MASCOT
(Matrix Science, www.matrixscience.com, London, UK). For each
spot one PMF and up to 8 MS/MS spectra were generated.
Parameters for the search were set as follow: up to two missed
cleavages allowed, 100 ppm tolerance in PMF, 0.75 Da mass
tolerance for precursor ion mass, carbamidomethyl cysteine as
ﬁxed modiﬁcation, oxidation of methionine and oxidation of
tryptophan (single oxidation, double oxidation and kynurenin) as
variable modiﬁcations. Identiﬁcations were considered to be
signiﬁcant when the combined MOWSE score had P < 0.05.
Statistics, including univariate analysis (ANOVA and t-test) and
multivariate analysis (two way ANOVA), was performed using the
Extended Data Analysis (EDA) module, which is present inside the
Decyder 7.0 software package.
Publicly available websites were used to retrieve additional
information on proteins (localization, function) and to perform
pathway analysis: UniProtKB database (http://www.uniprot.org/),
STRING: functional protein association networks, v 9.1 (http://
string-db.org/) (Snel et al., 2000; Franceschini et al., 2013), for
Rattus norvegicus proteins or genes, respectively, and for proteins
with accession numbers from UniProt.
STRING classiﬁes proteins of a candidate list according to Gene
ontology (GO) categories (cell component, function, process) and
allows graphical display of genes (and gene products) that previous
research has found connected (enrichment analysis can ﬁnd over-
or under-represented genes). STRING uses different databases as
input, among them also KEGG (Kyoto Encyclopedia of Genes and
Genomes, http://www.genome.jp/kegg/pathway.html), for map-
ping of genes/gene products in biological pathways and establish-
ing connections between them.
3. Results
3.1. Basic animal data and hormone measurements
The induction of hypothyroidism was successfully achieved as
the plasma concentration of TSH was increased over 40-fold, while
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respectively (Table 1). The body weight of the HT rats was
approximately half of that of the ET non-treated controls and did
not change over the course of the dietary HBCD exposure. Plasma
leptin concentrations were statistically signiﬁcantly elevated in the
HT rats (P < 0.001), whereas corticosterone and the levels of the
gonadotropins LH and FSH were not altered (Table 1).
3.2. HBCD tissue concentrations
Internal HBCD concentrations were determined in adipose
tissue to evaluate uptake and accumulation of HBCD in the rats
following exposure to 3 or 30 mg/kg/day HBCD for 7 days. Whereas
the a- and b-HBCD levels were below the limit of detection for all
of the non-exposed animals, and below the limit of quantiﬁcation
for the 3 mg/kg dose group, g-HBCD was present in the 30 mg/kg
treated rats. Accumulated g-HBCD content of the higher exposed
30 mg/kg/day dose groups was only about 2–3 times higher than
that of the 3 mg/kg/day groups for ET and HT rats, respectively
(Table 1).
3.3. HBCD effects on hormone levels
The 7-day exposure to HBCD did not result in changes in the
plasma TH or TSH concentrations, nor did it affect leptin or
corticosterone (two way ANOVA; Table 1). However, the increase in
TSH concentration was positively correlated with the internal
g-HBCD concentration in ET rats (Spearman’s Rho = 0.719,
P < 0.001), while no such correlation was observed in the HT rats,
which already had substantially elevated TSH levels (Spearman’s
Rho = 0.259, P = 0.299) (Fig. 1). The gonadotropic hormone LH, but
not FSH, were signiﬁcantly decreased in the 3 mg/kg/day HBCD
group compared to the non-exposed controls (P < 0.05). However,
no such effect was observed in the highly exposed groups (Table 1).
3.4. Proteomics
Two-dimensional electrophoresis of liver proteins resulted in
complex patterns of about 3000 spots per gel (Fig. 2). Patterns of
24 gels from different exposures of ET and HT rats were evaluated.Table 1
Animal data.
HBCD-
group
0 3 30 T
v
Body weight (g) ET 267  8 261  9 276  10 <
HT 143  15 136  9 132  10 
Liver weight (g) ET 9.50  0.44 8.95  0.57 9.63  0.47 <
HT 4.56  0.61 4.02  0.29 4.23  0.29 
TSH (ng/ml) ET 0.33  0.03 0.42  0.04 0.48  0.06 <
HT 14.68  4.18 16.36  2.60 11.86  0.66 
TT3 (ng/ml) ET 362  32 369  24 305  16 0
HT 305  8 259  40 265  22 
fT3 (pg/ml) ET 6.62  0.45 7.30  0.30 6.56  0.50 <
HT 1.41  0.40 1.66  0.08 1.91  0.40 
LH (ng/ml) ET 3.64  0.49 1.72  0.34 2.49  0.30 0
HT 3.09  0.76 1.91  0.54 2.81  0.60 
FSH (ng/ml) ET 2.8  0.7 3.7  1.3 3.6  1.0 0
HT 3.8  0.5 2.8  0.3 5.2  1.5 
Leptin (ng/ml) ET 5  1 5  1 5  1 <
HT 19  4 22  6 14  3 
Corticosterone (ng/ml) ET 281  69 413  119 338  73 0
HT 249  51 187  82 242  70 
Internal g-HBCD (mg/kg
lwa)
ET <lod 56.8  7.2 113.2  9.9 0
HT <lod 50.1  5.5 160.0  18.8
<lod, below detection limit.
n = 6 per group. Mean  SEM is given.
a lw, lipid weight.
92Thirty-one spots were of signiﬁcantly different abundance due to
HBCD exposure (Fig. 2 and Table 2). Overall 150 spots varied
signiﬁcantly when also including the thyroid status and the full
dataset is shown in (Fig. 1 and Table 2a in Miller et al., submitted),
whereas Table 2 displays only the proteins/protein spots discussed
in more detail here. Proteins were successfully identiﬁed by MS
analyses (Supplementary 1 and Table 1 in Miller et al., submitted).
Proteins may show up as a row of spots (reﬂecting micro-
heterogeneity, e.g. due to present post-translational modiﬁcations)
or consist of more than one spot row (in the case of subunits or
protein degradation). This is due to the separation conditions in
two-dimensional electrophoresis (denaturing, reducing). Also in
the current study, some proteins were found on more than one
location of the gel.
3.4.1. Inﬂuence of HBCD on liver protein patterns
A pairwise comparison of groups with different exposure to
HCBD (0, 3, 30 mg/kg/day) revealed 13 proteins (18 spots) with
signiﬁcant changes in abundance amongst ET rats and 9 proteins
(13 spots) between the HT groups (Table 2). The affected proteins
are mainly located in mitochondria and cytoplasm, and have
various functions (Table 2b in Miller et al., submitted). HBCD-
dependent changes in protein levels were generally small (in the
range of 30–60%), and resulted in different lists of affected proteins
depending on the actual thyroid status, with little overlap.
Whereas in ET animals similar numbers of spots showed either
increased or decreased abundance and the 3 mg/kg/day group
seemed to be more affected than the 30 mg/kg/day group, in HT
animals HBCD treatment led to reduced levels of proteins,
especially in the higher exposed group (Fig. 3a and b, Table 2,
Table 2a in Miller et al., submitted). For thirteen of the overall
31 affected spots signiﬁcant variations appeared between the two
HBCD exposed groups (e.g. serum albumin; Table 2, Table 2a in
Miller et al., submitted).
Only two proteins, namely aldehyde dehydrogenase family
1 member L1 (AL1L1) and electron transfer ﬂavoprotein subunit
beta (ETFB) showed a statistically signiﬁcant change depending on
both HBCD and thyroid status (Table 2 and Fig. 3a and b).
All proteins with signiﬁcant abundance changes were searched
in the various modules of the STRING database. In the category ofhyroid effect (P-
alue)
HBCD effect (P-
value)
Interaction (P-
value)
Spearman’s Rho
0.001 0.768 0.540 0.162
0.010
0.001 0.452 0.839 0.048
0.059
0.001 0.553 0.528 0.719*
0.259
.003 0.177 0.385 0.200
0.343
0.001 0.478 0.460 0.061
0.214
.487 0.042 0.795 0.346
0.060
.487 0.414 0.432 0.043
0.000
0.001 0.445 0.487 0.063
0.364
.090 0.904 0.497 0.101
0.007
.092 <0.001 0.016
Fig. 1. Plasma TSH concentration as function of white adipose tissue g-HBCD concentration in euthyroid (a) and hypothyroid (b) rats exposed to 0, 3 or 30 mg HBCD/kg bw
during 7 days (n = 6). In euthyroid rats the TSH concentration increases signiﬁcantly with higher HBCD exposure (Spearman’s Rho = 0.719, P < 0.001). The plasma TSH
concentration in hypothyroid control rats is elevated when compared to that of euthyroid rats (Table 1).
44 I. Miller et al. / Toxicology Letters 245 (2016) 40–51affected functions mainly binding of different small molecules
(organic cyclic or heterocyclic compounds, anions, organic acids,
drugs, cofactors, carboxylic acid) and several types of catalytic or
transferase activity were found. These functions are attributed
preferentially to processes like response to stress, external stimuli
or metal ions, regulation of apoptosis, lipid metabolism and
mitochondrial transport as well as response to nutrient level and
starvation. KEGG categorization further indicated that HBCD
treatment of ET animals affected proteins from metabolic path-
ways like lipid metabolism (e.g. butanoate metabolism, ketone
body synthesis and degradation), glycolysis/gluconeogenesis, and
processing of different amino acids (valine, leucine, isoleucine).
Proteins from HT rats are also linked to metabolic processes,
mainly concerning glycolysis/gluconeogenesis and amino acids
(glycine, serine, threonine) (Table 3).Fig. 2. Two-dimensional gel image of a rat liver sample.
2D-DIGE separation of rat liver sample (master gel, grey level image). Marked spots show 
(squares), 13 in HT rats (triangles). For details on these spots (spot numbers, identiﬁca
933.4.2. Inﬂuence of thyroid status on liver protein pattern as a function
of HBCD concentration
This evaluation approach focused on the spot intensity/protein
concentration differences between ET and HT animals of corre-
sponding HBCD exposure groups, to possibly evaluate differences
in susceptibility based on thyroid state. Forty-four spots were
statistically signiﬁcantly changed in abundance when comparing
unexposed animal groups of different thyroid status (23 up- and 21
down-) and belonged to 36 proteins (Fig. 4, Table 2, Table 2c in
Miller et al., submitted). This number increased considerably in
rats exposed to 3 mg HBCD/kg/day (102 spots from 71 proteins)
and dropped again at 30 mg HBCD/kg/day (49 spots from 39
proteins) (Table 2d in Miller et al., submitted).
Grouping affected proteins into categories (STRING database,
based on KEGG pathways) results for all three exposurestatistically signiﬁcant changes in abundance upon HBCD exposure: 18 in ET animals
tions, changes) see (Miller et al., submitted).
Table 2
Proteins found affected and discussed in more detail 74 items overall: 31 spots changed due to HBCD; 44 spots in controls due to thyroid status, one overlap; n = 4 per group.
The complete dataset of affected proteins (150 spots) can be found in (Miller et al., submitted).
Spot number Name Protein ID ET3/
ET0
ET30/
ET0
ET30/
ET3
HT3/
HT0
HT30/
HT0
HT30/
HT3
HT0/ET0
1097 2-Oxoglutarate dehydrogenase_mitochondrial ODO1_RAT 0.901 0.917 1.020 0.800 0.826 1.030 1.380
1314 3-Ketoacyl-CoA thiolase_mitochondrial THIM_RAT 0.800 1.100 1.370 0.840 0.901 1.070 1.120
1407 3-Oxo-5-beta-steroid 4-dehydrogenase AK1D1_RAT 1.050 1.090 1.050 0.704 0.862 1.220 1.490
1155 78 kDa glucose-regulated protein GRP78_RAT 0.877 1.000 1.140 1.050 0.901 0.855 0.746
1354 Actin_cytoplasmic 1 ACTB_RAT 1.120 0.917 0.820 1.060 1.180 1.120 0.671
1381 Adipocyte plasma membrane-associated protein APMAP_RAT 1.020 1.070 1.050 0.980 0.990 1.010 0.699
1260 Alanine–glyoxylate aminotransferase 2_mitochondrial AGT2_RAT 0.885 0.926 1.040 1.020 0.870 0.855 1.600
1111 Aldehyde dehydrogenase 1 family_member L2 gi|21961590 0.926 1.140 1.230 0.962 0.746 0.775 1.150
1099 Aldehyde dehydrogenase family 1 member L1 AL1L1_RAT 0.794 0.775 0.980 1.230 0.813 0.662 1.080
1104 Aldehyde dehydrogenase family 1 member L1 AL1L1_RAT 0.769 0.690 0.893 0.885 0.840 0.952 0.935
1105 Aldehyde dehydrogenase family 1 member L1 AL1L1_RAT 0.680 0.649 0.952 0.855 0.855 1.000 0.885
1107 Aldehyde dehydrogenase family 1 member L1 AL1L1_RAT 0.662 0.578 0.870 0.758 0.820 1.080 0.833
1108 Aldehyde dehydrogenase family 1 member L1 AL1L1_RAT 0.625 0.704 1.130 1.190 0.794 0.667 1.01
1109 Aldehyde dehydrogenase family 1 member L1 AL1L1_RAT 0.952 0.901 0.943 0.877 0.847 0.971 1.360
1110 Aldehyde dehydrogenase family 1 member L1 AL1L1_RAT 0.633 0.610 0.962 0.901 0.800 0.885 0.893
1114 Aldehyde dehydrogenase family 1 member L1 AL1L1_RAT 0.704 0.885 1.250 1.020 0.769 0.752 0.826
1246 Alpha-1-antiproteinase A1AT_RAT 0.699 0.877 1.260 1.050 1.030 0.971 1.030
1093 Alpha-aminoadipic semialdehyde synthase_mitochondrial AASS_RAT 0.971 0.943 0.971 0.800 0.746 0.926 1.570
1275 Alpha-enolase ENOA_RAT 0.926 0.909 0.980 0.935 0.769 0.826 1.030
1393 Arginase-1 ARGI1_RAT 1.070 1.120 1.050 0.704 0.877 1.240 1.780
1323 Argininosuccinate synthase ASSY_RAT 0.855 0.704 0.826 1.030 0.769 0.746 1.280
1326 Argininosuccinate synthase ASSY_RAT 1.000 1.030 1.030 1.060 0.794 0.752 1.060
1337 Aspartate aminotransferase_cytoplasmic AATC_RAT 1.010 1.050 1.040 0.893 0.794 0.893 1.690
1298 Betaine–homocysteine S-methyltransferase 1 BHMT1_RAT 1.100 1.040 0.935 1.010 0.730 0.719 1.410
1310 Betaine–homocysteine S-methyltransferase 1 BHMT1_RAT 0.901 0.862 0.952 0.990 0.637 0.645 1.440
1063 Carbamoyl-phosphate synthase CPSM_RAT 0.971 0.971 1.000 0.806 0.820 1.020 1.320
1071 Carbamoyl-phosphate synthase CPSM_RAT 0.901 0.971 1.080 0.935 0.901 0.962 1.380
1078 Carbamoyl-phosphate synthase CPSM_RAT 1.000 1.010 1.010 0.935 0.847 0.909 1.300
1496 Carbonic anhydrase 3 CAH3_RAT 1.010 1.280 1.270 0.885 0.917 1.040 2.080
1509 Carbonic anhydrase 3 CAH3_RAT 1.210 1.450 1.200 0.719 0.820 1.140 2.980
1344 Creatine kinase B-type KCRB_RAT 1.370 1.280 0.935 0.909 0.971 1.070 1.170
1449 D-beta-hydroxybutyrate dehydrogenase_ BDH_RAT 0.741 1.030 1.380 0.826 0.833 1.010 1.150
1129 Dimethylglycine dehydrogenase_mitochondrial M2GD_RAT 1.090 1.170 1.080 0.610 0.602 0.990 1.900
1477 Electron transfer ﬂavoprotein subunit beta ETFB_RAT 1.210 1.280 1.060 0.763 1.010 1.310 1.240
1483 Electron transfer ﬂavoprotein subunit beta ETFB_RAT 1.330 1.290 1.060 0.855 0.990 1.310 1.14
1121 Elongation factor 2 EF2_RAT 0.847 1.230 1.450 1.070 0.909 0.847 0.935
1388 Farnesyl pyrophosphate synthase FPPS_RAT 0.980 0.901 0.917 0.952 1.030 1.070 0.676
1365 Fructose-bisphosphate aldolase B ALDOB_RAT 1.050 0.952 0.901 1.150 0.833 0.725 1.160
1506 Glutathione S-transferase alpha-1 GSTA1_RAT 0.862 0.826 0.962 0.813 1.280 1.580 0.431
1507 Glutathione S-transferase alpha-2 GSTA2_RAT 0.730 0.769 1.050 0.952 1.470 1.550 0.415
1508 Glutathione S-transferase alpha-3 GSTA3_RAT 0.820 0.901 1.100 1.280 1.610 1.250 0.322
1513 Glutathione S-transferase alpha-4 GSTA4_RAT 0.746 0.794 1.060 0.901 1.130 1.260 0.629
1522 Glutathione S-transferase P GSTP1_RAT 0.305 0.266 0.870 0.926 1.080 1.170 0.215
1166 Heat shock cognate 71 kDa protein HSP7C_RAT 0.935 1.010 1.080 0.962 0.971 1.010 0.746
1127 Heat shock protein HSP 90-alpha HS90A_RAT 0.917 0.980 1.070 0.917 0.917 1.010 0.685
1569 Hemoglobin subunit alpha-1/2 HBA_RAT 1.150 1.340 1.160 0.826 0.794 0.962 0.758
1273 Hydroxymethylglutaryl-CoA synthase_mitochondrial HMCS2_RAT 0.769 0.917 1.190 0.847 0.833 0.980 1.100
1296 Iﬁ47 protein gi|
44890246
1.060 0.813 0.769 1.280 1.300 1.020 0.391
1480 Isoamyl acetate-hydrolyzing esterase 1 IAH1_RAT 1.080 1.120 1.040 0.943 0.943 1.000 0.730
1217 Liver carboxylesterase 4 EST4_RAT 0.893 0.926 1.040 0.952 0.990 1.030 0.685
1471 Nicotinate-nucleotide pyrophosphorylase – carboxylating-
homolog
NADC_RAT 1.010 1.020 1.020 0.909 1.110 1.210 0.699
1460 Nitrilase homolog 1 NIT1_RAT 0.847 0.787 0.926 0.980 0.962 0.980 1.360
1544 Peptidyl-prolyl cis-trans isomerase A PPIA_RAT 0.909 1.070 1.170 0.870 0.962 1.110 0.654
1540 Peptidyl-prolyl cis-trans isomerase F_mitochondrial PPIF_RAT 1.550 1.770 1.140 0.855 0.806 0.935 1.510
1270 Phenylalanine-4-hydroxylase PH4H_RAT 1.250 1.120 0.893 0.901 0.813 0.901 1.320
1212 PREDICTED aldehyde dehydrogenase 8 family_member A1-like
isoform 2
gi|
109460389
0.794 0.943 1.190 1.410 0.893 0.633 0.901
1219 Protein disulﬁde-isomerase A3 PDIA3_RAT 0.877 0.971 1.110 1.020 0.943 0.926 0.741
1495 Protein ETHE1_mitochondrial gi|
157819563
0.962 0.901 0.935 1.020 0.885 0.870 1.580
1077 Pyruvate carboxylase_mitochondrial PYC_RAT 0.855 0.840 0.980 0.971 0.893 0.917 0.714
1082 Pyruvate carboxylase_mitochondrial PYC_RAT 0.794 0.862 1.080 0.971 1.010 1.050 0.685
1213 Pyruvate kinase isozymes R/L KPYR_RAT 1.080 0.820 0.758 1.010 0.971 0.952 1.300
1112 Sarcosine dehydrogenase_mitochondrial SARDH_RAT 0.893 0.826 0.926 0.952 0.813 0.855 1.440
1115 Sarcosine dehydrogenase_mitochondrial SARDH_RAT 0.813 0.763 0.943 0.820 0.719 0.877 1.610
1116 Sarcosine dehydrogenase_mitochondrial SARDH_RAT 0.847 0.794 0.935 0.820 0.676 0.820 1.780
1117 Sarcosine dehydrogenase_mitochondrial SARDH_RAT 0.943 0.893 0.943 0.855 0.800 0.943 1.370
1119 Sarcosine dehydrogenase_mitochondrial SARDH_RAT 0.893 0.885 0.980 0.855 0.800 0.935 1.420
1135 Serotransferrin TRFE_RAT 0.735 0.794 1.080 1.080 1.040 0.962 0.667
1173 Serum albumin ALBU_RAT 0.617 0.847 1.370 0.885 1.010 1.140 1.080
1181 Serum albumin ALBU_RAT 0.662 0.862 1.300 0.840 1.050 1.240 1.130
1186 Serum albumin ALBU_RAT 0.625 0.847 1.360 0.855 1.040 1.210 1.060
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Table 2 (Continued)
Spot number Name Protein ID ET3/
ET0
ET30/
ET0
ET30/
ET3
HT3/
HT0
HT30/
HT0
HT30/
HT3
HT0/ET0
1366 Serum paraoxonase/lactonase 3 PON3_RAT 1.030 0.962 0.926 0.893 1.000 1.120 0.625
1438 Sulfotransferase 1A1 ST1A1_RAT 0.901 0.935 1.040 0.935 0.800 0.855 1.300
1473 Thiopurine S-methyltransferase TPMT_RAT 1.040 1.070 1.030 1.010 0.833 0.826 1.390
1443 Thiosulfate sulfurtransferase THTR_RAT 0.769 0.943 1.230 0.893 0.935 1.040 1.160
Bold values denote changing at least by 30% and P < 0.05.
Fig. 3. HBCD induced changes in liver proteome.
Spots/proteins statistically signiﬁcantly changed in HBCD exposure in ET rats (A) or HT rats (B), compared to healthy untreated controls of the respective thyroid status.
Proteins grouped according to biological functions. Protein abbreviations (for full names see Table 2a in Miller et al., submitted) are given together with the spot numbers
(“#”), as some proteins show up as several spots.
*: signiﬁcant change to control (at least 30% change, P  0.05, spot present in at least 75% of the gels)
	: signiﬁcant change between groups exposed to 3 and 30 mg/kg bw (at least 30% change, P  0.05, spot present in at least 75% of the gels).
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I. Miller et al. / Toxicology Letters 245 (2016) 40–51 47concentrations in a high protein count impacting metabolic
pathways (12–28 annotations, the highest number again at
3 mg/kg/day HBCD, Table 3, Supplement 3). The list suggests
changes in metabolism of various amino acids, and additionally
affected glycolysis/gluconeogenesis and lipid metabolism at the
3 mg/kg/day group. Interestingly, a group of 5–7 proteins
involved in glutathione metabolism (mainly glutathione-S-Table 3
Pathway analysis (STRING database) based on HBCD dependent protein abundance chang
given. For HT animals not enough changed proteins were found to establish a network
Changed proteins/KEGG
GO_id Term HBCD and ET number of
genes
GO_
rno01100 Metabolic pathways 6 rno0
rno00650 Butanoate metabolism 2 rno0
rno00280 Valine, leucine and isoleucine
degradation
2 rno0
rno00072 Synthesis and degradation of ketone
bodies
2 rno0
rno0
rno0
rno0
rno0
Changed proteins/Pprocess
(limited to the 20 most frequent terms)
GO:0006950 Response to stress 4 
GO:0051641 Cellular localization 3 
GO:0043067 Regulation of programmed cell death 3 
GO:0042981 Regulation of apoptotic process 3 
GO:0010941 Regulation of cell death 3 
GO:0009605 Response to external stimulus 3 
GO:2001233 Regulation of apoptotic signaling pathway 2 
GO:1902582 Single-organism intracellular transport 2 
GO:0060548 Negative regulation of cell death 2 
GO:0055114 Oxidation-reduction process 2 
GO:0051346 Negative regulation of hydrolase activity 2 
GO:0044255 Cellular lipid metabolic process 2 
GO:0043086 Negative regulation of catalytic activity 2 
GO:0043069 Negative regulation of programmed cell death 2 
GO:0043066 Negative regulation of apoptotic process 2 
GO:0042594 Response to starvation 2 
GO:0031667 Response to nutrient levels 2 
GO:0010038 Response to metal ion 2 
GO:0010035 Response to inorganic substance 2 
GO:0009991 Response to extracellular stimulus 2 
GO:0006839 Mitochondrial transport 2 
GO:0006629 Lipid metabolic process 2 
Changed proteins/Function
(limited to the 20 most frequent terms)
GO:0043168 Anion binding 5 
GO:0016740 Transferase activity 4 
GO:0008144 Drug binding 2 
GO:0008289 Lipid binding 2 
GO:0016746 Transferase activity, transferring acyl groups 2 
96transferases), but also in the processing of various xenobiotics
or drugs by cytochrome P450, show statistical signiﬁcance
only in control animals and the 3 mg/kg/day group, whereas
antigen processing and presenting proteins (esp. protein
disulﬁde-isomerase A3 and 78 kDa glucose-regulated protein)
are signiﬁcantly affected only under baseline and at the
30 mg/kg/day condition.es compiled in Table 2 or (Miller et al., submitted). Most frequent hits (up to 20) are
, therefore the combined ET + HT list was chosen.
id Term HBCD and (HT + ET) number of
genes
1100 Metabolic pathways 11
0010 Glycolysis/Gluconeogenesis 3
0650 Butanoate metabolism 2
0330 Arginine and proline metabolism 2
0280 Valine, leucine and isoleucine
degradation
2
0270 Cysteine and methionine metabolism 2
0260 Glycine, serine and threonine
metabolism
2
0072 Synthesis and degradation of ketone
bodies
2
GO:0044699 Single-organism process 14
GO:0008150 Biological_process 13
GO:0044710 Single-organism metabolic process 11
GO:0008152 Metabolic process 11
GO:0044763 Single-organism cellular process 10
GO:0009987 Cellular process 10
GO:0044281 Small molecule metabolic process 9
GO:0044237 Cellular metabolic process 9
GO:0044238 Primary metabolic process 8
GO:0071704 Organic substance metabolic process 8
GO:0050896 Response to stimulus 8
GO:0019752 Carboxylic acid metabolic process 7
GO:0043436 Oxoacid metabolic process 7
GO:0006082 Organic acid metabolic process 7
GO:1901575 Organic substance catabolic process 6
GO:0009056 Catabolic process 6
GO:0055114 Oxidation-reduction process 5
GO:0044712 Single-organism catabolic process 5
GO:1901564 Organonitrogen compound metabolic process 5
GO:0006793 Phosphorus metabolic process 5
GO:0006950 Response to stress 5
GO:0006810 Transport 5
GO:0005488 Binding 13
GO:0003674 Molecular_function 13
GO:0043167 Ion binding 9
GO:0003824 Catalytic activity 8
GO:1901363 Heterocyclic compound binding 8
GO:0097159 Organic cyclic compound binding 8
GO:0043168 Anion binding 7
GO:0005515 Protein binding 7
GO:0016740 Transferase activity 6
GO:0036094 Small molecule binding 6
GO:0000166 Nucleotide binding 5
GO:1901265 Nucleoside phosphate binding 5
GO:0005524 ATP binding 4
GO:0032559 Adenyl ribonucleotide binding 4
GO:0030554 Adenyl nucleotide binding 4
GO:0001883 Purine nucleoside binding 4
GO:0032550 Purine ribonucleoside binding 4
GO:0032549 Ribonucleoside binding 4
GO:0035639 Purine ribonucleoside triphosphate binding 4
GO:0001882 Nucleoside binding 4
Fig. 4. Comparison of rat liver protein abundance in untreated controls of different thyroid status.
Spots/proteins statistically signiﬁcantly changed between HT0 and ET0 (expressed as protein ratios). Statistical signiﬁcance deﬁned as at least 30% change, P  0.05, and spot
present in at least 75% of the gels. Proteins grouped according to biological functions. Protein abbreviations (for full names see Table 2a in Miller et al., submitted) are given
together with the spot numbers (“#”), as some proteins show up as several spots. For detailed data on changes and identiﬁcations see (Miller et al., submitted).
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depending on the thyroid status is presented with one sub-ﬁgure
for each selected HBCD concentration (Fig. 5, Supplement 2), as
retrieved from the STRING database. In control animals, differences
between ET and HT appear mainly in ﬁve separate clusters; a
strongly interconnected one consisting of GSTs (glutathione-S-
transferases), and four others of smaller size, mostly related to
binding functions of smaller molecules and increased abundance
of reaction partners (the clusters with cytoplasmic aspartate
aminotransferase (gene name: Got1) and sarcosine dehydrogenase
(gene name: Sardh)) as nodes, or one related to antigen processing
and presentation (mostly heat shock proteins) (Fig. 5a). In the low
HBCD exposure groups the previous single clusters are now
interconnected; the clusters include lipid or fatty acid binding
proteins (e.g. fatty acid binding protein from liver, albumin) or
structural proteins (actin), and an even stronger GST cluster
(Fig. 5b). In the higher HBCD exposure group, the interaction
network is characterized by fewer conﬁdent connections, a larger
but less conﬁdent cluster of heat-shock proteins, and disappear-
ance of a statistically signiﬁcant GST cluster (Fig. 5c).
Taking a closer look at the ﬁve most regulated members of the
GST family (Fig. 4, Table 2e in Miller et al., submitted) shows clear
differences in baseline values depending on thyroid status.
Additionally, HBCD treatment of ET animals leads to markedly
lower abundance of glutathione S-transferase P (GSTP1, P < 0.1;
Table 2).
Another protein with concentration-dependent changes is
mitochondrial dimethylglycine dehydrogenase (M2GD). It is one
of the few proteins found to show a clear inﬂuence of HBCD
treatment in HT rats (Fig. 3b), and at the same time a 1.9-fold
higher level in HT0 compared to ET0. Interestingly, HBCD
treatment decreases M2GD abundance of HT animals to almost
ET level (which is hardly inﬂuenced by HBCD concentration,
Table 2).
Database mining also locates some proteins/genes involved in
KEGG pathways connected to fatty acid metabolism and fat97digestion/adsorption in the 3 mg/kg/day group (Table 3, Supple-
ment 3, pathways rno00062, rno00071, and rno04975) besides
propanoate and butanoate metabolisms which include some lipid
processing features (pathways rno00640, and rno00650). Mem-
bers attributed to them are all increased during hypothyroidism,
except for liver fatty acid binding protein (Table 2a in Miller et al.,
submitted), and they appear in a big multi-component cluster
around Got1 and Got2 (aspartate aminotransferase, cytoplasmic
and mitochondrial, respectively, Fig. 5b, Supplement 2b). Some
additional proteins with functions in lipid metabolic processes are
also categorized under the general term “metabolic pathways”
(Supplementary 3, rno01100; e.g. mitochondrial pyruvate carbox-
ylase, farnesyl pyrophosphate synthase, isoamyl acetate-hydro-
lyzing esterase 1 homolog).
3.4.3. Inﬂuence of thyroid status on liver protein pattern independent
of HBCD exposure
From the dataset reported in the previous section, eleven
proteins are signiﬁcantly changed over all three HT/ET compar-
isons. Several others showed similar patterns over all comparisons,
but did not meet the very stringent ﬁltering criteria (mainly the
P-value cut-off; e.g. 21 additional proteins with two signiﬁcant
changes; Table 2e in Miller et al., submitted). Among the latter are
some of the proteins with largest fold changes of this study (but
P-values between 0.06 and 0.11), i.e. carbonic anhydrase 3, which is
increased in all comparisons and known as an oxidative stress
indicator, but also of some GST family members that all show
decreased abundance. All these proteins, which are mostly related
to stress response, lipid metabolism and detoxiﬁcation processes
(Supplementary 3) seem to be characteristic of the altered thyroid
status in all three exposure groups.
4. Discussion
HBCD is widespread in the environment and wildlife. Also
humans are, and still will be exposed for decades to come. The
Fig. 5. Networks of proteins differentially abundant in similarly exposed animals of different thyroid status.
Clustering of proteins with statistically different abundance between ET and HT of the respective HBCD exposure groups (data from Table 2d in Miller et al., submitted)
according to STRING-database (http://string-db.org/), for Rattus norvegicus proteins or genes, respectively, and for proteins with accession numbers from UniProt. For more
detailed view see Supplementary 1.
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compound both in healthy as well as vulnerable groups of the
population has great scientiﬁc and societal importance.
In line with earlier studies the iodide poor diet in combination
with perchlorate resulted in hypothyroidism, as seen by increased
plasma TSH concentrations and reduced T3 concentrations
(Rijntjes et al., 2009; van Wijk et al., 2008). This is essential to
test our main hypothesis that the effects of HBCD are depending on
the TH status. Gender-dependent effects of HBCD on key metabolic
pathways include metabolism of lipids, triacylglycerol, and
cholesterol and its derivatives like testosterone and estrogens,
as well as phase I and II biotransformation in rats orally exposed to
HBCD concentrations ranging from 3 to 100 mg/ kg bw/d (Canton
et al., 2008; van der Ven et al., 2006). The exposure concentrations
in the current study were chosen based on these earlier
publications. Only g-HBCD accumulated in the exposed rats, but
after 7 days tissue concentrations were not fully dose-related. The
10-fold higher HBCD dose resulted only in 2–3-fold higher tissue
concentrations, without differences between ET and HT animals.
The g-HBCD stereoisomer dominated in the white adipose tissue
as the only stereoisomer above the LLOQ for the low dose exposure
group. Though in contrast to observations in wildlife samples
where the a-HBCD stereoisomer was dominant (Covaci et al.,
2006), our data is in line with a 28-day toxicity study that found
predominance of g-HBCD and increase of a/g-ratios only in higher
dosed animal groups (van der Ven et al., 2006).
Liver was chosen as the tissue for proteomic investigation,
being the main detoxifying and protein synthesizing organ and
after oral exposure quickly exposed to HBCD. Two-dimensional
electrophoresis using 2D-DIGE was successfully performed and
revealed a complex protein spot pattern for rat liver, with a number
of spots (and thus proteins) changing intensity due to HBCD
exposure.
In ET rats, HBCD exposure affected three main groups of
proteins: proteins involved in metabolic processes, some with
speciﬁc transport functions (e.g. serum albumin or transthyretin),
and proteins connected with oxidative stress reactions. Previous
studies with rats receiving comparable to higher doses of HBCD
(daily oral exposure of 30–100 mg/kg bw) for 28 days reported that
key metabolic pathways were affected including metabolism of98lipids and cholesterol as well as steroids (Canton et al., 2008; van
der Ven et al., 2006). Gene expression proﬁles were determined
with microarrays and RT-PCR, and downregulation of single genes
was in general less than 50% of the controls’ values in the 30 mg/kg
bw group after 4 weeks of exposure (Canton et al., 2008). Our
present proteomic study is the ﬁrst to evaluate changes on the liver
protein concentrations in HBCD exposed rats, providing mecha-
nistic information including potential post translational effects,
thus giving a more functional picture of ongoing processes.
Although the changes in protein levels are relatively small after a
short (one week) exposure period, the same pathways, however,
were as affected as after one month of exposure, although
sometimes different proteins (Supplementary 4). Based on the
results by van der Ven et al. (2006) (HBCD exposure range
0.1–200 mg/kg/d for 28 d), Canton et al. (2008) hypothesized that
changes in cholesterol metabolism are related to hypothyroidism
caused by HBCD exposure. The link between these two pathways
is suggested to be hydroxymethyl-glutaryl-CoA (HMG-CoA),
whose conversion to mevalonate is catalysed by the enzyme
hydroxymethyl-glutaryl-CoA reductase (HMG-CoA reductase).
In our short-term study, liver weights were not affected by
HBCD exposure (Table 1, Supplement 4), but a few proteins
involved in lipid metabolism and in the 3 mg/kg/d exposed group
the protein hydroxymethylglutaryl-CoA synthase (substrate for
HMG-CoA reductase) decreased. This supports the hypothesis by
Canton, and shows how protein levels might be used as early
markers. In contrast to the paper by Canton et al. (2008), our data
suggest a considerable inﬂuence of HBCD on the gluconeogenesis/
glycolysis and the metabolism of several amino acids. This is not
necessarily a contradiction, as carbohydrate, protein and lipid
metabolisms are linked via acetyl-CoA for conversion of carbohy-
drates into lipids and/or for energy generation via the citric acid
cycle (Engelking, 2015). There is also a close connection to the
proteohormone leptin which is secreted by adipocytes and
involved in regulation of energy balance and appetite (Hynes
and Jones, 2001).
HBCD has been reported to induce oxidative stress (Deng et al.,
2009; Hu et al., 2009; Zhang et al., 2008). Also our data reﬂects
changes in oxidative stress related proteins like BDH (mitochon-
drial D-beta-hydroxybutyrate dehydrogenase), AL1L1 (aldehyde
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ﬂavoprotein). While BDH (involved in ketone body metabolism)
was altered only in ET animals, AL1L1 as well as ETFB (a component
of the electron transport chain and essential in the oxidative
phosphorylation pathway (Rakhshandehroo et al., 2007)) were
inﬂuenced by HBCD levels independent of the thyroid status.
In our study we found a similar panel of proteins with
metabolic, redox, or transport function as has been found in two
studies on zebraﬁsh liver cells exposed in vivo to HBCD (Kling et al.,
2008) or a mixture of 11 BFRs including HBCD tested in vitro (Kling
and Förlin, 2009). Differences in species, exposure and agents,
however, hamper detailed comparisons with our own ﬁndings.
Interestingly, no changes of CYPs (cytochrome P450 proteins)
were found in our proteomics approach while in a 28-day study
with daily HBCD doses similar to ours slight concentration changes
in CYP3A1 or CYP3A1 and CYP2B1/2 were reported for liver
microsomes using Western blots (Germer et al., 2006). These
differences may result from longer exposure, the enriched
organelle fraction or a very speciﬁc and sensitive antibody used.
The rationale for including HT animals in our study on female
rats was the hypothesis of Canton et al. that higher/prolonged
HBCD challenge leads to hypothyroidism (Canton et al., 2008; van
der Ven et al., 2006), which is a condition 10 times more frequent in
human females than males (Canaris et al., 2000). We hypothesized
that HT organisms cannot compensate as well as ETs, but found
the same pathways were inﬂuenced by HBCD in ET and HT animals,
although often different proteins were differentially expressed.
Also, a larger spectrum of spot/proteins changed in exposed
HT than ET rats compared to unexposed controls, and these
proteins were sometimes highly interconnected, especially in the
3 mg/kg/day group. This observation was supported by the protein
spot counts of signiﬁcant changes.
Functional cluster analysis revealed several members of the
glutathione-S-transferase (GST) family in much lower concentra-
tions in HT compared to ET animals. This could point to greater
compensation responses. GSTs are phase II metabolic enzymes that
catalyse the conjugation of glutathione group (GSH) to a wide
number of endogenous and exogenous hydrophobic compounds
(incl. drugs and xenobiotics). The conjugated products are normally
more soluble than the parent compounds, facilitating their removal
from circulation through the kidney (Wu et al., 2004).
The glutathione metabolism is an important mechanism to
prevent oxidative damage to cellular components by ROS (reactive
oxygen species). Low levels of GSTs may render animals less
protected against oxidative stress. The low levels may be due to
either lower production or higher consumption of GST in
detoxifying processes. Low levels of GST have been described
before for human hypothyroid individuals (measured as overall
GST activity (Pasupathi and Latha, 2008)) and mice (GSTA gene
expression in mouse liver (Faustino et al., 2011)). The resolving
power of 2D electrophoresis allows the differentiation between
four different GSTAs and one GSTP.
As reported by others (Canton et al., 2008; Crump et al., 2008;
Kling and Förlin, 2009), we observed upon HBCD exposure: a
decrease of several proteins involved in biosynthetic processes
(also lipid and glucose), upregulated proteins with catabolic
functions, inﬂuence on lipid and steroid metabolism (decreased
isoamyl acetate-hydrolyzing esterase 1 potentially reﬂecting
reduced lipid degradation). Hypothyroidism reduces metabolism
in general, and results in hypercholesterolaemia and inﬂuence on
lipoprotein levels (Santillo et al., 1999).
In a study applying cDNA microarrays, 55 of the 2225 tested
hepatic murine genes were found in vivo changed under the
inﬂuence of thyroid hormone, documenting impact on gluconeo-
genesis, lipogenesis, insulin signalling, cell proliferation, apoptosis
(Feng et al., 2000). Despite the differences in approach (species,99transcriptomics), affected pathways correspond largely to our
ﬁndings.
Perturbations of lipid and fatty acid metabolisms correlate well
with our ﬁndings of increased leptin levels in HT animals, increased
carbamoylphosphate synthase (a sign for increased triglyceride
catabolism) and reduced body weight of the HT animals. Leptin
plays a major role in the regulation of energy balance by
modulating food intake, glucose and lipid metabolism (Cettour-
Rose et al., 2005). In thyroidectomised rats given infusions of T4 or
T3, TH and leptin levels were determined as negatively correlated
(Escobar-Morreale et al., 1997), and also the results from our rats
suggest an inverse relationship between T3 (esp. free T3) and leptin
concentrations (Table 1).
5. Conclusions
In the present study rats were challenged with 3 or 30 mg/kg
bw/d concentrations of HBCD for a week. Using high-end
proteomics signiﬁcant effects were demonstrated on the lipid
metabolism at the protein level, which until now were only shown
at the level of gene regulation or as changed levels of metabolic
products after longer exposure periods (Canton et al., 2008; van
der Ven et al., 2006). Additionally, we revealed that HBCD also had
a strong inﬂuence on general metabolic processes, mainly glucose
and amino acid metabolism. It would be also interesting to perform
proteomics on animals that are exposed to lower HBCD dosages
over a longer period to conﬁrm the proteins that already after one
week can be indicative for adverse effects. Longer exposure time
may make proteins detectable whose changes were not yet obvious
(e.g. due to higher abundance and longer half-life or turnover
times, as discussed in (Miller et al., 2014)) or which are signs of
secondary effects. In this context pre-fractionation of the samples,
e.g. enrichment of organelles, before 2D-DIGE would be helpful to
target protein sub-populations and thus enhance their detectabili-
ty. It also would be worthwhile to study by proteomics effects on
plasma proteins of HBCD exposed organisms, as this could
potentially provide non-destructive biomarkers for effects in
experimental exposures over time and epidemiological studies.
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 Identiﬁcation of liver proteins from female rats altered due to HBCD exposure.
 Identiﬁcation of liver proteins from female rats changed in hypothyroid status.
 Data showing single and combined effects (HBCD exposure, hypothyroidism).
 Identiﬁed liver proteins form the basis for further studies to achieve a more detailed understanding
of involved mechanism.1. Data
Two-dimensional electrophoresis of liver protein lysates showed complex patterns of about 3000
spots per gel. Patterns of 24 gels from different exposures of eu- and hypothyroid rats were evaluated
quantitatively. The data from different animals groups were compared, taking different aspects into
account (HBCD exposure, thyroid status). Statistically signiﬁcant fold-changes of at least 30% between
groups (Po0.05 within group) were considered to be relevant.
The master gel is presented in Fig. 1, and all spots with signiﬁcant abundance changes in any of the
performed comparisons are labelled. Spot numbers refer to the protein identiﬁcations listed in Table 1
(peptide list in Supplemental Table 1), and to abundance changes in the various animal groups
(Supplemental Table 2).2. Experimental design, materials and methods
2.1. Animals, treatment and experimental protocol
The animal experiment was detailed in [1] and was approved under number 2007-041 by the
Animal Welfare Committee of Wageningen University. In brief, female Wistar WU (HsdCpbWU) rats
with normal or reduced thyroid function (hypothyroid) were orally exposed to 0, 3 or 30 mg/kg bw/d
HBCD, respectively, for 7 consecutive days. Four liver samples per group were analyzed by proteomic
methods.102
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Two-dimensional ﬂuorescence difference gel electrophoresis (2D-DIGE) was performed as pre-
viously described, with minor modiﬁcations [2,3]. Rat livers were homogenized using the GE sample
grinding kit in lysis buffer (urea 7 M; thiourea 2 M; CHAPS 2% w/w; tris 30 mM) containing protease
inhibitor Complete Mini (Roche, Brussels, Belgium). Supernatants obtained after centrifugation
(15 min at 30,000 g) were collected and stored at 20 °C until use. Protein concentration was
determined according to Bradford [4]. Fifty mg per sample were labelled with CyDyes according to the
manufacturer's instructions and separated on IPGs of a non-linear 3-10 pH-range. The second
dimensional SDS-PAGE was performed in 12.5% precast gels (SERVA Electrophoresis GmbH, Heidel-
berg, Germany). Gel images (acquired on a Typhoon 9400) were analyzed with the DeCyder
7.0 software package (both GE Healthcare, Diegem, Belgium). Gels were matched and subjected to
univariate and multivariate analysis in order to highlight differentially regulated spots (fold change at
least 1.3) with a P-value in the respective univariate ANOVA or two way ANOVA o0.05.
Differentially abundant spots were automatically picked, tryptically digested and spotted on the
MALDI target by the use of the Ettan Spot Handling Workstation (GE Healthcare, Diegem, Belgium).
Protein identiﬁcation was carried out on the Applied Biosystems MALDI-Tof-Tof 4800 Proteomics
Analyser (Applied Biosystem, Gent, Belgium) as previously described [2]. Protein identiﬁcation was
performed by searching protein mass ﬁngerprints (PMF) and MS/MS spectra against the SwissProt
database with “Rattus norvegicus” as taxonomy. Searches were performed using the ProteinPilot
software (Sciex, Nieuwerkerk aan den Ijssel, The Netherlands) and the searching algorithm MASCOT
(Matrix Science, www.matrixscience.com, London, UK). For each spot one protein mass ﬁngerprint
and up to 8 MS/MS spectra were generated. Parameters for the search were set as follow: up to twoFig. 1. Image of a rat liver 2D-DIGE gel (master gel, grey level image). All spots with statistically signiﬁcant abundance changes
are labelled; spot numbers refer to identiﬁcations in Table 1. For details on protein identiﬁcation see Supplemental Table 1, for
data on protein abundance, see Supplemental Table 2.
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Table 1
Proteins of the present dataset, identiﬁed by MALDI-TOF/TOF analysis.
Spot number Protein name Species Swiss-Prot
Acc. N°
1063, 1065, 1067–1071, 1074–
1076, 1078
Carbamoyl-phosphate synthase[ammonia], mitochondrial Rattus
norvegicus
CPSM_RAT
1072 Murinoglobulin-2 Rattus
norvegicus
MUG2_RAT
1077, 1082, 1083 Pyruvate carboxylase, mitochondrial Rattus
norvegicus
PYC_RAT
1086 ATP-citrate synthase Rattus
norvegicus
ACLY_RAT
1089 C-1-tetrahydrofolate synthase, cytoplasmic Rattus
norvegicus
C1TC_RAT
1093 Alpha-aminoadipic semialdehyde synthase, mitochondrial Rattus
norvegicus
AASS_RAT
1094, 1100 2-oxoglutarate dehydrogenase, mitochondrial Rattus
norvegicus
ODO1_RAT
1099, 1105, 1107–1110, 1114 Aldehyde dehydrogenase family1 member L1 Rattus
norvegicus
AL1L1_RAT
1111 Aldehyde dehydrogenase1 family, member L2 Mus
musculus
gi|21961590
1112, 1115–1117, 1119 Sarcosine dehydrogenase, mitochondrial Rattus
norvegicus
SARDH_RAT
1121, 1122 Elongation factor2 Rattus
norvegicus
EF2_RAT
1123 Cytoplasmic aconitate hydratase Rattus
norvegicus
ACOC_RAT
1129 Dimethylglycine dehydrogenase, mitochondrial Rattus
norvegicus
M2GD_RAT
1135 Serotransferrin Rattus
norvegicus
TRFE_RAT
1148 Propionyl-CoA carboxylase alpha chain, mitochondrial Rattus
norvegicus
PCCA_RAT
1155 78kDa glucose-regulated protein Rattus
norvegicus
GRP78_RAT
1161, 1165 Heat shock cognate 71 kDa protein Rattus
norvegicus
HSP7C_RAT
1163, 1164 rCG56002 Rattus
norvegicus
gi|149036727
1169, 1172, 1173, 1181, 1186 Serum albumin Rattus
norvegicus
ALBU_RAT
1191 Delta-1-pyrroline-5-carboxylate dehydrogenase,
mitochondrial
Cricetulus
griseus
gi|344249754
1203 UV excision repair protein RAD23 homolog B Rattus
norvegicus
RD23B_RAT
1212 PREDICTED: aldehyde dehydrogenase 8 family, member
A1-like isoform 2
Rattus
norvegicus
gi|109460389
1213 Pyruvatekinase isozymes R/L Rattus
norvegicus
KPYR_RAT
1216, 1219 Proteindisulﬁde-isomerase A3 Rattus
norvegicus
PDIA3_RAT
1217 Liver carboxylesterase 4 Rattus
norvegicus
EST4_RAT
1226 Formimidoyl transferase-cyclodeaminase Rattus
norvegicus
FTCD_RAT
1229 Calreticulin Rattus
norvegicus
CALR_RAT
1231 Methylmalonate-semialdehyde dehydrogenase[acylating],
mitochondrial
Rattus
norvegicus
MMSA_RAT
1246 Alpha-1-antiproteinase Rattus
norvegicus
A1AT_RAT
1260, 1268 Alanine-glyoxylate aminotransferase 2, mitochondrial AGT2_RAT
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Table 1 (continued )
Spot number Protein name Species Swiss-Prot
Acc. N°
Rattus
norvegicus
1261 Glutathione synthetase Rattus
norvegicus
GSHB_RAT
1262 4-trimethylaminobutyraldehyde dehydrogenase Rattus
norvegicus
AL9A1_RAT
1270, 1277 Phenylalanine-4-hydroxylase Rattus
norvegicus
PH4H_RAT
1271 Succinate-semialdehyde dehydrogenase, mitochondrial Rattus
norvegicus
SSDH_RAT
1273 Hydroxymethylglutaryl-CoA synthase, mitochondrial Rattus
norvegicus
HMCS2_RAT
1275 Alpha-enolase Rattus
norvegicus
ENOA_RAT
1296 Iﬁ47 protein Rattus
norvegicus
gi|44890246
1298, 1301, 1310 Betaine–homocysteine S-methyltransferase 1 Rattus
norvegicus
BHMT1_RAT
1300 Eukaryotic initiation factor 4A-II Rattus
norvegicus
IF4A2_RAT
1314 3-ketoacyl-CoA thiolase, mitochondrial Rattus
norvegicus
THIM_RAT
1323, 1326 Argininosuccinate synthase Rattus
norvegicus
ASSY_RAT
1332 Keratin, type I cytoskeletal 18 Rattus
norvegicus
K1C18_RAT
1337 Aspartate aminotransferase, cytoplasmic Rattus
norvegicus
AATC_RAT
1341, 1345, 1354 Actin, cytoplasmic 1 Rattus
norvegicus
ACTB_RAT
1344 Creatinekinase B-type Rattus
norvegicus
KCRB_RAT
1356 Aspartate aminotransferase, mitochondrial Rattus
norvegicus
AATM_RAT
1357 Serum paraoxonase/arylesterase2 Rattus
norvegicus
PON2_RAT
1363, 1365 Fructose-bisphosphate aldolase B Rattus
norvegicus
ALDOB_RAT
1366 Serum paraoxonase/lactonase 3 Rattus
norvegicus
PON3_RAT
1370, 1371, 1374, 1378, 1384 Fructose-1,6-bisphosphatase 1 Rattus
norvegicus
F16P1_RAT
1381 Adipocyte plasmamembrane-associated protein Rattus
norvegicus
APMAP_RAT
1388 Farnesyl pyrophosphate synthase Rattus
norvegicus
FPPS_RAT
1391, 1393 Arginase-1 Rattus
norvegicus
ARGI1_RAT
1404, 1417 3-oxo-5-beta-steroid 4-dehydrogenase Rattus
norvegicus
AK1D1_RAT
1406 Glyceraldehyde-3-phosphate dehydrogenase Rattus
norvegicus
G3P_RAT
1412 3-alpha-hydroxy steroid dehydrogenase Rattus
norvegicus
DIDH_RAT
1420, 1429 Glycerol-3-phosphate dehydrogenase[NADþ],
cytoplasmic
Rattus
norvegicus
GPDA_RAT
1422 L-lactate dehydrogenase A chain Rattus
norvegicus
LDHA_RAT
1428 Beta-lactamase-like protein 2 Rattus
norvegicus
LACB2_RAT
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Table 1 (continued )
Spot number Protein name Species Swiss-Prot
Acc. N°
1433 Ester hydrolase C11 orf 54 homolog Rattus
norvegicus
CK054_RAT
1438 Sulfotransferase 1A1 Rattus
norvegicus
ST1A1_RAT
1441, 1443 Thiosulfate sulfurtransferase Rattus
norvegicus
THTR_RAT
1445 Guanine nucleotide-binding protein subunit beta-2-like1 Rattus
norvegicus
GBLP_RAT
1447 Regucalcin Rattus
norvegicus
RGN_RAT
1449 D-beta-hydroxybutyrate dehydrogenase, mitochondrial Rattus
norvegicus
BDH_RAT
1450 Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial Rattus
norvegicus
HCDH_RAT
1460 Nitrilase homolog 1 Rattus
norvegicus
NIT1_RAT
1463 Proteasome activator complex subunit1 Rattus
norvegicus
PSME1_RAT
1471 Nicotinate-nucleotide pyrophosphorylase [carboxylating] Rattus
norvegicus
NADC_RAT
1473 Thiopurine S-methyltransferase Rattus
norvegicus
TPMT_RAT
1477, 1483 Electron transfer ﬂavoprotein subunit beta Rattus
norvegicus
ETFB_RAT
1480 Isoamyl acetate-hydrolyzing esterase 1 homolog Rattus
norvegicus
IAH1_RAT
1486 Glutathione S-transferase Mu2 Rattus
norvegicus
GSTM2_RAT
1488 Glutathione S-transferase alpha-5 Rattus
norvegicus
GSTA5_RAT
1489 Peroxiredoxin-4 Rattus
norvegicus
PRDX4_RAT
1495 protein ETHE1, mitochondrial Rattus
norvegicus
gi|157819563
1496, 1509, 1510 Carbonic anhydrase 3 Rattus
norvegicus
CAH3_RAT
1504 Endoplasmic reticulum resident protein 29 Rattus
norvegicus
ERP29_RAT
1506 Glutathione S-transferase alpha-1 Rattus
norvegicus
GSTA1_RAT
1507 Glutathione S-transferase alpha-2 Rattus
norvegicus
GSTA2_RAT
1508 Glutathione S-transferase alpha-3 Rattus
norvegicus
GSTA3_RAT
1512 Glutathione S-transferase alpha-4 Rattus
norvegicus
GSTA4_RAT
1514 NADH dehydrogenase [ubiquinone] ﬂavoprotein 2,
mitochondrial
Rattus
norvegicus
NDUV2_RAT
1522 Glutathione S-transferase P Rattus
norvegicus
GSTP1_RAT
1523 biliverdin reductase B (ﬂavinreductase(NADPH)) (pre-
dicted), isoform CRA_c
Rattus
norvegicus
gi|149056527
1524 Peroxiredoxin-1 Rattus
norvegicus
PRDX1_RAT
1528, 1530 Abhydrolase domain-containing protein 14B Rattus
norvegicus
ABHEB_RAT
1540 Peptidyl-prolyl cis-trans isomerase F, mitochondrial Rattus
norvegicus
PPIF_RAT
1543 Coﬁlin-1 Rattus
norvegicus
COF1_RAT
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Table 1 (continued )
Spot number Protein name Species Swiss-Prot
Acc. N°
1544 Peptidyl-prolyl cis-trans isomerase A Rattus
norvegicus
PPIA_RAT
1547 Lowmolecular weight phosphotyrine protein phosphatase Rattus
norvegicus
PPAC_RAT
1550 Ubiquitin-conjugating enzyme E2D2 Rattus
norvegicus
UB2D2_RAT
1560 Cytochrome b5 Rattus
norvegicus
CYB5_RAT
1567–1569 Hemoglobin subunit alpha-1/2 Rattus
norvegicus
HBA_RAT
1570, 1571 Fatty acid-binding protein, liver Rattus
norvegicus
FABPL_RAT
1586 Enoyl-CoA hydratase, mitochondrial Rattus
norvegicus
ECHM_RAT
I. Miller et al. / Data in Brief 7 (2016) 386–392392missed cleavages allowed, 100 ppm tolerance in PMF, 0.75 Da mass tolerance for precursor ion mass,
carbamidomethyl cysteine as ﬁxed modiﬁcation, oxidation of methionine and oxidation of tryptophan
(single oxidation, double oxidation and kynurenin) as variable modiﬁcations. Identiﬁcations were
considered to be signiﬁcant when the combined MOWSE score had Po0.05.
Statistics, including univariate analysis (ANOVA and t-test) and multivariate analysis (two way
ANOVA), was performed using the Extended Data Analysis (EDA) module, which is present inside the
Decyder 7.0 software package.Appendix A. Supplementary material
Supplementary data associated with this paper can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2016.02.047.References
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Abstract 
The influence of short-term (7-day) exposure of male rats to the brominated flame 
retardant hexabromocyclododecane (HBCD) was studied by investigation of the liver 
proteome, both in euthyroid and hypothyroid rats and by comparing results with general 
data on animal physiology and thyroid hormone, leptin, insulin and gonadotropin 
concentrations determined in parallel. Proteome analysis of liver tissue by two-
dimensional fluorescence difference gel electrophoresis (2D-DIGE) revealed that only 
small protein pattern changes were induced by exposure in males, on just a few proteins 
with different functions and not involved in pathways in common. This is in contrast to 
previous findings in similarly exposed eu- and hypothyroid female rats, where general 
metabolic pathways had been shown to be affected. The largest gender-dependent effects 
concerned basal concentrations of liver proteins already in control and hypothyroid 
animals, involving mainly the pathways which were also differently affected by HBCD 
exposure. Among them were differences in lipid metabolism, which – upon exposure to 
HBCD - may also be the reason for the considerably higher ratio of -HBCD accumulated 
in white adipose tissue of exposed female rats compared to males. The results further 
elucidate the already suggested different sensitivity of genders towards HBCD exposure 
on the protein level, and confirm the need for undertaking toxicological animal 
experiments in both genders.  
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1. Introduction 
Since 2013, the brominated flame retardant hexabromocyclododecane (HBCD) is banned 
in most European countries, but outside Europe still being produced and widely used (e.g. 
in the US). HBCD mainly serves as an additive in building industry (in polystyrene foams), 
but is also used for impregnation of equipment. Due to its persistent nature, HBCD is 
expected to remain present in food chains for several years to come. Like other substances 
of this chemical class, HBCD is lipophilic and accumulates in adipose tissue, not only in 
experimental animals but also in humans (Covaci et al., 2006; Darnerud, 2003; De Wit, 
2002; Kalachova et al., 2012; Tomko and McDonald, 2013). While animal studies have 
shown low acute toxicity of HBCD, there are toxicological effects, especially in liver, on 
the immune system and on serum thyroid hormone (TH) dependent developmental 
processes as well as indications of endocrine disrupting properties (Canton et al., 2008; 
Germer et al., 2006; van der Ven et al., 2006; 2009; Miller et al., 2016). Further elucidation 
of the underlying mechanisms of HBCD action would be needed for a better understanding 
of its adverse effects, and specific investigations applying modern analytical methods are 
likely to help in this task.  
Previous studies with 28d exposure of rats and variable doses of HBCD (between 0 and 
200 mg/kg bw per day) revealed dose- and gender-dependent effects on body and organ 
weights as well as on TH levels, suggesting that female rats were more sensitive to 
exposure than male rats (van der Ven et al., 2006). In a similar experimental setup, 
transcriptomic data of rat liver and specific investigation of cytochrome P450 family 
members (CYPs) (Canton et al., 2008; Germer et al., 2006) indicated gender-specific 
differences concerning affected genes/proteins related to metabolic pathways. Chronic 
exposure over longer intervals of time is likely to cause also secondary effects, which are 
likewise detected when screening for overall gene or protein level changes. Therefore, 
short term exposure may result in a different data set, better revealing primary effects of 
exposure to HBCD. Similarly, proteomic investigations are preferable to transcriptomic 
studies, as they show the actual protein concentrations in the organs under investigation 
(Greenbaum et al., 2003; Tian et al., 2004).  
A recent HBCD short term (7 day) exposure study investigated the changes in the liver 
proteome of female rats and found a number of proteins differentially regulated in 
abundance, mainly related to general metabolic processes (Miller et al., 2016). In the 
present study, this investigation is extended to male rats and the experiment was performed 
under identical setup and conditions. This included euthyroid and hypothyroid animals as 
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well as different HBCD exposure groups. Influences of dose, thyroid status and gender 
(including data from the previous experiment) on changes of the liver proteome are 
compared and further related to general animal data and hormone status determined in 
parallel. In the following, animal groups were named with an additional “m” and “f” 
depending on the gender (male, female) for easier comparison. 
 
 
2. Animals, Material and Methods 
2.1. Animals, treatment and experimental protocol 
The animal experiment was performed as the one described in detail in Miller et al. (2016), 
except that for the present investigation male euthyroid and hypothyroid rats were used 
instead of females. Hypothyroidism was induced during foetal life by feeding the dams an 
iodide-poor diet based on AIN 1993 requirements, supplemented with 0.75% sodium 
perchlorate to deplete endogenous iodide stores, as described in detail by Rijntjes et al. 
(2009). After weaning the offspring continued on the same diet as the dams until the 
experimental intervention. In brief, 86-day-old male healthy euthyroid controls (mET) or 
hypothyroid (mHT) rats were fed 0, 3 or 30 mg of HBCD / kg body weight added to 
commercial custard pudding for 7 days. Group size was 6 animals (6 groups). At the 
termination of the experiment, blood was collected by heart puncture (5 IU heparin per ml 
blood), and animals were sacrificed by decapitation. Liver and white adipose tissues were 
collected, snap frozen and stored at -80 °C, plasma was prepared and stored at -20 °C.  
The animal experiment was approved under number 2006-051 by the Animal Welfare 
Committee of Wageningen University. 
 
2.2. Hormone measurements 
Concentrations of total and free triiodothyronine (T3), corticosterone, leptin, luteinizing 
hormone (LH), follicle-stimulating hormone (FSH), and thyroid stimulating hormone 
(TSH) were determined by radioimmunoassays (RIAs), as previously described (Rijntjes 
et al., 2009; Miller et al., 2016). In addition, RIAs for total thyroxine (T4) (Diagnostic 
Systems Laboratories, Texas, USA) (DSL-3200), testosterone (DSL-4100), and insulin 
(Linco Research, St. Charles, USA) were performed according to the manufacturers’ 
protocols. The detection limits of these assays were: 5 ng/ml for total T4, 0.1 ng/ml for 
testosterone and 0.5 ng/ml for insulin. Intra- and interassay variations were determined 
using several pools of rat sera and were less than 10%. 
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2.3. Determination of internal HBCD dose 
Chemical analyses to determine the internal levels of HBCD were performed at IMARES, 
The Netherlands. In brief, adipose tissue samples spiked with 13C-labeled HBCD as 
internal standards. Samples were then extracted and α-, β- and -diastereomeres were 
determined by LC-ESI-MS as described by Miller et al. (2016).  
 
2.4. Statistical Analysis (for hormonal measurements) 
Data is expressed as mean ± standard error of the mean (SEM). Statistical analysis was 
carried out using SPSS 19.0 for Windows. Data was tested for normality using the Shapiro-
Wilk test. If normality could not be assumed, data were LOG10 transformed. Group means 
were compared using a two-way Univariate Analysis of Variance (ANOVA). Correlation 
between internal -HBCD dose and other parameters was tested with the Spearman’s rank 
correlation test. Values of P<0.05 were considered to be significant. 
 
2.5. Proteomics 
For the proteomic experiments, four liver samples per experimental group (mET and mHT; 
0, 3 and 30 mg/kg/day HBCD, respectively) were randomly selected, subjected to two-
dimensional fluorescence difference gel electrophoresis (2D-DIGE) and further evaluated 
as previously described (Miller et al., 2016). In brief, rat livers were homogenized in lysis 
buffer (urea 7M; thiourea 2M; CHAPS 2% w/w; tris 30 mM, containing protease inhibitor) 
and proteins in the supernatant after centrifugation minimally labelled with CyDyes. 
Separation was performed on 24 cm IPGs of a non-linear 3-10 pH-range followed by SDS-
PAGE in 12.5% gels, and images were captured on a Typhoon 9400 (DeCyder 7.0 software 
package, GE Healthcare, Diegem, Belgium). Gels were matched and subjected to 
univariate and multivariate analysis in order to determine differentially regulated spots 
with following criteria: fold change of at least 1.3 and P-value <0.05. These spots were 
automatically picked, tryptically digested and underwent MALDI-TOF/TOF analysis. 
Protein identification was performed by searching spectra against the SwissProt database 
with Rattus norvegicus as taxonomy, usually one PMF and up to 8 MS/MS spectra per 
spot. Parameters for the search were set as follow: up to two missed cleavages allowed, 
100 ppm tolerance in PMF, 0.75 Da mass tolerance for precursor ion mass, 
carbamidomethyl cysteine as fixed modification, oxidation of methionine and oxidation of 
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tryptophan (single oxidation, double oxidation and kynurenin) as variable modifications. 
Identifications were considered to be significant when the combined MOWSE score had 
P<0.05. 
Statistics, including univariate analysis (ANOVA and t-test) and multivariate analysis 
(two-way ANOVA), was performed using the Extended Data Analysis (EDA) module, 
which is present inside the Decyder 7.0 software package.  
Additional information on proteins (localization, function) and pathway analysis were 
retrieved from publicly available databases: UniProtKB database 
(http://www.uniprot.org/), STRING: functional protein association networks, v 9.1 
(http://string-db.org/) (Snel et al., 2000; Franceschini et al., 2013), for Rattus norvegicus 
proteins or genes, respectively, and for proteins with accession numbers from UniProt.  
 
 
3. Results and Discussion 
 
3.1. Male rats 
 
Basic animal data and hormone measurements 
The mHT rats had significantly higher serum TSH and significantly lower free T3, total T3 
and total T4 concentrations than mET rats (for all P<0.001), which is in accordance with 
earlier work (Rijntjes et al., 2009) (Table 1). HBCD did not induce any significant changes 
in total T4 and T3 concentrations, only free T3 concentrations showed a mild HBCD effect 
in males (P=0.044). The Spearman’s correlation for free T3 and HBCD, however, was not 
significant. The already increased corticosterone concentrations of mHT tended to increase 
further with HBCD exposure (P=0.056). Serum leptin concentrations were not further 
influenced by HBCD exposure, but only by thyroid status (P=0.006) (in line with Escobar-
Morreale et al. (1997)). Insulin secretion capacity is known to be reduced in the offspring 
of hypothyroid dams, in the current experiment, however, the rats were not fasted prior to 
sacrifice, so this effect could not be reliably determined (measured insulin concentrations 
were significantly lower in HT animals, P<0.001). The internal HBCD concentration in 
the white adipose tissue, however, was negatively correlated to insulin (Rho=-0.613, 
p<0.01) in the hypothyroid rats (Table 1). The HBCD-related alterations of insulin and  
Table 1
Male rats' hormone data
Animals were exposed to 0, 3, or 30 mg/kg bw/d for 7 days
HBCD-group 0 3 30 Thyroid effect 
(P -value)
HBCD effect 
(P -value)
Interaction 
(P -value)
Spearman
's Rho
ET 427 ± 15 428 ± 14 430 ± 12 -0.045
HT 165 ± 9 153 ± 18 146 ± 13 -0.272
ET 16.30 ± 16.14 ± 16.44 ± 0.058
HT 5.49 ± 5.12 ± 4.78 ± -0.295
ET 0.38 ± 1.27 ± 0.49 ± 0.168
HT 17.01 ± 14.51 ± 16.76 ± -0.012
ET 4.4 ± 0.1 3.9 ± 0.3 4.2 ± 0.2 -0.306
HT <lod <lod <lod 0.433
ET 230 ± 20 234 ± 17 196 ± 4 -0.35
HT 165 ± 5 177 ± 10 161 ± 19 -0.148
ET 5.95 ± 6.30 ± 5.27 ± -0.341
HT 1.56 ± 2.39 ± 1.80 ± 0.041
ET 0.61 ± 1.22 ± 0.88 ± 0.33
HT 0.54 ± 0.62 ± 0.55 ± 0.018
ET 3.81 ± 5.04 ± 4.00 ± 0.161
HT 3.72 ± 4.16 ± 2.91 ± -0.359
ET 2.23 ± 1.09 ± 1.24 ± -0.308
HT 0.98 ± 1.35 ± 1.64 ± 0.233
ET 8 ± 1 7 ± 1 8 ± 1 0.022
HT 13 ± 2 12 ± 2 8 ± 2 -0.428
ET 6.02 ± 5.18 ± 8.81 ± 0.261
HT 4.38 ± 2.26 ± 2.09 ± -0.613**
ET 149 ± 29 103 ± 25 222 ± 31 0.35
HT 183 ± 19 242 ± 46 353 ± 106 0.193
ET <lod 25.5 ± 2.1 81.0 ± 
HT <lod 40.7 ± 3.5 130.0 ± 
<lod, below detection limit
n=6 per group. Mean ± SEM is given.
lw, lipid weight
n.a., not analysed
<0.001 0.867 0.766
FSH (ng/ml)
 total T4 (µg/dl)
Corticosterone (ng/ml)
<0.001 0.189 0.587
<0.001
<0.001 0.828 0.736
<0.001 0.189 0.229
<0.001 0.81 0.409
Body weight (g)
Liver weight (g)
TSH (ng/ml)
total T3 (ng/ml)
free T3 (pg/ml)
LH (ng/ml)
0.044 0.326
0.002 0.021 0.088
0.065 0.039 0.491
0.056
0.006 0.205 0.134
Testosterone (ng/ml) 0.645 0.751 0.217
0.549
Leptin (ng/ml)
0.002 <0.001 0,013
Insulin (ng/ml) <0.001
internal g-HBCD (mg/kg lw) 
0.174 0.035
0.027
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partly also leptin levels may indicate an influence of HBCD on glucose and lipid 
metabolism (Hynes and Jones, 2001). 
Body weights and liver weights (given in Table 1) were both considerably smaller in mHT 
animals (similar to Rijntjes et al. (2009)), but did not differ between HBCD treated and 
non-treated groups of the same thyroid status.  
Overall, the observed changes upon exposure to HBCD in mET animals were consistent 
with earlier reported HBCD effects on TH levels in the 28d study by van der Ven et al. 
(2006) with ET rats. No studies have been reported with mHT rats. 
 
HBCD adipose tissue concentrations 
The α- and β-HBCD concentrations in the white adipose tissue were below the lower limit 
of quantification for all groups. -HBCD was detected in HBCD treated rats, and was 
significantly higher in mHT animals compared with mET animals (by about 60 %). This 
cannot be explained by the smaller body weight of the HT animals, as the HBCD dose to 
which animals were exposed was related to the body weight. Accumulated -HBCD 
content was about 2 to 3 times higher in both 30 mg/kg/day groups compared to the 
respective 3 mg/kg/day groups (Table 1). -HBCD was the dominating stereoisomer in 
adipose tissue, similar to what was observed in a 28d study performed in ET animals (van 
der Ven et al., 2006). Both in vitro as well as in vivo research has shown that -HBCD can 
interfere with TH-functioning in the presence of TH, but not without (Schriks et al, 
2006a;b).  
 
 
Proteomics: 
Two-dimensional electrophoresis of liver protein gave complex patterns of about 3000 
spots per gel (Figure 1) and the evaluation included 24 gels of male rats’ samples of 
different exposure and thyroid state. Only a few spots were of significantly different 
abundance due to HBCD exposure or thyroid state (Figure 1, Table 2), and were subjected 
to MS analyses (Suppl. Table 2; Miller et al., submitted).  
 
Influence of HBCD on liver protein patterns of male rats 
Pairwise comparison of mET animals with different exposure to HCBD (0, 3, 30 
mg/kg/day) revealed only two proteins with significant changes between 3 and 30 mg/kg/d 
120 
 
 
Figure 1: Two-dimensional gel image of a rat liver sample  
2D-DIGE separation of rat liver sample (master gel, grey level image). Marked spots show statistically significant changes in abundance upon HBCD exposure:  
2 in mET animals (white squares), 6 in mHT rats (white triangles). In addition, 8 spots are of different abundance in ET and HT males (6 white diamonds + spots #1165, #1376 
with other symbols). Detailed data on identifications is compiled in Suppl. Table 2. 
Table 2
Comparison of HBCD-treated male rats
a) Effect of HBCD in ET-animals
Spot number Protein Name UniProt ID keywords/GO keywords/GO keywords/GO
Av. Ratio T-test Av. Ratio T-test Av. Ratio T-test biological process cellular component molecular function
1165 rCG56002 0.877 0.548 1.310 0.135 1.490 0.0189
1413
Small glutamine-rich tetratricopeptide repeat-
containing protein alpha SGTA_RAT 0.980 0.897 1.270 0.0527 1.300 0.00644
binds directly to HSC70 
and HSP70 and cytoplasm chaperone
b) Effect of HBCD in HT-animals
Spot number Protein Name UniProt ID keywords/GO keywords/GO keywords/GO
Av. Ratio T-test Av. Ratio T-test Av. Ratio T-test biological process cellular component molecular function
1226 Formimidoyltransferase-cyclodeaminase FTCD_RAT 0.676 0.00852 0.800 0.0378 1.180 0.0753 His metabolism
cytoplasm, cytoskeleton, 
Golgi
folic acid binding, His 
catabolic process
1357 Serum paraoxonase/arylesterase 2 PON2_RAT 0.877 0.193 1.340 0.144 1.530 0.0436
aromatic compound 
catabolic process membrane arylesterase activity
1376 Serum paraoxonase/arylesterase 1 PON1_RAT 1.050 0.619 1.660 0.0501 1.580 0.0387
multiple 
regulation/response secreted, HDL hydrolase
1502 Guanidinoacetate N-methyltransferase GAMT_RAT 1.340 0.292 1.380 0.0477 1.030 0.708
biosynthetic/metabolic 
processes
methyltransferase, 
transferase
1554 Cytochrome b5 CYB5_RAT 0.658 0.0411 0.877 0.512 1.330 0.22
electron transport, 
transport
ER, membrane, 
microsome
metal ion binding 
electron carrier activity
1559 Calmodulin CALM_RAT 1.560 0.041 1.390 0.341 0.885 0.588 multitude of regulations cytoplasm, cytoskeleton modulation by Ca++
c) Effect of TH status (same HBCD treatment)
Spot number Protein Name UniProt ID keywords/GO keywords/GO keywords/GO
Av. Ratio T-test Av. Ratio T-test Av. Ratio T-test biological process cellular component molecular function
1105 Aldehyde dehydrogenase family 1 member L1 AL1L1_RAT 0.917 0.528 1.070 0.668 0.741 0.0407 one-carbon metabolism cytoplasm oxidoreductase
1107 Aldehyde dehydrogenase family 1 member L1 AL1L1_RAT 0.877 0.625 1.080 0.729 0.595 0.0245 one-carbon metabolism cytoplasm oxidoreductase
1165 rCG56002 0.847 0.46 1.350 0.0618 0.621 0.00384
1271
Succinate-semialdehyde 
dehydrogenase_mitochondrial SSDH_RAT 0.806 0.0326 0.763 0.0404 1.200 0.416
succinate metabolism, 
central nervous system mitochondrion oxidoreductase
1289 Keratin_type I cytoskeletal 18 K1C18_RAT 0.909 0.438 0.438 0.952 0.735 0.05
cytoplasm, intermediate 
filament, keratin nucleus
structural molecule 
activity
1349 Cystathionine gamma-lyase CGL_RAT 0.684 0.00202 1.070 0.82 0.820 0.655
amino acid biosynthesis, 
Cys biosynthesis cytoplasm lyase
1358 Cystathionine gamma-lyase CGL_RAT 0.735 0.00429 1.000 0.989 0.820 0.545
amino acid biosynthesis, 
Cys biosynthesis cytoplasm lyase
1395 Serum paraoxonase/arylesterase 1 PON1_RAT 0.980 0.952 0.769 0.0394 1.130 0.305
multiple 
regulation/response secreted, HDL hydrolase
mHT0/mET0 mHT3/mET3 mHT30/mET30
significant changes
mET3/mET0 mET30/mET0 mET30/mET3
mHT3/mHT0 mHT30/mHT0 mHT30/mHT3
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exposure (Table 2a). In mHT animals 6 proteins were significantly altered, most of them 
having regulatory or transfer functions (Table 2b). In particular, two of the affected 
proteins belong to the paraoxonase family (PON1, PON2), a group of enzymes involved 
in the hydrolysis of organophosphates and lactones. Members of this family differ in 
cellular localization (PON1 is secreted into circulation, PON2 is present in tissues) and 
activity, but all act as cellular antioxidants (Li et al., 2003).  
In any of these group comparisons, pathway analyses failed to find connections between 
these few regulated proteins. 
 
Influence of thyroid status on liver proteome 
This evaluation focused on comparison of male rats of different thyroid status but similar 
HBCD exposure. Six proteins (8 protein spots) showed statistical differences in pairwise 
comparison (mHT/mET), but in general only within one of the HBCD dose groups (Table 
2c). All 6 proteins were involved in metabolic processes and decreased in hypothyroid 
status. One of them, serum paraoxonase/arylesterase 1 (PON1), was also differentially 
abundant in hypothyroid animals as a function of HBCD challenge, at least when 
comparing responses between 3 and 30 mg/kg/d dose groups. 
 
In summary, only very limited alterations of the liver proteome of male rats were observed 
between any of the exposed groups and thyroid status. Although a few significant changes 
of single proteins are noticed, they do not seem functionally connected, belonging to quite 
different pathways. The only protein family with more than one regulated member in these 
group comparisons are the PONs. One of their main functions is to metabolize toxic 
oxidized lipids in LDL (low-density lipoproteins) and HDL (high-density lipoproteins) 
particles, which may be created by environmental factors or drugs (Costa et al., 2005). The 
noticed small impacts on PON abundance in our experiments, in parallel to changes seen 
in leptin concentrations (Table 1), both dependent on HBCD exposure and/or thyroid 
status, may be interpreted as a small disturbance of lipid metabolism in the liver of male 
animals. 
 
 
3.2. Comparison of changes in male and female animals 
A previous study from our groups has reported proteomic data as well as hormonal and 
general animal data in an identical experimental setup with female rats (Miller et al., 2016) 
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and performed in parallel. This allows the comparison with the here presented data of males 
in order to filter for gender specific effects.  
General animal and hormone data of animals of both genders are summarized in Suppl. 
Table 1 and show the expected differences in body weight, liver weight and gonadotropins 
between males and females. Especially in ET status, male rats accumulate much less 
HBCD in adipose tissue compared to female animals (gender effect P=0.001). Van der 
Ven et al. (2006) also reported a lower accumulation of -HBCD in liver lipid for mET 
than for fET rat. However, a major difference between the present study and the 
investigation by van der Ven and colleagues is that most of their animals received much 
higher doses of HBCD (up to 200 mg/kg bw/d), and the overall exposure time was 4 times 
longer compared to the present study. This resulted in changes in liver weights in females, 
an observation that was not confirmed in our studies, neither for ET nor for HT animals.  
 
3.2.1. Comparison of HBCD affected liver proteins of male and female rats 
Protein regulation data of all 12 animal groups (all genders, treatments, thyroid states) were 
filtered by ANOVA evaluation and resulted in 496 differentially regulated protein spots 
(Miller et al., submitted). PCA analysis of this spot set showed a clear grouping of values, 
resulting in three different populations: fET, fHT, and all male animal groups independent 
of treatment (Figure 2a). mET and mHT group close together, and there is also no major 
dispersion in the fET and fHT groups induced by HBCD exposure. Similarly, a heat map 
and hierarchical clustering based on single spot abundance changes sorted animal groups 
according to gender and clearly differentiated between thyroid states in females (Miller et 
al., submitted). 
The loading plot of the 496 regulated spots visualizes similarity of single spot abundance 
between PCA1and PCA2, and most spots group in a compact cluster (Figure 2b). The 
distance of the spots from the centre of the cluster reflects their similarity in regulation 
behaviour. Some spots/proteins at the border area of the cluster are the ones that had 
already been found regulated in female rats depending on thyroid status (e.g. glutathione-
S-transferases, Miller et al., 2016), but also some typical serum proteins with known 
functions as protease inhibitors or reactants in inflammation, being known for their 
concentration differences between genders (Miller et al., 1999). The spots farthest from the 
centre are those with most different behaviour between PC1 and PC2, i.e. three spots in the 
lower right, belonging to the protein carbonic anhydrase 3. Carbonic anhydrase 3 is known  
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Figure 2: PCA of proteomic data  
PCA of the 496 differentially regulated protein spots (from ANOVA):  
A) comparison of experimental groups (scope plot), B) comparison of all selected proteins (loading plot). 
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as a growth hormone-dependent liver enzyme, its concentration is gender-dependent, and 
changed in diabetes/obesity (Shiels et al., 1983; Lynch et al., 1993; Nishita et al., 1995). It 
is one of the proteins already noticed in a previous paper as consistently increased in fHT 
liver (Miller et al., 2016). Frémont et al. (1987) have reported previously the presence of a 
connection between thyroid status and carbonic anhydrase 3 concentration in skeletal 
muscle. Gender-dependent abundance differences noticed in this study are even higher, 
more than 10-fold in mET and more than 5-fold in mHT rats with comparable HBCD 
exposure, and all highly significant. 
 
Gender-influence in response towards HBCD exposure has been shown on the 
transcriptomic level, in a study with a much longer exposure time and different doses (most 
of them much higher than ours), in ET rats (Canton et al., 2008). In the study by Canton in 
females genes related to lipid metabolism, triacylglycerol and cholesterol metabolism were 
markedly down-regulated. In contrast, genes involved in phase I and II metabolism were 
found upregulated, especially in males, which, for the authors, represented the reason of 
the lower susceptibility to HBCD of males as compared to females. The described changes 
were more obvious at higher HBCD doses, and at doses similar to our study, the overall 
differences between genders and between exposed and unexposed were rather limited. In 
our study, investigating the proteome, and after the one week exposure, we detected only 
minor changes in male rats, limited to very few singular proteins. Compared to previous 
reports, this is a much shorter exposure time, and a time delay between gene regulation and 
protein synthesis has to be expected. Still, in an identical experiment with females rats 
(Miller et al., 2016) changes in lipid and carbohydrate metabolism were clearly visible, 
which is in accordance with the transcriptomics results reported by Canton et al. (2008).  
The only other proteomic study that involved HBCD (administered in a mixture with other 
flame retardants) and determined its impact on the liver proteome was performed in 
zebrafish (Kling et al., 2008). Though different to the present study in many main 
parameters (species, mixed compound, exposure time), it also reported gender-specific 
effects. 
 
3.2.2. Comparison of liver proteins of unexposed male and female rats 
Gender specific differences in response towards HBCD administration led us to take a 
closer look at the liver proteome of control rats of both genders and check for gender 
differences in the 2D-DIGE pattern, by comparing previous data on female animals (Miller 
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et al., 2016) with the here presented data for male rats. Unexposed animal groups displayed 
109 spots (belonging 76 proteins) with statistically significant differential abundance 
between genders for ET, and 201 spots (belonging 109 proteins) for HT. Changes included 
an almost similar number of increased and decreased proteins (Figure 3). 
 
 
Figure 3:    
Significant changes between male and female rats 
(controls)  
   
   
   
 euthyroid hypothyroid 
changed spots 109 201 
higher in females 53 117 
higher in males 56 84 
changed proteins 76 109 
   
   
   
   
   
   
       Venn diagram illustrates protein numbers 
 
Grouping of these spots and network analysis put the vast majority of these proteins in 
connection with metabolic processes (Suppl. Table 3). For ET animals, there were strong 
clusters of differentially regulated proteins between genders related to cytochrome P450 
(drug metabolism, metabolism of xenobiotics) and glutathione metabolism. Many more 
members of these protein families were represented in ET animals than in HT animals. In 
HT animals quite a number of proteins from the fatty acid metabolism were differentially 
regulated between male and female rats (Suppl. Table 3, Figure 4). Comparison of figures 
4a and 4b (as well as Suppl. Fig. 1) shows gender differences in the number of interacting 
proteins, influenced by thyroid status.  
Several gender-specific differences in lipid metabolism have been reported earlier, e.g. in 
rats fed a high fat diet different strategies to maintain energetic and metabolic homeostasis 
in response to feeding have been elicited (Amengual-Cladera et al., 2012; Nadal-Casellas 
et al., 2010), in the liver proteome (Wang et al., 2012), as well as in plasma proteins (Liu 
et al., 2012) and in a rat model of alcoholic steatohepatitis (Banerjee et al., 2008). These 
reports on gender-dependency in lipid metabolism confirm our proteomic results. We 
noticed small changes in the leptin levels, which were significant in gender*thyroid status  
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Pathway analysis (STRING): Networks created from proteins differentially regulated in male and female rats 
(controls) in ET animals (A) or HT rats (B). Members from pathways related to Glycolysis / Gluconeogenesis 
(Glyco), Fatty acid metabolism (FA), Drug metabolism or Metabolism of xenobiotics by cytochrome P450 
(Cyp450), Glutathione metabolism (GSH) are boxed. Further details on pathways and gene/protein names 
are compiled in Suppl. Table 3. 
128 
 
interaction, but not in gender effect alone (MANOVA 0.167). Still, gender-related 
differences in lipid metabolism may also be the reason for the gender differences in HBCD 
accumulation in adipose tissue in our rats (Suppl. Table 1). Studies on liver mitochondrial 
oxidative metabolism showed gender dimorphism as well (Borras et al., 2003, Ståhlberg 
et al., 2004; Justo et al., 2005), namely a different profile of Cyp450 isoforms in 
microsomes (Nisar et al., 2004; Germer et al., 2006; Huang et al., 2011). In our study we 
could not detect any differentially regulated Cyp450 proteins, probably due to the choice 
of analysing complete, unfractionated liver lysates, however pathway analysis (Figure 4, 
Suppl. Table 3) clearly filtered out gender-specific differences in proteins connected to 
metabolism of xenobiotics/drug metabolism, specifically members of the GST family.  
Interestingly, the observed gender-specifically regulated pathways are also the ones 
affected by HBCD exposure in a gender specific way in the present (and previous) study. 
Also other reports have shown differences in gender-susceptibility (in rat serum proteins 
in health and inflammation (Miller et al., 1999; Ballerio et al., 2007), in mouse proteins in 
muscle (Dimova et al., 2011) or in the aging kidney (Amelina and Cristobal, 2009)). This 
approach is in line with a recent NIH directive/recommendation for gender-balance in 
further biomedical research studies (Clayton and Collins, 2014; Clayton, 2016). 
 
 
4. Conclusions 
In male rats exposed to levels up to 30 mg/kg HBCD during 7 days, only limited changes 
in liver protein content and plasma hormone concentrations could be observed. This is in 
clear contrast to previous findings in female rats (Miller et al., 2016) using the same model. 
Based on pathway analysis involving the whole set of proteins separated and identified by 
this proteomic study, we could attribute these differences to alterations in metabolism in 
male and female rats, both under ET and HT conditions, mainly in lipid metabolism and 
glycolysis/gluconeogenesis, but also in redox and CYP protein related responses. This 
supports the need to include both genders in animal experiments. 
Proteomics proved its usefulness in toxicological investigations, detecting i) first signs of 
dysregulation on the protein level after only one week of HBCD exposure, ii) protein 
pattern differences in female rats based on thyroid status and – as a main influence – iii) 
gender-dependent protein regulation of metabolic pathways, which have a major impact 
on the body’s reactivity towards noxious substances. 
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Supplementary Data  
 
Suppl. Table 1: 
Complete set of animal data (females and males).  
 
Suppl. Table 2: 
MALDI TOF/TOF data of identified protein spots regulated in concentration in male rats. 
Numbering as in Figure 1. For regulation data see Table 2, complete peptide list is to be 
found in (Miller et al., submitted). Abbreviations: Protein Id (protein identification, from 
UniProt or NCBI database), Cov. % (sequence coverage). 
 
Suppl. Table 3: 
Proteins with significant abundance changes between male and female rats (controls) were 
classified according to STRING (KEGG), in ET and HT status. Members of different 
pathways found in the present study are detailed. 
 
Suppl. Figure 1: Pathway analysis (STRING)  
Identical to Figure 4 (for print version, colour). 
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Abstract 
Effects of exposure of male Wistar rats with different thyroid status (eu-, hypothyroid) to 0, 
3 or 30 mg/kg body weight of the flame retardant HBCD for 7 days were studied in 
comparison with a previous study in females [1]. Proteomic investigation of liver protein 
patterns obtained by 2D-DIGE was performed and differences between animals groups 
recorded, based on the factors exposure, thyroid status and gender. All proteins with 
significantly changed abundance in any of these comparisons were identified by mass 
spectrometry. General, hormone and proteomic data of both the present and the previous 
studies are discussed in “Hexabromocyclododecane (HBCD) induced changes in the liver 
proteome of eu- and hypothyroid female rats” [1] and in "Gender specific differences in the 
liver proteome of rats exposed to hexabromocyclododecane (HBCD)" [2]. 
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Specifications Table  
Subject area Biology 
More specific subject 
area 
Environmental Toxicology 
Type of data Tables, figure (PCA), image (annotated gel image) 
How data was acquired 2D Fluorescence Difference Gel Electrophoresis (2D-DIGE) and mass 
spectrometry 
Data format Analyzed and filtered data 
Experimental factors Liver lysates of eu- and hypothyroid male and female rats exposed to 
different concentrations of HBCD 
Experimental features Comparative proteomic analysis of rat liver lysates using 2D-DIGE. 
Proteins present in differentially abundant protein spots (regarding 
HBCD exposure, amount, thyroid status, and gender) were identified 
using MALDI TOF/TOF analysis. 
Data source location Origin of samples: Wageningen University, Wageningen, The 
Netherlands 
Data collection: Luxembourg Institute of Science and Technology, Esch-
sur-Alzette, Luxembourg  
Data accessibility Data is with this article as Supplementary Material 
 
 
Value of the data  
 Identification of liver proteins from male rats altered due to HBCD exposure 
 Identification of liver proteins from male rats changed in hypothyroid status 
 Comparison of male and female rats exposed in a similar exposure experiment, but 
showing different response in the liver proteome 
 Identified liver proteins form the basis for a more detailed understanding of involved 
mechanisms for the investigated compound, of differences in gender susceptibility and of 
gender dimorphic liver protein composition. 
 
 
Data 
Rat liver protein lysates show a complex spot pattern in high-resolution two-dimensional 
electrophoresis (about 3000 spots per gel). Patterns of 24 gels from different exposures of eu- and 
hypothyroid male rats were evaluated quantitatively. The same number of gels from an identical 
experiment with female rats from a previously described study [1, 3] was re-evaluated together 
with the newly obtained males' data, and additional MS identifications of regulated spots in females 
vs. males were performed. Data from different animals groups in both genders were compared, 
taking different aspects into account (HBCD exposure, thyroid status, gender). Statistically 
significant fold-changes of at least 30 % between groups (P<0.05 within group) were considered to 
be relevant.  
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Suppl. Figure 1 presents the master gel of the combined gel set, and all spots with significant 
abundance changes in any of the performed comparisons are labelled. Overall, single proteins in 
496 spots, selected by ANOVA evaluation, were successfully identified by MS analyses. Their spot 
numbers together with relevant peptide identifications are listed in Suppl. Table 1. Abundance 
changes of the various animal groups are compiled in Suppl. Table 2. Hierarchical clustering gave a 
clear grouping of regulated spots according to gender, and in females also according to thyroid state 
(Suppl. Figure 2). This is in line with PCA results (score plot of experimental groups) reported in [2]. 
The loading plot of this PCA is shown in more detail in Figure 1, with additional identification of 
single proteins in the border area or close to the main cluster.  
 
Experimental Design, Materials and Methods 
 
Animals, treatment and experimental protocol 
The animal experiment was detailed in [1, 2] and approved under number 2006-051 by the Animal 
Welfare Committee of Wageningen University. In brief, male Wistar WU (HsdCpbWU) rats with 
normal or reduced thyroid function (hypothyroid) were orally exposed to 0, 3 or 30 mg/kg bw / d 
HBCD, respectively, for 7 consecutive days. Four liver samples per group were analyzed by 
proteomic methods. The experimental setup was identical to the one used in [1], but applying it on 
male rats. 
 
Proteomic Analysis 
Rat liver lysates were subjected to two-dimensional fluorescence difference gel electrophoresis (2D-
DIGE) as previously described, without modifications, to make it compatible to the previously 
performed study in females [1-3]. This comprised a classical 2D-DIGE experiment, by separating 
CyDye-labeled proteins from liver lysates in a non-linear 3-10 pH-range and subsequently in large-
format SDS-PAGE gels (260 x 200 x 1 mm). Gel images (acquired on a Typhoon 9400) were 
evaluated with the DeCyder 7.0 software package (both GE Healthcare, Diegem, Belgium), including 
all gels of the previous study on females in matching and statistics [1, 3]. Univariate and multivariate 
analyses were applied to highlight differentially regulated spots (fold change at least 1.3) with a P-
value in the respective univariate ANOVA or two way ANOVA <0.05.  
136 
 
Spots differentially regulated in any of the group comparisons (including samples/gels from males 
and females) were automatically picked, trypsin digested and proteins identified by MALDI-TOF/TOF 
5800 (Sciex) as previously described [1-3]. This included also spots from female rat livers previously 
not analyzed, as only now they were found regulated in the comparison with male rats' data. 
Protein identification was based on searches of mass fingerprints (PMF) and MS/MS spectra against 
the SwissProt database with “Rattus norvegicus” as taxonomy, using the ProteinPilot software 
(Sciex, Nieuwerkerk aan den Ijssel, The Netherlands) and the searching algorithm MASCOT (Matrix 
Science, www.matrixscience.com, London, UK). For each spot one protein mass fingerprint and up 
to 8 MS/MS spectra were generated. Parameters for the search were set as in the previous study [1, 
3]: up to two missed cleavages allowed, 100 ppm tolerance in PMF, 0.75 Da mass tolerance for 
precursor ion mass, carbamidomethyl cysteine as fixed modification, oxidation of methionine and 
oxidation of tryptophan (single oxidation, double oxidation and kynurenin) as variable 
modifications. Identifications were considered to be significant when the combined MOWSE score 
had P<0.05. 
For statistics the Extended Data Analysis (EDA) module as well as univariate analysis (ANOVA and t-
test) and multivariate analysis (two way ANOVA), all part of the Decyder 7.0 software package, were 
applied.  
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Figure 1: 
PCA Loading plot of the 496 differentially regulated spots. Spot numbers (corresponding to labelling 
in gel image in Suppl. Figure 1 and regulation data in Suppl. Table 2) and UniProt accession 
numbers (Suppl. Table 1) used for labelling.  
Abbreviations:  
A1AT_RAT, Alpha-1-antiproteinase 
ACOX1_RAT, Peroxisomal acyl-coenzyme A oxidase 1 
AGT2_RAT, Alanine--glyoxylate aminotransferase 2_mitochondrial 
AK1D1_RAT, 3-oxo-5-beta-steroid 4-dehydrogenase 
AL1B1_RAT, Aldehyde dehydrogenase X_mitochondrial 
BHMT1_RAT, Betaine--homocysteine S-methyltransferase 1 
CAH3_RAT, Carbonic anhydrase 3 
DOPD_RAT, D-dopachrome decarboxylase 
protein ETHE1_mitochondrial 
FABPL_RAT, Fatty acid-binding protein_liver 
FRIL1_RAT, Ferritin light chain 1 
GRP78_RAT, 78 kDa glucose-regulated protein 
GSTA1_RAT, Glutathione S-transferase alpha-1 
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GSTA2_RAT, Glutathione S-transferase alpha-2 
GSTA3_RAT, Glutathione S-transferase alpha-3 
GSTP1_RAT, Glutathione S-transferase P 
HBA_RAT, Hemoglobin subunit alpha-1/2 
HPT_RAT, Haptoglobin 
Ifi47 protein 
K2C8_RAT, Keratin_type II cytoskeletal 8 
KNT2_RAT, T-kininogen 2 
M2GD_RAT, Dimethylglycine dehydrogenase_mitochondrial 
PON1_RAT, Serum paraoxonase/arylesterase 1 
PON3_RAT, Serum paraoxonase/lactonase 3 
PRDX3_RAT, Thioredoxin-dependent peroxide reductase_mitochondrial 
rCG56002 
RD23B_RAT, UV excision repair protein RAD23 homolog B 
RET1_RAT, Retinol-binding protein 1 
SARDH_RAT, Sarcosine dehydrogenase_mitochondrial 
SPA3N_RAT, Serine protease inhibitor A3N 
UB2D2_RAT, Ubiquitin-conjugating enzyme E2 D2 
 
 
 
Supplemental material: 
 
Suppl. Figure 1: Image of a rat liver 2D-DIGE gel (master gel, grey level image). All spots with 
statistically significant abundance changes in any of the different comparisons (HBCD exposure, 
thyroid state, gender) are labelled; spot numbers refer to identifications in Suppl. Table 1. For data 
on protein abundance, see Suppl. Table 2. 
 
Suppl. Figure 2: Heat map and hierarchical clustering of all 496 differentially regulated spots. 
 
Suppl. Table 1: Protein identifications by MALDI-TOF/TOF analysis. 
For spot locations on the gel see gel image in Suppl. Figure 1.  
 
Suppl. Table 2: All spots found affected in the complete/combined dataset (male and female rats). 
Ratios between different animal groups (n=4). Abbreviations: f, females; m, males; ET, euthyroid 
rats; HT, hypothyroid rats; 0, 3, 30 refer to amounts of HBCD (mg/kg bw / d) administered in the 7-
day exposure period. 
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Proteins of rat serum: III. Gender-related
differences in protein concentration under baseline
conditions and upon experimental inflammation as
evaluated by two-dimensional electrophoresis
We have previously described the major components of rat serum (Electrophoresis
1998, 19, 1484–1492 and 1493–1500). In this report we examine sex-related differen-
ces in protein concentrations, both in control animals and upon experimentally induced
inflammation. Under baseline conditions approximately one third of the spots resolved
in serum by two-dimensional electrophoresis (2-DE) are expressed at levels ³ 25%
higher in female rats than in male rats and a further 10% at levels ³ 25% lower. Inflam-
mation increases the expression of the positive acute-phase reactants: hemopexin,
ceruloplasmin, a1-antitrypsin (all approximately 2-fold), C-reactive protein (3- to 5-fold),
serine protease inhibitor-3 (4- to 5-fold), thiostatin (> 5-fold in females, > 20-fold in
males), clusterin, orosomucoid, haptoglobin chains and a2-macroglobulin. The base-
line level of the last four markers is below the detection limit, hence no percent
increase can be computed. Conversely, negative acute-phase reactants are reduced
on inflammation: a1-inhibitor III, a2-HS-glycoprotein, kallikrein-binding protein and
transthyretin (all reduced to between 1/2 to 1/3 of the baseline levels), retinol-binding
protein (to about 1/2 to 1/4) and albumin (to 2/3). Except for thiostatin, the changes in
acute-phase protein levels are similar in male and female rats.*
Keywords: Rat serum / Two-dimensional polyacrylamide gel electrophoresis / Inflammation / Sex
/ Acute-phase reactants EL 3364
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1 Introduction
Our groups have recently detailed the 2-DE map of rat se-
rum by identifying the major protein components through
a combination of immunoblotting and HPLC-MS/MS-
based protein identification [1]. In a further step, the pro-
teins typical of the acute-phase response to experimental
inflammation have been identified [2]. Altogether, the
above include 28 proteins, corresponding to about 80 in-
dividual spots. A compilation of all our rat data can be ac-
cessed [3, 4]. We wish to extend this database through
the addition of further spot identifications and, further-
more, of annotations on physiological and pathological
properties for individual components. One condition of
special interest to our current research is experimental in-
flammation. We examine whether evaluation of serum
levels of the acute-phase reactants may become a useful
tool for the screening of anti-inflammatory drugs [5]. De-
tailed quantitative parameters characterizing the acute-
phase response are a preliminary step towards this goal.
Additional aspects of this investigation are sex-related dif-
ferences in serum protein expression after inflammation
as well as under control conditions; a typical animal model
for chronic inflammation is adjuvant arthritis in female
Lewis rats. Preliminary data [2] imply that the baseline
concentrations of some of the acute-phase markers, e.g.,
kallikrein-binding protein and thiostatin, differ significantly
between male and female rats. For humans, in the compi-
lation by Putnam [6], different normal concentration rang-
es are reported for men and women for a2-macroglobulin,
IgM, and b-lipoprotein.
Correspondence: Dr. Elisabetta Gianazza, Istituto di Scienze
Farmacologiche, Facoltµ di Farmacia, Universitµ degli Studi di
Milano, via Balzaretti 9, I-20133 Milano, Italy
E-mail: elisabetta.gianazza@unimi.it
Fax: +39-02-29404961
Abbreviations: apo, apolipoprotein; CRP, C-reactive protein;
Gc, Gc-globulin; Hp, haptoglobin; Hpx, hemopexin; a1-I3, a1-in-
hibitor III; a1-M, a1-macroglobulin; a1-MAP, thiostatin (1 and 2);
a2-M, a2-macroglobulin; NC, nitrocellulose; OD, optical density;
PAA, polyacrylamide; RBP, retinol binding protein; Tf, transferrin
836 Electrophoresis 1999, 20, 836–845
 WILEY-VCH Verlag GmbH, 69451 Weinheim, 1999 0173-0835/99/0405-0836 $17.50+.50/0
* Procedures involving animals and their care were conducted at
Istituto di Scienze Farmacologiche, Universitµ di Milano, in
conformity with the institutional guidelines that comply with na-
tional (D.L. No. 116, G.U. Suppl. 40, February 18, 1992 and
Circolare No. 8, G.U. July 1994) and international laws and pol-
icies (EEC Council Directive 86/609, OJ L 358.1, December
12, 1987, and Guide for the Care and Use of Laboratory Ani-
mals, US National Research Council, 1996).
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2 Materials and methods
2.1 Samples
Three female and three male Sprague Dawley rats, 10
weeks old, 230–250 g, on a standard chow diet, were
probed both before (control) and 48 h after intramuscular
injection of 5 mL turpentine/kg body weight (as a stimulus
inducing inflammation) [7]. Blood was drawn from the
caudal vein under diethylether anesthesia at the begin-
ning of the test period; the animals were killed by decapi-
tation at the end of the treatment. Aliquots of the sera
were stored at –20o.
2.2 Electrophoresis
Most analytical procedures were identical to those al-
ready detailed in the previous papers of this series [1, 2].
2-DE maps were obtained by IPG-DALT [8] on 5 mL ali-
quots of sera. Under standard conditions, whole serum
proteins were resolved on a nonlinear pH 4–10 IPG [9]
and SDS-PAGE was then run on 7.5–17.5%T polyacryl-
amide (PAA) gradients; the slab size was 16 ´ 14 cm.
Protein patterns were stained with 0.3% w/v Coomassie;
a-mannose-containing glycoproteins were revealed by
concanavalin A/peroxidase interaction [10, 11] after blot-
ting onto a nitrocellulose (NC) membrane. In addition to
the standard 2-DE protocol given above, enhanced reso-
lution of individual areas or for a given class of proteins
was achieved by variation of pH gradient or acrylamide
concentration of the gels. Orosomucoid from 7.5 mL se-
rum was focused on a pH 2.5–5 IPG [12] prior to SDS-
PAGE as above. For glycoprotein detection (required for
theresolution of even the basic isoforms of hemopexin),
2 mL of serum were run under standard conditions, then
blotted on an NC membrane and affinity-stained with
Concanavalin A-peroxidase [10]. For proteins in the
crowded area around a2-HS glycoprotein, 2-DE was also
performed on a pH 4–6 IPG (the acidic 60% of the wide
range above) followed by SDS-PAGE on 4.5–9%T PAA
gradient gels. With high Mr proteins, showing minimal
overlap in size, 1-DE gave satisfactory results even on
6 ´ 8 cm slabs. The best resolution was achieved by
SDS-PAGE on a 4–6%T PAA gradient, with sample loads
of 0.1 mL per lane for Coomassie stain and of 0.002 mL
per lane for glycoprotein detection. Ceruloplasmin was
immunostained with an antiserum raised in goats against
the human protein (Sigma, St. Louis, MO, USA).
2.3 Protein quantitation
The 2-DE gels and the blots were scanned with a video
camera (Sony, Japan) under the control of NIH Image, re-
lease 1.52, and analyzed with the software PDQUEST
Version 5.1 (PDI, Huntington Station, NY, USA) run on a
Sun SPARCstation 4 (Sun Microsystems, Mountain View,
CA, USA). A matchset was created from the patterns of
the four pools of rat sera (control males, inflamed males,
control females and inflamed females) in a given run. A
standard gel (master) was generated out of the image
with the highest spot number by including additional spots
from the other three gels [13]. As all gels within one series
were processed “in one batch”, results were evaluated in
terms of spot volumes without further correction/normali-
zation. The reports for individual proteins (spots, or spot
chains, already identified by immunological or physico-
chemical means [1, 2]) (or single, unidentified spots) are
referred to by percentage values of the highest figure
among the four samples. Albumin was determined by the
immediate bromocresol green assay [14, 15].
2.4 Protein identification by peptide mapping
through HPLC-MS/MS
Some proteins influenced in their expression by inflam-
mation and not already included in our database [3, 4]
were identified by HPLC-MS/MS. After blotting and stain-
ing with Amido Black, material from individual spots was
digested with trypsin according to [16]. The resulting pep-
tides were resolved by chromatography on microbore
HPLC system (Ultrafast Microprotein Analyzer; Michrom
Bioresources, Auburn, CA, USA) equipped with a 100 ,
5 mM Reliasil C18 BDX column (0.5 ´ 150 mm; Michrom).
Peptides were eluted using buffer A (6% v/v acetonitrile,
0.1% acetic acid, 0.005% v/v heptafluorobutyric acid) and
buffer B (80% v/v acetonitrile, 0.1% acetic acid, 0.005%
v/v heptafluorobutyric acid), at a flow rate of 15 mL/min.
The gradient used was 0% B for 2 min, followed by a lin-
ear increase to 60% B over 48 min. Tandem mass spec-
trometry was performed on-line in a triple quadrupole
mass spectrometer (TSQ 7000; Finnigan, San Jose, CA,
USA) connected to the HPLC via a microspray interface
[17]. Spectra were scanned over a range of 380–1500
mass units at 1.5 s intervals. Automatic peak recognition
and daughter ion scanning were performed using the
built-in instrument control language (ICL) [18]. Tandem
mass spectra were analyzed using SEQUEST, which al-
lows the correlation of experimental data with theoretical
spectra generated from known protein sequences [19,
20]. Briefly, SEQUEST matches a precursor ion of a given
mass with any peptide present within the protein sequen-
ces of a given database, within a specified mass accura-
cy. An initial ranking is obtained by considering the pres-
ence and intensity of the peptide fragment ions in the
experimental spectrum. A theoretical collision-induced
dissociation (CID) spectrum of the five hundred best-
ranked peptides is then generated and correlated with the
experimental CID spectrum to find the best match. All
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spectra were searched against the OWL protein data-
base, release V30.1 [21, 22]. The criteria used for positive
peptide identification were a correlation factor greater
than 2.0, a delta cross-correlation factor greater than 0.1
(indicating a significant difference between the best
match reported and the next best match), and a high pre-
liminary score [17]. The search data were summarized
using the sequest_summary program [19, 20], which as-
signs a dimensionless numerical value to search results
based on a sliding scale where 10 units are given for a
peptide ranked as the best match, 8 units for a second-
best match, 6 for a third-best match, 4 for a fourth-best
match and 2 for a fifth-best match. The scores assigned
to peptides from a common protein are summed, to give a
sequest_summary score for each potential protein match.
The criterium we used for a positive protein identification
was a sequest_summary score of greater than 20, indi-
cating at least two peptides from a potential matching pro-
tein had been positively identified [17].
2.5 Lipoprotein purification and analysis
Total lipoproteins were collected by flotation on a KBr sol-
ution (d = 1.21 g/mL) and delipidated by treatment with di-
ethylether:ethanol 3:1 v:v [23]. Equal amounts of the puri-
fied apoproteins (10 mg) were run in SDS-PAGE on a 4–
20%T PAA gradient in order to resolve components of
such different size as apoB and apoC at the same time.
3 Results
3.1 HPLC-MS/MS protein identifications
Three proteins not included in our previous database
were identified by HPLC-MS/MS as being among the
spots whose expression was modulated upon inflamma-
tion. Their positions in the 2-DE map are indicated (by
ovals) in Fig. 1. The identifications of these three (Table
1) were a1-inhibitor III [24–26], C-reactive protein (CRP)
[27, 28] and clusterin [29, 30]. a1-Inhibitor III was ana-
lyzed on a blot from 2-DE as well as on the SDS-PAGE of
a control serum; clusterin was identified next to orosomu-
coid on a map from a 2.5–5 IPG. The component identi-
fied as CRP is located in the immunoglobulin light chain
region (results from immunoblotting [1]) which extends to
acidic pIs. One spot close to CRP had been previously
identified as belonging to the immunoglobulin k isotype
(spot 50 of Fig. 2 in [1]) by HPLC-MS/MS in the serum of
normal male rats. No peptides of this protein were found
in the present analysis when investigating samples from
normal and inflamed animals. Since immunoglobulin pop-
ulations are known to be heterogeneous and variable, de-
pending on the individuals (outbred mice share only 30%
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Figure 1. 2-DE map of serum
proteins from female rats 48 h
after the intramuscular injection
of turpentine; Coomassie stain
on a 5 mL sample. The inset is
from a 2-DE gel whose first di-
mension was run on a 2.5–5
IPG, with a serum load of 7.5
mL. Histograms of the abun-
dance of the various proteins,
as marked on the top of each
panel, in the sera of (from left to
right) control males, inflamed
males, control females, inflamed
females. All data are referred to
as % value to the highest figure
among the four samples. Arrows
point to the prolongation of bro-
ken lines (for a1-AT, a2-HS and
Gc). a1-AG, a1-acid glycopro-
tein; a1-AT, a1-antitrypsin; a1-I3,
a1-inhibitor III; a1-M, a1-macro-
globulin; a1-MAP, thiostatin (1
and 2); a2-HS, a2-HS-glycopro-
tein; a2-M, a2-macroglobulin;
apo, apolipoprotein; Cp, ceruloplasmin; CRP, C-reactive protein; Gc, Gc-globulin; Hp, haptoglobin; Hpx, hemopexin; KBP,
kallikrein-binding protein; RBP, retinol-binding protein; SPI3, serine protease inhibitor-3; Tf, transferrin; TTR, transthyretin.
The spots outlined by ovals correspond to proteins newly identified by HPLC-MS/MS; the asterisk marks a further spot
identified as ceruloplasmin.
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of their Ig light chain spots, and inbred mice 70–80%
[31]), it appears that this isotype was not present at signif-
icant levels in the animals used in these studies. HPLC-
MS/MS was also used to identify some of the high Mr
spots (Fig. 1). Ceruloplasmin [32, 33] was found to over-
lap with an inter-a-inhibitor H4 [34, 35]. Ceruloplasmin
was also detected at the position marked with an asterisk.
One further protein, previousy detected only by immuno-
blotting, was confirmed by HPLC-MS/MS to be a2-macro-
globulin.
3.2 Protein evaluation
2-DE evaluation of the rat sera for spot quantitation was
only performed on gel series which had been processed
in the same batch (in all steps, i.e., from IPG to destaining
after 2-DE and scanning) to keep variation levels as low
as possible. A constant volume of serum was loaded onto
the gel, although samples from inflamed animals are
known to vary slightly in protein concentration and distri-
bution [7]. All quantitations were based on (absolute) spot
volumes; it was a priori not clear which protein was unaf-
fected in its level and could serve as internal standard. As
serum protein content varies upon inflammation [7], %
based on total optical density (OD) in a given slab appear
less reliable than constant serum volume. The reproduci-
bility of the system was tested by running several gels of
the same sample (male rat serum), in different batches.
Gels were evaluated in the way described, and variation
was determined for all proteins. Variation coefficients
whithin one batch were 20% on average, smaller for com-
pact, round and darker spots, e.g., transferrin (Tf) 7–9%,
apolipoprotein (apo) AIV 7–11%, haptoglobin (Hp) b/a1-M
9% and higher for the more diffuse, fainter, and oval-
shaped ones, e.g., a1-inhibitor III (a1-I3) within 36%. No
correlation between Mr of the protein and variation coeffi-
cient was found.
3.3 Protein concentration in control and
inflamed rats
The master gel pattern produced by PDQUEST software
contains 151 different single spots resolved under stand-
ard conditions (as in Fig. 1). For males the number of
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Table 1. Proteins identified by HPLC-MS/MS
Protein (abbreviation) ID OWL [21] Sequest_scoresa) Notes
a1-Inhibitor III (a1-I3) A1I3_RAT Total of 368 32 peptide best matches
+ 3 peptides of s 15904
(a variant of A1I3_RAT)
a2-Macroglobulin (a2-M) A2MG_RAT 144 Confirmation of data from
immunoblotting [1]
Ceruloplasmin (Cp) CERU_RAT 130 Overlap with RNITIH4
Cp* CERU_RAT 128
C-reactive protein (CRP) CRP_RAT 118, 144, 146, 78 4 different analyses
Clusterin CLUS_RAT 48, 68 2 different analyses
Inter-a-inhibitor H4 RNITIH4 52
a) See Section 2.4 for further details
Figure 2. (A, B) Close-up of the
2-DE region of pH 4.5–5.5 and
Mr 45–65 kDa for control female
(on the left) and inflamed female
animals (on the right). The sec-
ond dimension was run on a
4.5–9%T slab. (C, D) Details
from 2-DE using standard IPG,
but 10–15% gels in second di-
mension, run for an extended
period (migration distance for
apoAI 12 cm instead of 6 cm)
and silver-stained; patterns cor-
respond to 0.2 mL serum. a1-M
light chain (upper row) and Hp
b-chain (lower double row) are
resolved. Control female animal
on the left, inflamed female on
the right.
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quantitated spots is lower (113 for control animals, 124
for inflamed) than for females (120 for control, 148 for in-
flamed animals), with more saturated spots for females
than for males (mainly albumin and Tf). Under baseline
conditions, 29% of the single spots are expressed at lev-
els at least 25% higher in females than in males, 10% at
levels at least 25% higher in males than in females. Upon
experimental treatment, an increase above control levels
exceeding 25% is recorded for 25% of the protein spots in
males and for 28% in females, a decrease exceeding
25% for 32 and 34% of the spots, respectively.
The largest number of protein spots is found in the serum
of inflamed female rats; the 2-DE map of such a sample is
shown in Fig. 1, with an inset from a 2-DE gel from a 2.5–
5 IPG to fully resolve orosomucoid and clusterin. A close-
up details the region with the most dramatic changes in
protein patterns due to the treatment, i.e., the region of pI
4.5–5.5 and molecular mass 45–65 kDa (Fig. 2, panels
A–B). For identified proteins, single spot volumes of the
respective chain were summed and plotted, while uniden-
tified spots were treated individually. Figure 1 shows the
identified proteins and single spots of high intensity (cut-
off chosen arbitrarily). Histograms are linked to the pro-
tein, or protein spot, to which each refers, and are marked
with the protein abbreviation, or a spot number (according
to PDQUEST listing). For one as yet unidentified protein,
designated X, the sum of volumes for all spots in a row
was computed. In each histogram, the series, from left to
right, includes: control males, inflamed males, control fe-
males, inflamed females.
Thiostatin (a1-MAP) is five times higher in females than in
males, hemopexin (Hpx) almost 50% higher, CRP and
apoE ca. 25% higher in females. Gc-globulin (Gc) and ret-
inol-binding protein (RBP) are about twice as high in
males, and a2-HS glycoprotein and a1-antitrypsin about
25 and 30% higher in males than in females, respectively.
Once expressed after inflammation, the concentration of
a2-macroglobulin is about 40% higher, and that of oroso-
mucoid about 30% higher in male rats. Among the noni-
dentified proteins, protein X and spot 6403 are found only
in females, being either strongly or slightly up-regulated in
inflammation. Spot 4001 appears only in the course of
treatment, and several others are reduced in concentra-
tion (#5301, 7101, 8103, 8301, 8302).
Variations in serum levels are brought about by the exper-
imental treatment for virtually all proteins, although the or-
der of magnitude of the changes differs widely. Among
the major identified proteins only transferrin does not
seem to change its absolute concentration (also see [5]).
Inflammation increases the expression of the positive
acute-phase reactants hemopexin, ceruloplasmin and a1-
antitrypsin (all approximately 2-fold), C-reactive protein
(3- to 5-fold), serine protease inhibitor-3 (4- to 5-fold), thi-
ostatin (> 5-fold in females, > 20-fold in males), clusterin,
orosomucoid, haptoglobin chains, and a2-macroglobulin.
The baseline level of the last four markers is below the
detection limit, hence no percent increase may be com-
puted. Upon inflammation orosomucoid represents ca. 2–
3%, haptoglobin a-chain 3–4%, haptoglobin b (together
with a1-macroglobulin (a1-M) 13–14% and a2-macroglob-
ulin 5% of total serum proteins. Among the nonidentified
components, spot #4001 is only detected after inflamma-
tion. Conversely, negative acute-phase reactants are re-
duced on inflammation: for example, a1-inhibitor III, a2-
HS glycoprotein, kallikrein-binding protein and transthyre-
tin (all of them being reduced to 1/2 or 1/3 of their baseline
levels), retinol binding protein (to 1/2 or 1/4), transthyretin
(to 1/2 to 1/3) as well as a number of relatively faint, un-
identified protein spots (not included in the histograms of
Fig. 1). Albumin is reduced to about 2/3 of its concentra-
tion by inflammation; the same is observed for some
spots previously identified as albumin fragments [1].
As for apolipoproteins, the amount of apoE is increased,
while that of apoAI is decreased by inflammation (Fig. 1).
If the percent concentrations of the various apoproteins in
a purified lipoprotein preparation are computed (Fig. 3),
the reduction for apoAI equals 50%, while the level of
apoB doubles. As discussed (see [5]), the distribution
among pI isoforms is not influenced by the experimental
treatment (not shown).
Concordance is usually observed between the sexes as
for the extent of the changes following inflammation. A
strong difference is only found for thiostatin, for which the
increase in males is four times higher than in females.
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Figure 3. Percent distribution
of the various apoproteins in
the lipoproteins of (from left to
right) control males, inflamed
males, control females, in-
flamed females.
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4 Discussion
4.1 Assessment of the quantitation procedures
As detailed under Section 2.3, as a second step after
2-DE under standard conditions, the quantitations for
many proteins were repeated under electrophoretic condi-
tions maximizing resolution in specific areas. A counter-
check of values revealed consistency of the trends ob-
served throughout all the methods, although absolute
spot volumes differed. The spots of the two proteins with
the highest concentration in serum, albumin and Tf, were
usually saturated in 2-DE with standard sample loads.
Transferrin could be evaluated after 1-D SDS-PAGE on a
4–6%T gel. Albumin was determined by a photometric as-
say based on the reaction with bromocresol green [36].
Two proteins could not be fully resolved from neighbors
with overlapping molecular properties. In the Hpx/albumin
pair, lectin affinity staining was able to clearly differentiate
the glycoprotein from the nonglycoprotein component and
was used for quantitation (histogram in Fig. 1). The spots
of a1-macroglobulin light chain and haptoglobin b-chain
overlap almost completely in the standard 2-DE system;
both proteins are glycosylated and no cross-reactive anti-
body is available [2]. Improved resolution in 2-DE was ob-
tained by prolonging the second-dimension runs, lowering
sample loading amounts, and using silver staining as a
detection method [37, 38]. In this way, a1-M (a single row)
was found to remain constant, whereas the levels of Hp b
(a double chain) rose 9–10 times (Fig. 2 C–D).
4.2 Newly identified proteins
In the course of our new experiments several spots were
investigated in more detail, especially those showing var-
iations in serum levels upon treatment. All of the proteins
newly identified by HPLC-MS/MS showed considerable
differences from the human homologs. CRP, a pentame-
ric glycoprotein with identical subunits, displays a much
more acidic pI in rats than in humans. It is one of the early
markers of inflammation in humans [39] and is reported to
be little affected in rats (by a factor of 2 versus 1000 [40]).
In contrast to the human counterpart, rat CRP is present
in serum at higher baseline levels [41], it is a glycoprotein
(see Fig. 4) [28], and its binding properties for phosphoryl-
choline differ (it contains three instead of five binding sites
[42]). Rat clusterin is also much more acidic than the hu-
man homolog. In mice and humans, this protein, an ex-
tensively glycosylated disulfide-linked heterodimer with
subunits of similar Mr, is known as apo J and is associat-
ed with apoptosis and inflammation [29]. a1–I3 is a rat-
specific protein, belonging to the macroglobulin family
and acting as a protease inhibitor [25]. Whereas the first
two proteins described are increased upon inflammation,
the level of a1–I3 drops.
During the search for new inflammation markers, two high
Mr spots were identified as ceruloplasmin (Cp) by HPLC-
MS/MS. The previously described immunostaining of cer-
uloplasmin [1] had been performed with a weakly cross-
reacting antibody raised against the human protein. It pro-
duced multiple spots or spot chains of different intensity,
among them the position indicated in Fig. 2 of [1] and the
spot named Cp in Fig. 1 of this paper. When performing
the immunoblot after 1-D SDS-PAGE, there was also a
fainter double band with lower Mr. As it could not be veri-
fied whether the latter was identical to spot Cp* (Fig. 1),
quantitation was only based on the main cross-reactive
component. Human Cp is thought to be a single-chain
polypeptide, but was found as a major type I with four
sugar chains and a minor type II with three sugar chains
[43], which could also correspond to the general Cp pat-
tern given in SWISS-2DPAGE [42]. Rat Cp is reported to
be more acidic than the human homolog [32] and contains
an even larger number of potential glycosylation sites (6
versus 4). However, these different properties cannot
completely explain the spot pattern in our 2-DE runs.
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Figure 4. Comparison between
the quantitations from Coomas-
sie-stained pattern (solid bars)
and concanavalin-positive affini-
ty blotting for the glycyl moiety
(open bars) of some glycopro-
teins. In each series the se-
quence of the samples is, from
left to right: control males (CM),
inflamed males (IM), control
females (CF), inflamed females
(IF); for each type of staining,
data are referred to as percent-
age values relative to the high-
est figure among the four sam-
ples.
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4.3 Changes in protein levels
With ELISA, Ikawa and Shozen [44] have determined nor-
mal values of several acute phase proteins in an (unspe-
cified) rat strain. The detection system was validated and
found to have a variation of less than 10% for most pro-
teins, but the concentration ranges reported for some of
the analytes vary between 10 and 25% (e.g., Hp, Hpx, or-
osomucoid). Sprague-Dawley as an outbred strain may
also be expected to display a certain degree of variation
in serum protein levels. Most changes noticed in inflam-
mation are much more marked than the error in our quan-
titation (determined in the reproducibility testing) or the
normally expected variation in the respective rat popula-
tion.
Several procedures have been reported in the literature to
induce inflammation processes, most often injection of
turpentine. However, the strength of the stimulus used
varied among authors, as well as the time intervals after
which the shifts in protein levels were recorded (usually
one to three days), which results in differences in the
magnitude of the changes described. For an overview on
previous results, see Table 2. As for the major proteins,
our present findings confirm current knowledge about
positive and negative acute-phase reactants, although
the extent of variation we report sometimes differs from
literature data. As for CRP, we could only confirm a much
lower rise than in humans [40] but still a clear-cut increase
in its levels. Contrary to Schreiber et al. [45] who report
Gc and apoAI not to be affected by the acute-phase re-
sponse, we observe an increase for the former and a de-
crease for the latter. Rat Tf has been reported to change
little in inflammation [7] and has therefore been suggested
for reference as an internal standard. Tf data at the time
point chosen for our present investigation would support
this hypothesis; however, detailed studies in time course
experiments provide evidence for a more complex behav-
ior [5]. Some of the changes in protein levels brought
about by acute experimental inflammation are reproduced
by such different noxious stimuli as exposure to solvents
in toxicological tests (dimethylformamide [46]).
Slight to moderate differences were found in baseline lev-
els for single proteins when comparing male and female
rats. Sevenfold higher kallikrein-binding protein (KBP)
and a1-antitrypsin (a1-AT) values have been reported for
male rats [47]; a similar trend was noticed in our animals,
but not exceeding a factor of 2 [2]. Gc and RBP level of
our male and female controls also varied. The most
marked difference was the almost complete absence of
thiostatin (a1-MAP) in the serum of healthy males, where-
as it was clearly detectable in control females [2]. Except
for the latter, the changes in acute-phase protein levels
were similar in male and female rats. a2-Macroglobulin
was higher in inflamed males, in agreement with earlier
reports [48].
842 I. Miller et al. Electrophoresis 1999, 20, 836–845
Table 2. Changes reported for rat serum proteins upon
inflammation
Protein Type of change Reference
a1-AG : 20 ´ Urban et al., 1979 [60]
: 20 ´ in 24 h,
: 14 ´ in day 3 Schreiber et al., 1982 [7]
a1-AT : 2 ´ in day 2 Gauthier et al., 1978 [24]
: 2 ´ Urban et al., 1979 [60]
: <1.50 ´ Koj et al., 1982 [61]
a1-I3 ; 0.3 ´ in day 2 Gauthier et al., 1978 [24]
; 0.5 ´ in day 2 Lonberg-Holm et al., 1987 [25]
; 0.3–0.25 ´ in 24 h Braciak, 1988 [26]
; 0.25–0.2 ´ in 24 h Aiello et al., 1988 [62]
a1-M : 1.4 ´ in day 3 Gordon et al., 1976 [63]
« Gauthier et al., 1978 [24]
« Lonberg-Holm et al., 1987 [25]
: <1.5 ´ Koj et al., 1982 [61]
a1-MAP : 20 ´ in 24 h Urban et al., 1979 [60]
: 20 ´ in 24 h,
: 18 ´ in day 3 Schreiber et al., 1982 [7]
: 20 ´ Cole et al., 1985 [64]
a2-HS ; Schreiber et al., 1988 [45]
a2-M : 90 ´ in day 2 Gordon et al., 1976 [63]
: (rapid) Gauthier et al., 1978 [24]
: 110–140 ´ in 24 h Okubo et al., 1981 [65]
: 70 ´ in day 2 Lonberg-Holm et al., 1987 [25]
Albumin ; 0.6 ´ Urban et al., 1979 [60]
; 0.4 ´ in 24 h,
; 0.6 ´ in day 3 Schreiber et al., 1982 [7]
ApoAI « Schreiber et al., 1989 [45]
ApoAIV ; Schreiber et al., 1989 [45]
ApoE ; Schreiber et al., 1989 [45]
Clusterin Associated with
apoptosis [42]
Cp : Schreiber et al., 1989 [45]
CRP : 2 ´ Kushner et al., 1988 [41]
Undetectable Schreiber et al., 1989, [45]
Gc « Schreiber et al., 1989 [45]
Hp : 10 ´ Lombart et al., 1965 [66]
: 3 ´ Koj et al., 1982 [61]
Hpx : Kushner, 1984 [40]
KBP ; Chao et al., 1990 [67]
; Pages et al., 1990 [68]
; Chai et al., 1991 [47]
RBP ; Schreiber et al., 1989 [45]
SPI-3 : Pages et al., 1990 [68]
Tf : 1.3 ´ in 24 h Schreiber et al., 1982 [7]
Transthyretin ; Schreiber et al., 1989 [45]
:, increased
«, no change
;, decrease in concentration
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The major acute-phase protein (a1-MAP) of rat serum
has been given different synonymous designations, to
stress one or another of its functions. It is also named
T-kininogen 1 precursor, after the sequence of T-kinin it
contains, and thiostatin, after its inhibitory effect on cys-
teine proteases. Two genes exist for this protein, result-
ing from a duplication event: MAP1 and MAP2 [49, 50].
Two types of proteins are indeed found in plasma, dif-
fering in their pI by about 0.3 pH units, in agreement
with computation based on amino acid composition [42].
Their baseline levels are different: a1-MAP (2) is more
abundant than a1-MAP (1) in female rats, and is also
the only form present (in very small amounts) in control
males. The concentration of each peptide and, in detail,
of each glycoform, appears to be raised to a similar
extent by acute inflammation (not shown). Strict coregu-
lation of a1-MAP (1) and a1-MAP (2) is not a rule, how-
ever. Pharmacological treatments [5] as well as different
phlogistic stimuli may bring about a differential modula-
tion of the two peptides.
The glycosylation pattern of serum proteins has been re-
ported to change under various physiological and patho-
logical conditions [51], including inflammation [52]. In hu-
mans, detailed studies have been devoted, for instance,
to Tf [53] and to orosomucoid [54]. In the present investi-
gation no systematic comparison of the differences in gly-
cosylation between control and inflamed pattern was per-
formed since the concentrations were adjusted to the
detection of few proteins of specific interest while the
stainability of the various glycoproteins differs widely (as
shown in [2]). Quantitations after protein blotting are fur-
ther complicated by the limited binding capacity of the NC
membrane as well as by the narrow dynamic range of the
zymograming techniques. However, among the assayed
serum components, for a1–I3 and Tf the protein secreted
during inflammation appears more glycosylated than un-
der basal conditions (Fig. 4).
4.4 Biological aspects
It has been shown that the concentration of about 30% of
the liver proteins differs between male and female Wistar
rats, the reason for this gender-related distinction being
the level of estrogen [55]. It is not surprising that a similar
trend is likewise observed for the plasma proteins, also
synthesized by the liver and then secreted to the circula-
tory stream instead of being released within the parenchy-
mal cells. With a cut-off at 25% difference in baseline lev-
els, and with reference to individual spots, approximately
40% of the serum components were found to be present
at higher concentrations in females, while only 10% of the
serum components were found to be higher in males. For
almost all proteins the responses to the inflammatory
stimulus were found to be similar in male and female rats.
The effects of the mediators of inflammation and of the
steroid hormones thus appear additive and not synergis-
tic. The only major exception to this trend is thiostatin, for
which, however, the baseline level for most of the iso-
forms in males is almost below the detection limit so that
computations of percent increase are highly inaccurate.
The overall impression from the observations above is
that serum proteins behave as a coordinate system. In
fact, the concentration of virtually all serum components
is affected by inflammation, which means – owing to our
selection on data reduction – that their synthesis rate is
modified. The total protein concentration in inflamed sera
changes slightly [7]. A significant drop is observed for the
most abundant among the serum proteins, albumin. It
might be speculated that its levels could decrease during
inflammation by a compensatory effect, so that down-reg-
ulation would not occur at the genetic level, but rather as
a result of competition for available resources, such as
aminoacyl-tRNA or ATP. The opposite situation has been
described in detail, namely the compensatory adjust-
ments observed in the serum of analbuminemic rats [56];
the concentration of globulins (a1-AT, Tf, Cp, IgG, IgA
and IgM but not orosomucoid) rises [57], with especially
large effects on high Mr components such as a2-M
(whose concentration increases 12-fold) and a1-I3 (whose
concentration doubles) [58]. Also, in humans, lack of albu-
min is compensated for so as to obtain unchanging total
protein concentration and oncotic pressure [59].
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Chapter 7 
 
General discussion and conclusions 
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General discussion  
 
The mechanisms of action of sub-lethal effects of toxic compounds can be hard to 
explain based on general toxicological data from animal experiments only or from 
determination of single biochemical parameters which are hypothesized to be altered. 
Sometimes results are inconsistent or even contradictory, and mechanisms of actions are 
not clear (yet). In these cases, modern analytical methods like proteomics, offering a 
holistic and non-targeted approach, may help to shed light to specific aspects and add a 
new perspective to research in this field. Proteomic methods investigate all proteins 
detectable in an analytical system under clearly defined conditions and not specifically a 
few that had been preselected by induction based on previous results. Thus, proteomic 
methods are able to detect not yet known to be affected or still little explored proteins and 
to relate them to specific pathways. In this way proteomics may help to reveal new or 
clarify ill understood mechanisms of actions of different toxic compounds. Proteomics of 
serum/plasma offers as a non-invasive technique also the possibility to study exposure 
induced effects over time getting more data from the same number of animals. This can 
also greatly contribute to the 3R strategy of replacement, reduction and refinement of 
animal experiments. 
 
This thesis aims at evaluating the use of proteomics in toxicological research both by 
compiling proteomic literature data on halogenated organic compounds in a review and 
by experimentally investigating effects of a model halogenated organic compound. To 
achieve this, gel-based proteomics is applied to study the influence of the brominated 
flame retardant hexabromocyclododecane (HBCD) on the liver proteome of female and 
male rats exposed to sub-lethal doses of this compound for one week. The animals had 
either a normal thyroid status (euthyroid, ET) or were hypothyroid (HT) as it was 
suggested that a HT status could render animals more susceptible to HBCD [van der Ven 
et al., 2006]. 
 
Liver is chosen as target tissue, as it is the main detoxifying and protein synthesizing 
organ and one of the first tissues exposed to HBCD after oral uptake. Rats of both 
genders are studied in separate groups because gender-specific responses have been 
indicated [van der Ven et al., 2006, Cantón et al., 2008; Germer et al., 2006].  
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Firstly, in Chapter 2 a general overview about possibilities and strategies in gel-based 
proteomics is provided, taking into account different separation strategies as well as 
adaptations of the workflow made necessary by the sample type under investigation. It 
contains also a brief survey on sample pre-fractionation options to facilitate investigation 
of minor proteins. 
 
Next a more detailed overview about proteomic methods is given in Chapter 3, with 
special attention for the additional benefit of proteomic methods in toxicological 
investigations. Compounds of interest are halogenated organic compounds like dioxins, 
polychlorinated biphenyls (PCBs), and polybrominated diphenyl ethers (PBDEs) whose 
influence on the liver proteome of various species had been studied by different 
proteomic approaches. 
 
Thus, based on literature data, these two chapters give a detailed and positive answer to 
research question 1: What are the possibilities and strategies in proteomics as a tool 
to study sub-lethal toxicological effects of compounds with a long term effect? The 
following chapters provide answers obtained from own experiments. 
 
 
Chapters 4 and 5 investigate pattern changes in the liver proteome of ET and HT rats 
which underwent short-time exposure with HBCD: Chapter 4 in females, Chapter 5 in 
males, both in an identical experimental setup.  
 
Proteomic analysis and data evaluation allow answering the following research questions:  
 
 
2) Is it possible to see changes in the rat liver proteome in sub-lethal and short-term 
exposure to HBCD, by using a modern gel-based proteomic method?  
 
Two-dimensional fluorescence difference gel electrophoresis (2D-DIGE), as applied in 
the presented proteomic studies, is known as a very sensitive method, allowing 
determination of small relative abundance differences between single proteins/protein 
spots in complex samples with high precision [Marouga et al., 2005; Timms and Cramer, 
2008]. These requirements are especially important in studies like the presented ones 
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where only small changes in the protein pattern were expected. The large gel size in the 
selected 2D-DIGE system resulted in complex protein spot patterns of about 3000 protein 
spots. Stringent statistical evaluation of patterns of the differently exposed animals (12 
groups of 4 animals each) revealed that the majority of spots in the patterns (> 80%) were 
of constant appearance, only a small percentage of them showing significant changes in 
abundance due to HBCD exposure, thyroid state and gender. Thus, the test system proved 
suitable for in-depth investigation of different factors of influence, as addressed in 
research questions 3 and 4.  
This was the first proteomic study investigating HBCD effects on rat liver, whereas 
previous reports described changes on the gene level, consisting of transcriptional data 
from microarrays and quantitative PCR [Cantón et al., 2008]. Such changes on the 
transcriptional level may be transient only and not translated into changes of the 
proteome at all, as has been shown in other investigations [Greenbaum et al., 2003; Tian 
et al., 2004]. Proteomics in turn has the advantage to give a functional picture of ongoing 
processes in which changed proteins are involved. Furthermore, the present investigation 
studied direct effects of short term exposure, with a lower chance to monitor also 
secondary effects of chronic exposure. Therefore, short term exposure may result in a 
different data set, better reflecting primary effects of exposure to HBCD, though it bears 
the risk of smaller changes of fewer analytes, showing only the early response.  
 
 
3) Which liver proteins and pathways are influenced by short-term exposure to 
HBCD in euthyroid versus hypothyroid animals? 
 
Though gender is the topic of research question 4, it proved to have a considerable (and 
combined) effect in response to HBCD, also in proteomic studies. In female rats, about 1 
% of all spots detected in the overall liver protein pattern were significantly altered in 
abundance due to HBCD exposure, in either ET or HT status, while in male rats very 
limited effects were found. Affected proteins were mainly related to general metabolic 
pathways like lipid metabolism, glycolysis/gluconeogenesis, and processing of different 
amino acids, but also to oxidative stress response. This confirmed findings of previous 
studies with female ET rats receiving higher doses of HBCD (daily oral exposure of 30 to 
100 mg/kg bw for 28 days) which had reported an influence on gene expression of key 
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metabolic pathways including metabolism of lipids and cholesterol as well as steroids 
[Cantón et al., 2008; van der Ven et al., 2006].  
In contrast to females, the liver proteome of male animals showed only a few 
differentially abundant protein spots, which belonged to different metabolic pathways 
with no obvious connection. Gene microarray data on chronically exposed ET rats had 
reported an influence of HBCD in lipid metabolism also in males [Cantón et al., 2008], 
whereas in the present study only a not significant influence on (the increased) serum 
leptin concentrations of HT males was noticed. This might be interpreted as a preliminary 
stage for changes in the lipid metabolism also on the protein level, possibly also as a sign 
for different susceptibility depending on thyroid status. Clear differences in gene 
expression levels of various glutathione transferases (proteins which help excrete e.g. 
xenobiotics) after 28d [Cantón et al., 2008] were also in contrast to their unchanged 
protein concentrations after one week (Chapter 5), both determined in males rats. The 
latter may be either explained by the differing exposure times (development of chronic 
effects) or by discrepancy between gene and protein levels.  
 
It is interesting to note that hypothyroid state alone has a marked impact on the protein 
pattern of female rats with similar (or no) exposure (about 1.5-3.4 % of the detected spots 
were significantly thyroid-regulated). In unexposed females proteins with changed 
abundance are connected to metabolism of various amino acids, glycolysis/gluconeo-
genesis, and especially lipid metabolism. Cantón et al. hypothesized that the reported 
effects are the indirect consequences of higher/prolonged HBCD challenge leading to 
hypothyroidism [Cantón et al., 2008; van der Ven et al., 2006]. In the present study, 
however, with a much shorter exposure period the same pathways were found influenced 
by HBCD both in ET and HT females. Reported perturbations of genes related to lipid 
and fatty acid metabolisms [Cantón et al., 2008] correlate well with proteomic findings of 
increased triglyceride catabolism in female HT, and of increased levels of the satiety 
hormone leptin, and reduced body weight. In the 3 mg/kg/day group comparison, 
additionally 5-7 proteins (mainly glutathione-S-transferases) were found differentially 
regulated, these are proteins involved in both the glutathione metabolism and the 
processing of various xenobiotics or drugs by cytochrome P450. Eleven proteins were 
consistently changed between female animals of similar exposure but different thyroid 
state. They are mostly related to stress response, lipid metabolism and detoxification 
processes and seem to be characteristic of the altered thyroid status.  
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In contrast to this, a similar evaluation of the male rat liver patterns found only a few 
single proteins affected by thyroid state, mainly involved in metabolic processes. 
 
Thus, proteomic investigation in this short-term model showed for female rats the 
following interesting findings: i) liver protein patterns reflect thyroid status, and ii) there 
is an overlap in pathways influenced by HBCD exposure and thyroid status. At the same 
time, both factors have little impact on the liver proteome of male rats, at least in short-
time exposure. This goes in parallel with values for HBCD accumulation in white 
adipose tissue, where a clear gender dependent effect (P=0.001) was noticed, with less 
accumulation in male rats. Female rats thus seem much more vulnerable to HBCD 
accumulation, and effects from both HBCD exposure as well as thyroid status.  
 
The proteomic investigation on liver thus confirms (and details) findings from previous 
studies with a much longer exposure time and higher total and often daily doses [Cantón 
et al, 2008] regarding HBCD influence on to lipid metabolism, triacylglycerol and 
cholesterol metabolism in female ET. In the reported study, especially in males, genes 
involved in phase I and II metabolism were upregulated, which the authors explained as 
the cause for lower susceptibility to HBCD of males as compared to females. In the 
present proteomic studies, no influence on corresponding proteins could be seen. This 
might be related to shorter and lower exposure as only limited differences in those gene 
levels were found at daily doses similar to our study [Cantón et al., 2008]. Similarly, 
changes in the liver weight of exposed animals were only found in female rats of the 28 
day study with high exposure [van der Ven et al., 2006] and not in our present 
experimental setup, in neither of the thyroid states.  
 
 
4) What is the impact of gender on the liver proteome? 
 
The gender aspect on the liver proteome, already demonstrated to be important in the 
previous question in relation to HBCD, was additionally studied in more depth in the 
complete proteomic data set of unexposed male and female rats. This revealed a 
considerable number of significant gender-related abundance changes in spots belonging 
to 76 proteins in ET state (corresponding to 3.6 % of all detected spots), and even to 109 
proteins in HT state (about 6.7 % of overall spots), with an almost similar number of up- 
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and downregulated proteins. The vast majority of them were connected to metabolic 
processes, but there was also a strong cluster of proteins related to cytochrome P450 
(drug metabolism, metabolism of xenobiotics) and glutathione metabolism, especially in 
ET animals. In HT animals a considerable number of proteins from the fatty acid 
metabolism were differentially affected between genders. This is confirmed by literature 
data on rat feeding experiments to investigate obesity and alcoholic steatohepatitis in rats 
[Amengual-Cladera et al., 2012; Nadal-Casellas et al., 2010; Banerjee et al., 2008, Wang 
et al., 2012]. Gender-related differences in lipid metabolism may be the reason for the 
observed different accumulation of HBCD in adipose tissue in the present studies. 
Previous studies report also gender dimorphism in liver mitochondrial oxidative 
metabolism [Borras et al., 2003, Ståhlberg et al., 2004; Justo et al., 2005], namely in 
CYP450 isoforms in microsomes [Nisar et al., 2004; Germer et al., 2006; Huang et al., 
2011]. The present proteomic study, investigating complete unfractionated liver, detected 
- though not differentially regulated CYP450 proteins - but gender-specific differences in 
proteins connected to metabolism of xenobiotics/drug metabolism, specifically members 
of the glutathione S-transferase family. It is not yet clarified whether CYP450 
concentrations were not significantly changed in the present study or whether they were 
too low abundant to be detected in the chosen setup using complete liver lysates. 
Interestingly, there is a large overlap between pathways reported in this section as 
gender-dependently regulated and the previous section about HBCD-influenced proteins. 
This leads to the hypothesis that physiological differences in protein concentrations 
between genders may be the reason for different susceptibility towards HBCD between 
male and female rats. This aspect should be detailed/deepened in further studies, also 
focusing on single pathways to further elucidate gender- and HBCD-specific reactions 
and protein modifications. Understanding this aspect will enable predictions of other 
pathways that can expected to be affected in a gender-specific way. 
 
 
Chapter 6 connects research question 4 from recent liver proteomic studies with a 
previous study on gender specific serum proteome differences of rats under control 
conditions or during inflammation. Though performed on a quite different sample set and 
not in connection to a toxicology study, results from this chapter help to discuss the 
question: 
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5) Is gender reflected in serum protein composition and what implications does this 
have on the search for biomarkers? 
 
Serum and plasma represent body fluids potentially interesting also for toxicological 
screening, allowing less invasive and multiple testing on the same individual over time, 
to study time-dependent changes in protein patterns. Protein pattern comparison in sera 
of male and female Sprague Dawley rats has been performed in a classical 2-DE setup 
with a colorimetric stain and was the first proteomic study of this effect. It was performed 
both in healthy controls and after stimulation of an acute phase reaction, i.e. induction of 
the body’s first and general reaction in defence against bacteria or viruses. In healthy 
controls about one third of the high to medium abundance proteins were shown to differ 
in concentrations in a gender-dependent way, with at least 25 % change in concentration. 
Experimentally induced inflammation influenced the overall abundance of proteins 
known to be involved in the acute phase reaction (increase of positive and decrease of 
negative acute phase proteins), mostly in a very similar way for males and females.  
Several of these inflammation markers or enzymes with inhibitory properties had also 
been detected in the gender-specifically regulated liver protein set (question 4), 
connecting the outcomes derived from the liver and the plasma samples. Similarly, serum 
protein composition reflected gender-specific differences in lipid and lipoprotein 
metabolism, namely in the distribution of serum apolipoproteins. This fits very well to 
the noticed lipid metabolism changes in liver proteins in this study and in literature. A 
few studies on rats have connected gender-dimorphism in plasma proteins with 
susceptibility to diseases such as diabetes [Choi et al., 2013], hypertension, renal and 
brain damage [Ballerio et al., 2007]), but also to protein modulation in high fat diet [Liu 
et al., 2012]. 
Serum and plasma represent body fluids potentially interesting also for toxicological 
screening, allowing less invasive and multiple testing on the same individual over time, 
to study time-dependent proteome changes. However, there are a few points to consider: 
- Serum contains large amounts of proteins with concentrations spanning over more than 
ten orders of magnitude [Anderson and Anderson, 2002]. Only a very small fraction of 
them are considered as molecules potentially interesting as reflecting health/disease 
status of organ systems, i.e. tissue leakage products. Selected and specific markers 
reflecting e.g. status of the liver have to be very well distinguishable from the 
overwhelming amount of serum proteins, and need very specific and sensitive detection. 
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Compared to abundance in the target organ, they often appear delayed in time in serum or 
altered in structure, and are likely diluted within the circulation [Hartwell et al., 2006]. 
This aim is easier to reach in chronic biomonitoring, with higher or accumulated 
compound load, but more prone to detect secondary (e.g. compensation) effects. 
Therefore, primary research will still focus on the target organ, e.g. liver, and – after 
careful validation of these findings - potentially interesting and specific marker proteins 
could in a second step be searched for in blood with a very sensitive assay.  
- Potentially interesting biomarkers need to be carefully selected to characterize the 
condition of interest (and clearly distinct from other disorders that occur frequently or to 
be easily confused with) and the regulation, taking into account also factors like age or 
life stage. Over the years proteomic studies have become more and more sensitive and 
found out that – in contrast to previous assumptions – disease or exposure induced 
alternations are seldom appearance / disappearance of proteins but are of quantitative 
nature or affect only single modifications (e.g. due to glycosylation or phosphorylation) 
or forms of a protein (e.g. truncated or breakdown products), the so-called proteoforms or 
protein species [Smith et al., 2013; Jungblut et al., 2008]. A mixture of these effects was 
also seen in serum under inflammation (Chapter 6). Proteoforms are influenced also by 
the cellular location of the protein, e.g. the secretion of a protein into blood circulation, 
compared to its appearance in liver tissue. 
- The previous paragraph already pointed out the importance of selecting appropriate 
marker proteins. An additional point to consider is that exposure to agents often leads to a 
combination of general and specific protein responses. There is a general reaction of the 
organism/cell giving rise to changes in an often similar set of proteins (general stress 
proteins as described by [Petrak et al., 2008; Wang et al., 2009]) apart from specific 
reactions such as induced by a toxic agent like PCB-153 [Berg et al., 2011]. Candidates 
of interest should ideally be related to specific responses or be a set of candidates which 
are supposed to react in a specific manner. 
 
 
Concluding remarks 
 
Proteomics is a promising analytical method presently underrepresented in toxicological 
studies, but may well contribute to gain more insight into yet not fully understood 
mechanisms. This is equally illustrated in a review on previously published studies 
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dealing with liver proteome changes due to exposure to selected organic compounds 
known to act as endocrine disruptors, and in own studies on the HBCD induced effects 
detectable in exposed rats of bother genders.  
Described investigations on the liver proteome were the first performed in a short-term 
low concentration HBCD model, selected based on literature findings, trying to avoid 
monitoring also protein changes arising from secondary effects. Clear gender dependent 
influence of HBCD was noticed, affecting primarily female rats and influencing mainly 
proteins involved in lipid metabolism, in gluconeogenesis/glycolysis and metabolism of 
different amino acids, as well as response to oxidative stress. This had till now only be 
shown at the level of gene regulation or as changed levels of metabolic products after 
longer exposure periods. Additionally, this is the first comparison on the liver proteomes 
of eu- and hypothyroid rats, showing altered levels of a number of proteins in females, 
but no marked influence in males. The largest influence in protein pattern came from 
animal gender, and involved main metabolic pathways, mainly those which were also 
affecting in HBCD exposure. Thus, it is hypothesized that those gender differences are 
also the reason for higher susceptibility of female rats indicated by other authors in 
investigations focusing on single analytes. Liver is not the only organ whose protein 
composition is influenced by gender, this effect has also been seen e.g. in serum/plasma 
(affecting lipid metabolism, but also acute phase reaction).  
The gender-specific aspects noticed in our own studies (on liver, but also serum proteins) 
and literature reports underline the importance to study toxicological effects in males and 
females, also in pharmacological models. This is in line with a recent NIH 
directive/recommendation for clinical studies [Clayton, 2014; Clayton, 2016]. 
Presented results point out not only the sensitivity of proteomics as a family of methods 
suitable to study sub-lethal toxicological effects which may cause only minor changes in 
the proteome, but also provide evidence for differences in the liver and serum proteome 
of rats, offering a good basis for further studies in this field.  
 
 
Future perspectives 
 
Basic research, on the effect of the investigated compounds, e.g. HBCD, as well as 
evaluation of gender and life stage specific baseline patterns in the sample material and 
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the influence on different parameters, e.g. gender, is paramount as a first step towards 
developing alternative biochemical methods for early detection of toxicological effects.  
Future studies should aim at deepening research in this field, for example by  
a) a follow-up of single proteins found regulated in the present studies and impact of their 
regulation of the respective pathways. 
b) by focusing on a more detailed characterization of the candidates filtered out in the 
present studies: most proteins exist in multiple proteoforms (different modifications, e.g. 
post-translational like glycosylation or phosphorylation, or breakdown products). Many 
of the proteoforms differ in their electrophoretic migration behaviour in gel-based 
proteomics and can thus be detected [Rogowska-Wrzesinska et al., 2013; Oliveira et al., 
2014]. Determination of the nature of the modification needs often sophisticated mass 
spectrometry methods which go beyond the setup for determining protein identity. Still, 
the importance of these modifications is presently more and more acknowledged, as 
studies show that 1) differently modified proteins are processed in the organism in a 
different way, and 2) the modification depends on the appearance and localization of the 
protein in the body which may change [Jungblut et al., 2016].  
c) by pre-fractionation of the samples to mine deeper into the liver proteome, e.g. to 
investigate different cell compartments (enrichment of organelles, see Chapter 2 and 
[Germer et al., 2006; Nürnberger et al, 2012]). This may for instance help to find out 
whether the lack of detecting CYP450 proteins in the present studies was due to the short 
exposure time, too variable or too low concentrations of these proteins.  
d) by investigating slightly different exposure schemes (concentration, times) to evaluate 
influence of HBCD on the proteome as a function of time.  
In chronic experiments with higher accumulated exposure, additional monitoring of the 
serum proteome would be advisable and would allow studying time-course dependent 
variations. However, prerequisite for this would be a previous selection of one or more 
promising specific candidates, preferably not generally detectable in serum (or pre-
fractionated serum). 
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Summary 
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This thesis aims at evaluating the use of proteomics in toxicological research both by 
compiling proteomic literature data on halogenated organic compounds in a review and 
by experimentally investigating effects of a model halogenated organic compound. To 
achieve this, a gel-based proteomic approach was applied to study the influence of the 
brominated flame retardant hexabromocyclododecane (HBCD) on the liver proteome of 
female and male rats of different thyroid state exposed to sub-lethal doses of this 
compound for one week. 
 
In Chapter 1 background information is presented on proteomics in general, but also 
specifically on gel-based approaches, as well as on HBCD, the chemical compound of 
interest, its industrial use and its known adverse effects, as potential risk for humans and 
environment.  
Proteomics, the study of the complete, unfiltered set of proteins in a given complex 
sample, is a modern biochemical analytical family of methods that may help to further 
elucidate underlying mechanisms of HBCD action to better understand its adverse effect. 
HBCD is a lipophilic compound that accumulates in adipose tissue from which it is only 
slowly metabolized and excreted. Although the use of HBCD has been banned in most 
European countries in 2013, it is still produced and intensively used in other industrial 
countries, mainly in the building industry. Due to its persistence, accumulation and a not 
fully understood mechanism of action, it still remains a potential risk for humans, 
animals and environment, also in countries where its use has been abolished.  
 
Proteomics can be applied as a gel-based approach (by separating proteins by two-
dimensional electrophoresis prior to identification by mass spectrometry), but also in a 
gel-free setup, where proteins are enzymatically digested into peptides which are 
separated and detected by a combination of chromatographic steps, followed by mass-
spectrometric analyses. Chapter 2 gives an overview on strategies applied in gel-based 
proteomic approaches. A variety of modifications for this separation in two successive 
steps of electrophoresis exist, depending on the sample type, analysis conditions and 
methods to detect the separated proteins. There are also a number of possibilities for 
sample pretreatment and fractionation, usually to reduce the complexity of the specimen 
and to enrich minor components. Proteins of high to medium abundance often are not the 
main molecules of interest and responsible for adverse effects noticed in 
exposure/disease. 
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Chapter 3 summarizes main strategies in the field of proteomics, stressing the specific 
needs and issues in toxicology which often investigate animal species with not 
completely annotated proteomes. Main examples to illustrate the application and 
additional benefit of proteomic methods in this field are taken from studies of 
halogenated compounds such as dioxins, polychlorinated biphenyls (PCBs), and 
polybrominated diphenyl ethers (PBDEs). Special focus is also on liver as target organ, 
as it is the main detoxifying and protein synthesizing organ and also the tissue of choice 
for investigations in the two following chapters. Compiled studies show that, due to its 
non-targeted and holistic nature, proteomics can both confirm findings of other methods 
and detect connections to not yet known to be affected proteins or pathways.  
 
Chapters 4 and 5 investigate the influence of low dose and short time orally 
administered HBCD on the liver proteome of male and female rats of different thyroid 
state (eu-, hypothyroid). High-resolution 2D-DIGE with subsequent identification of 
differentially regulated spots was performed, comparing 12 animal groups differing in 
gender, exposure and thyroid state. Findings were put in relation to basic animal data and 
hormone values.  
Chapter 4 focused on female rats and detected distinct regulation of proteins involved in 
general metabolism (carbohydrate, lipids, aminoacids), together with oxidative stress 
related reactions. This is the first study to show HBCD influence on rat liver at the 
protein level and confirms previous findings from gene regulation studies. However, it is 
also the first investigation of this kind in hypothyroid animals, being performed as it has 
been postulated in literature that an altered thyroid status will increase susceptibility to 
HBCD. In the present short-term study, exposure-induced changes in eu- and 
hypothyroid status affected similar pathways, but thyroid status per se had a much 
stronger influence on the spot pattern than exposure.  
The same experiment was also performed in male rats, as presented in Chapter 5. In 
contrast to females, hardly any regulated spots/proteins due to exposure could be 
detected, and also little influence of thyroid status on the overall protein pattern. This is 
in line with published observations of different susceptibility of male and female rats 
towards HBCD, though these experiments had been performed in longer exposure (up to 
4 times) experiments with higher doses (daily doses up to 7 times larger). Further 
investigation of unexposed control groups revealed a considerable gender-specific 
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difference in the liver protein composition with altered concentrations of protein involved 
in glycolysis/gluconeogenesis, fatty acid and metabolism of xenobiotics/drugs. These 
pathways are also the ones which are affected in females due to HBCD exposure, thus it 
can be hypothesized that their involvement may be the reason for gender-dimorphic 
reaction towards HBCD.  
 
Chapter 6 provides evidence for gender-specific protein concentration differences in rat 
serum, both under baseline conditions and in inflammation. It also links this former 
approach, on a different set of animals, to the recent studies performed in liver, as also a 
few serum proteins with known gender-dependent concentrations had been detected in 
the control group comparisons.  
 
Chapter 7 discusses the benefit and contribution of proteomics to the existing knowledge 
about HBCD specific effects in rats of both genders. Collected data demonstrate that the 
proteomic approach was successful, proving the usefulness of gel-based proteomics in 
the field of environmental proteomics. They also underline the importance of performing 
animal studies in bother genders, whereas the proteomic results can help explain and 
predict gender-specific sensitivities. Suggestions to deepen knowledge on the changed 
proteins and pathways are provided and usefulness of other sample material obtained by 
less invasive methods is discussed.  
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